THIS SHARE PURCHASE AGREEMENT is made on 10th April 2008 Between: Whereas:

Exhibit 10.5

THIS SHARE PURCHASE AGREEMENT is made on 10th April 2008

Between:

(1)

PreIPO CAPITAL PARTNERS LIMITED, a limited liability company incorporated under the laws of the British Virgin Islands whose registered office is situated at P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands (PreIPO);

(2)

MADE IN CHINA LTD., a limited liability company incorporated under the laws of the Cayman Islands whose registered office is situated at Offshore Incorporations (Cayman) Limited, Scotia Centre, 4th Floor, P.O. Box 2804, ▇▇▇▇▇▇ Town, Grand Cayman, Cayman Islands, and having registration number CR-119214 (MIC); and

Whereas:

(A) Pursuant to the Share Subscription Agreement dated 21st March 2008 (the SSA) entered into between the PreIPO and several other parties (a copy of which is appended to this Agreement), PreIPO agreed to subscribe 27,420 shares (the Shares) issued and allotted by China Linong International Limited (the Company).

(B) PreIPO wishes to nominate MIC as the subscription party of the Shares, MIC has agreed to accept such nomination and purchase the Shares, on the terms and conditions set out in this Agreement.

Now, Therefore, in consideration of the premises and mutual covenants contained herein, the parties hereto mutually agree as follows:

1.

Interpretation

Unless the context otherwise requires, words and expressions defined in the SSA shall have the same meanings where used in this Agreement and, subject as aforesaid, the provisions of Article 1 (Definition and Interpretation) of the SSA shall apply to this Agreement, mutatis mutandis, as if they were set out herein.

2.

Transfer

2.1 In consideration of the mutual undertakings contained in this Agreement, and with effect from the date of this Agreement:

(a)

MIC shall accept the transfer of the Shares in accordance with the terms and conditions of the SSA and at all times be bound by, observe and perform all of the covenants; duties, agreements, terms, conditions and obligations to be observed and performed by PreIPO in relation to the Shares under the SSA, whose terms shall be deemed incorporated herein by reference, to the extent applicable.

(b)

PreIPO shall transfer the Shares to MIC in accordance with the terms and conditions of the SSA.

Execution Version

2.2 For avoidance of doubt, the Subscription Price for the Shares shall be US$.1,999,688 which shall be paid to China Linong International Limited in accordance with the SSA by MIC.

3.

Further assurance

Each party agrees to perform (or procure the performance of) all further acts and things, and execute and deliver (or procure the execution and delivery of) such further documents, as may be required by law or as may be necessary or reasonably desirable to implement and/or give effect to this Agreement.

4.

Governing Law

This Agreement shall be governed by and construed in accordance with the laws of Hong Kong.

5.

Counterpart

This Agreement may be executed in any number of counterparts, all of which taken together shall constitute, one and the same document.

[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]

Execution Version

Appendix

Share Subscription Agreement Dated 21st March 2008

Dated ▇▇▇▇▇ ▇▇, ▇▇▇▇

▇▇▇▇▇ ▇▇▇▇▇▇ INTERNATIONAL LIMITED

SHARE SUBSCRIPTION AGREEMENT

TABLE OF CONTENTS

1.   AGREEMENT TO PURCHASE AND SELL SHARES			3
2.   CLOSINGS; DELIVERY			3
3.   REPRESENTATIONS AND WARRANTIES OF THE COMPANY, THE SUBSIDIARIES AND THE FOUNDERS			3
4.   REPRESENTATIONS AND WARRANTIES OF THE INVESTORS			13
5.   COVENANTS OF THE COMPANY, THE SUBSIDIARIES AND THE FOUNDERS			13
6.   CONDITIONS TO INVESTORS’ OBLIGATIONS AT THE CLOSING			16
7.   CONDITIONS TO COMPANY’S OBLIGATIONS AT THE CLOSING			18
8.   MISCELLANEOUS			18

[Series B Share Subscription Agreement]

CHINA LINONG INTERNATIONAL LIMITED

SERIES B PREFERRED SHARE SUBSCRIPTION AGREEMENT

THIS SERIES B PREFERRED SHARE SUBSCRIPTION AGREEMENT (tile “Agreement”) is made and entered into as of March 21, 2008, by and among:

1.		China Linong International Limited. a business company incorporated under the laws of the British Virgin islands (the “Company”);
2.		Land V, Group Limited, a business company incorporated under the laws of the British Virgin Islands (the “BVI Subsidiary”);
3.		Land V. Limited, a company incorporated under the laws of Hong Kong (“HK Subsidiary A”);
4.		Hong Kong Linong Limited, a company incorporated under the laws of Hong Kong (“HK Subsidiary B”, and collectively with HK Subsidiary A, the “HK Subsidiaries”);
5.		Each of the companies listed on EXHIBIT A hereto, each a wholly foreign owned enterprise organized under the laws of PRC (collectively, the “PRC Subsidiaries” and each, a “PRC Subsidiary”; and collectively with the BVI Subsidiary and the HK Subsidiaries, the “Subsidiaries”);
6.		Each of the individuals listed on EXHIBIT B hereto (collectively, the “Founders” and each, a “Founder” and together with the Company, the Subsidiaries, the “Warrantors” and each a “Warrantor”); and
7.		Each of the persons listed on EXHIBIT C hereto (collectively, the “Investors” and each, an “Investor”).

RECITALS:

     A. The Company owns and controls the businesses of the Subsidiaries.

     B. The Company desires to allot and issue to the Investors and the Investors desire to subscribe from the Company 329,100 Series B preferred shares, a par value of US$0.001 per share, of the Company (the “Series B Shares”) on the terms and conditions set forth in this Agreement.

     C. The BVI Subsidiary was established on March 24, 2005 under the International Business Companies Act, 1984 of the British Virgin Islands and was re-registered as a business company under the Business Companies Act, 2004 of the British Virgin Islands on January 1, 2007, with its registered address at P. O. Box, 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands;

     D. HK Subsidiary A was established on October 31, 2001 under the laws of Hong Kong with its registered address at Rooms A and B, 14/F, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇ Building, ▇▇.▇▇▇-▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇ ▇▇▇▇; HK Subsidiary B was established on November 10, 2006 under the laws

of Hong Kong with its registered address at Room 1602, Tower 1, the Metropolis Residence, ▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇ ▇▇▇, ▇▇, ▇▇▇▇ ▇▇▇▇;

     E.  The Company owns 100% of the equity interest in the BVI Subsidiary; the BVI Subsidiary owns 100% of the equity interest in the HK Subsidiaries; and HK Subsidiary A further owns 100% of the equity interest in each of the PRC Subsidiaries except for Land V. Limited (Fujian), Land V. Limited (Huizhou), Land V. Limited (Zhangjiakou), Xiamen Land V. Group Co., Ltd, and Land V. Limited (Shantou) which are directly and solely owned by the BVI Subsidiary;

     F. Land V. Limited (Fujian) (“Fujian Land V”) is a wholly foreign owned enterprise established on July 23, 2004 under the laws of the PRC with its registered address at Suite 30H, Guomao Plaza, No. ▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇;

     G. Land V. Limited (Shenzhen) (“Shenzhen Land V”) is a wholly foreign owned enterprise established on April 23, 2004 under the laws of the PRC with its registered address at No. 125 Industrial Workshop, Guowei Company, Shensha Road, Luohu District, Shenzhen, PRC;

     H. Land V. Limited (Hangzhou) is a wholly foreign owned enterprise established on September 28, 2004 under the laws of the PRC with its registered address at ▇▇. ▇▇▇-▇▇▇, ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, the Sixth Branch of Qiaosi Farm, Zhejiang Province, PRC;

     I. Land V. Limited (Tianjin) is a wholly foreign owned enterprise established on May 16, 2005 under the laws of the PRC with its registered address at North Caodian Village, Lintingkou Town, Baodi District, Tianjin, PRC;

     J. (Weifang) Land V. Limited is a wholly foreign owned enterprise established on March 22, 2005 under the laws of the PRC with its registered address at Guanwang Industrial Zone, Anqiu City, Shandong, PRC;

     K. Land V. Limited (Liaoyang) (“Liaoyang Land V”) is a wholly foreign owned enterprise established on July 7, 2004 under the laws of the PRC with its registered address at Shao-ertai Village, Guchen Jiedao, ▇▇▇▇▇▇, Liaoning Province, PRC;

     L. Land V. Limited (Huizhou) is a wholly foreign owned enterprise established on December 28, 2006 under the laws of the PRC with its registered address at Dabu Village, Pingshan, Huidong County, Huizhou, Guangdong, PRC;

     M. Land V. Limited (Zhangjiakou) is a wholly foreign owned enterprise established on October 18, 2006 under the laws of the PRC with its registered address at Miaopu Street, Guyuan County, Zhangjiakou, Hebei, PRC;

     N. Xiamen Land V. Group Co., Ltd. is a wholly foreign owned enterprise established on March 20, 2007 under the laws of the PRC with its registered address at ▇▇. ▇ ▇▇▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇ District, Huli District, Xiamen, Fujian Province, PRC;

     O. Land V. Limited (Shantou) is a wholly foreign owned enterprise established on May 9, 2007 under the laws of the PRC with its registered address at ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇, PRC; and

     N. The Subsidiaries are all engaged in the business of the production, sale and trading of agricultural and food products and related activities (“Principal Business”).

AGREEMENT

NOW, THEREFORE, in consideration of the foregoing recitals, the mutual promises hereinafter set forth, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

     1. AGREEMENT TO SUBSCRIBE AND ISSUE SHARES

          1.1. Authorization. As of the Closing (as defined below), the Company will have authorized the issuance, pursuant to the terms and conditions of this Agreement, of 329,100 Series B Shares (as defined below) having the rights, preferences, privileges and restrictions as set forth in the Amended and Restated Memorandum and Articles of Association of the Company attached hereto as EXHIBIT D (the “Restated Articles”).

          1.2. Agreement to Subscribe and Issue. Subject to the terms and conditions hereof, the Company hereby agrees to allot and issue to each Investor, and such Investor hereby agrees to subscribe from the Company, on the date of the Closing, that number of Series B Shares set forth opposite its name on EXHIBIT C at a price of US$72.9281 per share (the “Purchase Price”), amounting to an aggregate purchase price of US$24,000,637. The Series B Shares to be issued and subscribed pursuant to this Agreement will be collectively hereinafter referred to as the “Subscribed Shares” and the ordinary shares of the Company issuable upon conversion of the Subscribed Shares will be collectively hereinafter referred to as the “Conversion Shares”.

     2. CLOSINGS; DELIVERIES

          2.1. Closing. Subject to the fulfillment of the conditions to closing as set forth in Sections 6 and 7, the sale of the Subscribed Shares shall be held within seven (7) days after the date hereof at the offices of Dechert LLP at ▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇ Plaza, 3 Garden Road, Central, Hong Kong, or at such other date and place as Company and the Investors may mutually agree upon (the “Closing”).

          2.2. Deliveries. At the Closing,

               (a) the Company will deliver to each Investor, in addition to any items the delivery of which is made an express closing condition pursuant to Section 6, a certificate or certificates representing the Series B Shares to be subscribed by such Investor as set forth opposite the name of such Investor in EXHIBIT C; and

               (b) each Investor shall pay its respective portion of the Purchase Price as set forth opposite the name of such Investor in EXHIBIT C by electronic transfer of immediately available US dollar funds to the bank account of the Company, the details of which shall be provided to each Investor by the Company not less than five (5) business days prior to the Closing.

     3. REPRESENTATIONS AND WARRANTIES OF THE COMPANY, THE SUBSIDIARIES AND THE FOUNDERS

          The Company, the Subsidiaries and each Founder, jointly and severally, hereby represent and warrant to each Investor, except as set forth in the Disclosure Schedule (the “Disclosure Schedule”) attached to this Agreement as EXHIBIT E (which Disclosure Schedule shall be deemed to be representations and warranties to such Investor), as of the date hereof and the date of the Closing hereunder, as follows. In this Agreement, any reference to a party’s “knowledge”

means such party’s actual knowledge after due and diligent inquiries of officers, directors and other employees of such party reasonably believed to have knowledge of the matter in question; “Group Companies” means the Company and the Subsidiaries (each a “Group Company”).

          3.1. Organization, Standing and Qualification. Each Group Company is duly organized, validly existing and in good standing (or equivalent status in the relevant jurisdiction) under, and by virtue of, the laws of the place of its incorporation or establishment and has all requisite power and authority to own its properties and assets and to carry on its business as now conducted and as proposed to be conducted, and to perform each of its obligations hereunder and under any agreement contemplated hereunder to which it is a party. Each Group Company is qualified to do business and is in good standing (or equivalent status in the relevant jurisdiction) in each jurisdiction where failure to be so qualified would have a material adverse effect on the condition (financial or otherwise), assets relating to, or results of operation of or business (as presently conducted and proposed to be conducted) of the Group Companies, taken as whole, or of the Major Subsidiaries (as defined below), taken as a whole (a “Material Adverse Effect”). For the purpose of this Agreement, a “Major Subsidiary” shall mean any subsidiary of the Company (i) whose net asset value exceeds 25% of the net asset value of the Company on a consolidated basis, or (ii) whose net profit after tax accounts for more than 25% of the net profit after tax of the Company on a consolidated basis, in either case, to be determined by reference to the then latest audited financial statements of such subsidiary and the Company.

          3.2. Capitalization. Immediately prior to the Closing, the authorized share capital of the Company consists of the following:

               (a) Ordinary Shares. A total of 50,000,000 authorized ordinary shares, with a par value of US$0.001 per share, of the Company (the “Ordinary Shares”), of which 1,050,000 shares are issued and outstanding.

               (b) Preferred Shares. (i) A total of 215,060 Series A preferred shares and 80,710 Series A1 Shares, with a par value of US$0.001 per share, of the Company (collectively, the “Series A and A-1 Shares”), all of which are issued and outstanding; and (ii) a total of 329,100 Series B Shares, none of which are issued and outstanding immediately prior to the Closing (collectively with the Series A and A-1 Shares, the “Preferred Shares”).

               (c) Options, Warrants, Reserved Shares. Except for (i) the conversion privileges of the Subscribed Shares to be issued at the Closing and Series A and A-1 Shares, (ii) the preemptive rights provided in the Shareholders Agreement to be entered into at the Closing and attached hereto as EXHIBIT F (the “Shareholders Agreement”), (iii) 66,580 Ordinary Shares reserved for issuance upon the exercise of the option currently held by Winsome Group Limited on behalf of Ma ▇▇▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ Ho, Ma Wen Lie, ▇▇▇▇ Lo Yin, Li Jin and other officers, employees and advisors of the Company during the period from May 23, 2007 and ending on the earlier of (A) the closing date of a Qualified IPO (as defined in the Shareholders Agreement), or (B) May 23, 2017, (iv) up to 151,430 Ordinary Shares reserved for issuance upon exercise of options granted pursuant to the employee equity incentive plans approved by the compensation committee of the Company during the period from September 1, 2008 and ending on the earlier of (A), the closing date of a Qualified IPO (as defined in the Shareholders Agreement), or (B) August 31, 2011), and (v) as contemplated hereby, there are no options, warrants, conversion privileges or other rights, or agreements with respect to the issuance thereof, presently outstanding to purchase any of the shares of the Company, Apart from the exceptions noted in this Section 3.2 and the Shareholders Agreements, no shares (including the Subscribed Shares and the Conversion Shares) of the Company’s outstanding share capital, or shares issuable upon exercise or exchange of any outstanding options or other shares issuable by the Company, are subject to any preemptive rights,

rights of first refusal or other rights to purchase such shares (whether in favor of the Company or any other person).

               (d) Outstanding Security Holders. A complete and current list of all outstanding shareholders, option holders and other security holders of the Company as of the date hereof is set forth in Section 3.2(d) of the Disclosure Schedule, indicating the type and number of shares, options or other securities held by each such shareholder, option holder or other security holder.

          3.3. Subsidiaries; Group Structure. Except for the Subsidiaries, 100% of the equity interests of which are, directly or indirectly, owned by the Company, the Company does not presently own or control, directly or indirectly, any interest in any other corporation, partnership, trust joint venture, association, or other entity. The PRC Subsidiaries do not have any subsidiaries, do not own or control, directly or indirectly, any interest in any other corporation, partnership, trust, joint venture, association or other entity.

          3.4. Due Authorization. All corporate action on the part of the Company, each Subsidiary and each Founder and, as applicable, their respective officers, directors and shareholders necessary for (i) the authorization, execution and delivery of, and the performance of an obligations of the Company, each Subsidiary and each Founder under this Agreement, the Shareholders Agreement and any other agreements to which it is a party and the execution of which Is contemplated hereunder (the “Ancillary Agreements”), and (ii) the authorization, issuance, and delivery of all of the Subscribed Shares being subscribed under this Agreement and of the Ordinary Shares issuable upon conversion of such Series B Shares has been taken or will be taken prior to the Closing. Each of this Agreement, the Shareholders Agreement and the Ancillary Agreements is a valid and binding obligation of the Company, each Subsidiary and each Founder enforceable in accordance with its terms, subject, as to enforcement of remedies, to applicable bankruptcy, insolvency, moratorium, reorganization and similar laws affecting creditors’ rights generally and to general equitable principles. Neither the issuance of the Subscribed Shares nor the Ordinary Shares to be issued upon conversion thereof is subject to any preemptive rights or rights of first refusal.

          3.5. Valid Issuance of Subscribed Shares.

               (a) The Subscribed Shares, when issued and subscribed in accordance with the terms of this Agreement, will be duly and validly issued, fully paid and non-assessable.

               (b) The outstanding capital shares of the Company are duly and validly issued, fully paid and non-assessable, and all outstanding shares, options, warrants and other securities of the Company have been issued in full compliance with the requirements of all applicable securities laws and regulations.

          3.6. Liabilities. No Group Company has any indebtedness for borrowed money that it has directly or indirectly created, incurred, assumed, or guaranteed, or with respect to which the Group Company has otherwise become directly or Indirectly liable.

          3.7. Title to Properties and Assets. Each Group Company has good and marketable title to its properties and assets held in each case subject to no mortgage, pledge, lien, encumbrance, security interest or charge of any kind. With respect to the property and assets it leases, each Group Company is in compliance in all material respects with such leases and, to Its and each Founder’s Knowledge, such Group Company holds valid leasehold Interests in such assets free of any liens, encumbrances, security interests or claims of any party other than the lessors of such property and assets.

          3.8. Status of Proprietary Assets. For purpose of this Agreement, (i) “Proprietary Assets” shall mean all patents, patent applications, trademarks, service marks, trade names, domain names, copyrights, copyright registrations and applications and all other rights corresponding thereto, inventions, databases and all rights therein, all computer software including all source code, object code, firmware, development tools, flies, records and data, including all media on which any of the foregoing is stored, formulas, designs, trade secrets, confidential and proprietary information, proprietary rights, know-how and processes of a company, and all documentation related to any of the foregoing; and (ii) “Registered Intellectual Property” means all Proprietary Assets of any Group Company, wherever located, that is the subject of an application, certificate, filing, registration or other document Issued by, filed with or recorded by any government authority. Each Group Company (i) has independently developed and owns free and clear of all claims, security interests, liens or other encumbrances, or (ii) has a valid right or license to use all Proprietary Assets, including Registered Intellectual Property, necessary and appropriate for its business as now conducted and as proposed to be conducted and, to the knowledge of the Company, the Subsidiaries and the Founders, without any conflict with or infringement of the rights of others. Section 3.8 of the Disclosure Schedule contains a complete list of Proprietary Assets, including all Registered Intellectual Property but excluding know-how, of each Group Company. There are no outstanding options, licenses, agreements or rights of any kind granted by any Group Company or any other party relating to any Group Company’s Proprietary Assets, nor is any Group Company bound by or a party to any options, licenses, agreements or rights of any kind with respect to the Proprietary Assets of any other person or entity, except, in either case, for standard end-user agreements with respect to commercially readily available intellectual property such as “off the shelf computer software. No Group Company nor Founder has received any communications alleging that it has violated or, by conducting its business as proposed, would violate any Proprietary Assets of any other person or entity, nor, to the knowledge of the Company, the Subsidiaries and the Founders, is there any reasonable basis therefor. None of the Founders nor, to the knowledge of the Company, each Founder and each Subsidiary, any of the current or former officers, employees or consultants of any Group Company (at the time of their employment or engagement by a Group Company) has been or is obligated under any contract (including licenses, covenants or commitments of any nature) or other agreement, or subject to any Judgment, decree or order of any court or administrative agency, that would interfere with the use of his, her or its best efforts to promote the interests of such Group Company or that would conflict with the business of such Group Company as proposed to be conducted or that would prevent such officers, employees or consultants from assigning to such Group Company inventions conceived or reduced to practice in connection with services rendered to such Group Company. Neither the execution nor delivery of this Agreement, the Shareholders Agreement and any Ancillary, Agreement, nor the carrying on of the business of any Group Company by its employees, nor the conduct of the business of any Group Company as proposed, will, to the knowledge of the Company, each Subsidiary and each Founder, conflict with or result in, in any material respect, a breach of the terms, conditions or provisions of, or constitute a default under, any contract, covenant or instrument under which any of such employees is now obligated, including without limitation any non-compete, invention assignment or confidentiality obligations under any agreement between any Founder and any former employer of such Founder. Each Group Company and Founder believes that it will not be necessary to utilize any inventions of any of the Group Companies’ employees (or people the Group Companies currently intend to hire) made prior to or outside the scope of their employment by the relevant Group Company. No government funding, facilities, of any educational institution or research center or funding from third parties has been used in the development of any Proprietary Assets of any Group Company.

          3.9. Material Contracts and Obligations. All agreements, contracts, leases, licenses, instruments, commitments, (oral or written), indebtedness, liabilities and other obligations to which each Group Company is a party or by which it is bound that (i) are material to the conduct and

operations of its business and properties, (ii) involve any of the officers, consultants, directors, employees or shareholders of the Group Company; or (iii) obligate such Group Company to share, license or develop any product or technology are listed in Section 3.9 of the Disclosure Schedule and have been made available for inspection by the Investors and their counsel. For purposes of this Section 3.9, “material” shall mean (i) having an aggregate value, cost or amount, or imposing liability or contingent liability on any Group Company, in excess of (x) HK$3,000,000 in case of any item of capital expenditure in connection with constructing and equipping any production base or (y) HK$400,000 in any other cases, (ii) containing exclusivity, non-competition, or similar clauses that impair, restrict or impose conditions on any Group Company’s right to offer or sell products or services in specified areas, during specified periods, or otherwise, (iii) not in the ordinary course of business, (iv) transferring or licensing any Proprietary Assets to or from any Group Company (other than licenses granted in the ordinary course of business or licenses from commercially readily available “off the shelf” computer software) or (v) an agreement the termination of which would be reasonably likely to have a Material Adverse Effect.

          3.10. Litigation. There is no action, suit, proceeding, claim, arbitration or investigation (“Action”) pending (or, to the knowledge of the Company, each Subsidiary and each Founder, currently threatened) against any of the Group Companies, any Group Company’s activities, properties or assets or, to the Company’s, each Subsidiary and Founder’s knowledge, against any officer, director or employee of each Group Company in connection with such officer’s, director’s or employee’s relationship with, or actions taken on behalf of the Company, or otherwise. To the knowledge of the Company, each Subsidiary and each Founder, there is no factual or legal basis for any such Action that is likely to result, individually or in the aggregate, in any material adverse change in the business, properties, assets, financial condition, affairs or prospects of any Group Company. By way of example, but not by way of limitation, there are no Actions pending against any of the Group Companies or, to the knowledge of the Company, each Subsidiary and each Founder, threatened against any of the Group Companies, relating to the use by any employee of any Group Company of any information, technology or techniques allegedly proprietary to any of their former employers, clients or other parties. None of the Group Companies is a party to or subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality and there is no Action by any Group Company currently pending or which it intends to initiate.

          3.11. Compliance with Laws; Consents and Permits.

               (a) None of the Group Companies is in violation of any applicable statute, rule, regulation, order or restriction of any domestic or foreign government or any instrumentality or agency thereof in any material respects in respect of the conduct of its business or the ownership of its properties. All material consents, permits, approvals, orders, authorizations, or registrations, qualifications, designations, declarations or filings by or with any governmental authority and any third party which are required to be obtained or made by each Group Company and each Founder in connection with (x) the consummation of the transactions contemplated hereunder, and (y) the ordinary course of business, shall have been obtained or made prior to and be effective as of the Closing. Based in part on the representations of each of the Investors set forth in Section 4 below, the offers, sale and issuance of the Subscribed Shares in conformity with the terms of this Agreement are exempt from the registration and prospectus delivery requirements of the United States Securities Act of 1933, as amended (the “Act”), and each other analogous provision of applicable securities law. Each Group Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business as currently conducted and as proposed to be conducted, the absence of which would be reasonably likely to have a Material Adverse Effect. None of the Group Companies is in default in any material respect under any of such franchises, permits, licenses or other similar authority.

               (b) No Group Company or any Founders, director, employee or any other person acting for or on behalf of such Group Company under its express authorisation, has directly or indirectly (i) made any contribution, bribe, payoff, kickback, or any other fraudulent payment in violation of any applicable laws and regulations to any officer of any governmental authority (A) to obtain favorable treatment in securing business for such Group Company or any other member of the Group Company, to pay for favorable treatment for business secured or (B) to obtain special concessions or for special concessions already obtained, for or in respect of such Group Company or any other Group Company or (ii) established of maintained any fund or assets in which such Group Company has proprietary rights that are required by applicable laws and regulations to be recorded in the books and records of such Group Company but which have not been so recorded.

               (c) The operations of the Company and each of the Subsidiaries are and have been conducted at all times in compliance with applicable financial record keeping and reporting requirements and money laundering statutes in Hong Kong, and all other jurisdictions in which the Company and the Subsidiaries conduct business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines issued, administered, or enforced by any governmental agency, authority or body (collectively “Money Laundering Laws”) and no action, suit, proceeding by or before any governmental agency, authority or body or any arbitrator involving the Company or any of the Subsidiaries with respect to Money Laundering Laws is pending and, to the best of the Company’s knowledge, no such actions, suits or proceedings are threatened or contemplated.

          3.12. Compliance with Other Instruments and Agreements. None of the Group Companies is in, nor shall the conduct of its business as currently or proposed to be conducted result in, violation, breach or default in any material respect of any term of its constitutional documents of the respective Group Company (the “Constitutional Documents”), or any term or provision of any mortgage, indenture, contract, agreement or instrument to which the Group Company is a party or by which it may be bound, (the “Group Company Contracts”) or of any provision of any judgment, decree, order, statute, rule or regulation applicable to or binding upon the Group Company. None of the activities, agreements, commitments or rights of any Group Company is ultra ▇▇▇▇▇ or unauthorized. The execution, delivery and performance of and compliance with this Agreement, the Shareholders Agreement and any Ancillary Agreement and the consummation of the transactions contemplated hereby and thereby will not, to the knowledge of the Company, each Subsidiary and each Founder, result in any such violation, breach or default, or be in conflict with or constitute, with or without the passage of time or the giving of notice or both, either a default under any Group Company’s Constitutional Documents or any Group Company Contract, or a violation of any statutes, laws, regulations or orders, or an event which results in the creation of any lien, charge or encumbrance upon any asset of any Group Company.

          3.13. Disclosure. Each of the Group Companies and each Founder has provided each Investor with all the information that such Investor has reasonably requested for deciding whether to purchase the Subscribed Shares and all information that each of the Group Companies and the Founders believes is reasonably necessary to enable such Investor to make such decision. No representation or warranty by the Company, the Subsidiaries or any Founder in this Agreement and no information or materials provided by the Group Companies or any Founder to each Investor in connection with the negotiation or execution of this Agreement or any agreement contemplated hereby contains or will contain any untrue statement of a material fact, or omits or will omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances in which they are made, not misleading.

          3.14. Registration Rights. Except as provided in the Shareholders Agreement, neither the Company any Founder, nor any other Group Company has granted or agreed to grant

any person or entity any registration rights (including piggyback registration rights) with respect to, nor is the Company obliged to list, any of the Company’s shares (or the Subsidiaries’ shares) on any securities exchange. Except as contemplated under this Agreement and the Shareholders Agreement, there are no voting or similar agreements which relate to equity interests in the Company or the Subsidiaries.

          3.15. Insurance. Each Group Company has obtained the insurance coverage of the same types and at the same coverage levels as other similarly situated companies.

          3.16. Financial Statements. Each of the Company, the Subsidiaries and the Founders hereby represents and warrants that prior to the Closing, the Company shall have delivered to the Investors (i) consolidated unaudited management accounts for the Group Companies as of December 31, 2007 and (ii) additionally and separately, consolidated unaudited management accounts for the PRC Subsidiaries as of December 31, 2007 (the foregoing management accounts and any notes thereto are hereinafter referred to as the “Financial Statements” and December 31, 2007, the “Balance Sheet Date”). Such Financial Statements, to the knowledge of the Company, each Subsidiary and each Founder, (a) are in accordance with the books and records of the applicable Group Company and (b) are true, correct and complete and present fairly the financial condition of such Group Company at the date or dates therein indicated and the results of operations for the period or periods therein specified, and the consolidated unaudited management accounts for the PRC Subsidiaries have been prepared in accordance with PRC generally accepted accounting principles (“PRC GAAP”) applied on a consistent basis. Specifically, but not by way of limitation, the respective balance sheets of the Financial Statements disclose all of the respective Group Company’s material debts, liabilities and obligations of any nature, whether due or to become due, as of their respective dates (including, without limitation, absolute liabilities, accrued liabilities, and contingent liabilities) to the extent such debts, liabilities and obligations are required to be disclosed in accordance with the PRC GAAP. Each Group Company has good and marketable title to all assets set forth on the balance sheets of the respective Financial Statements, except for such assets as have been spent, sold or transferred in the ordinary course of business since their respective dates. Except as disclosed in the Financial Statements, none of the Group Companies or any Founder is a guarantor or indemnitor of any indebtedness of any other person or entity. Each Group Company (x) maintains and will continue to maintain a standard system of accounting established and administered in accordance with generally accepted accounting principles, and (y) maintains and will continue to maintain all books and records relating to its respective business, operations and conditions in accordance with relevant legal requirements and industry standards.

          3.17. Activities Since Balance Sheet Date. Since the Balance Sheet Date, with respect to any Group Company, there has not been:

               (a) any change in the assets, liabilities, financial condition or operating results of such Group Company from that reflected in the Financial Statements, except changes in the ordinary course of business that have not been, in the aggregate, materially adverse;

               (b) any material change in the contingent obligations of such Group Company by way of guarantee, endorsement, indemnity, warranty or otherwise;

               (c) any damage, destruction or loss, whether or not covered by insurance, materially and adversely affecting the assets, properties, financial condition, operating results, prospects or business of such Group Company (as presently conducted and as presently proposed to be conducted);

               (d) any waiver by such Group Company or any Founder of a valuable right or of a material debt;

               (e) any satisfaction or discharge of any lien, claim or encumbrance or payment of any obligation by such Group Company, except such satisfaction, discharge or payment made in the ordinary course of business that is not material to the assets, properties, financial condition, operating results or business of such Group Company;

               (f) any material change or amendment to a material contract or arrangement by which such Group Company or any of its assets or properties is bound or subject, except for changes or amendments which are expressly provided for or disclosed in this Agreement;

               (g) any material change in any compensation arrangement or agreement with any present or prospective employee, contractor or director;

               (h) any sale, assignment or transfer of any Proprietary Assets or other material intangible assets of such Group Company;

               (i) any resignation or termination of any key officer or employee of such Group Company, including any Founder;

               (j) any mortgage, pledge, transfer of a security interest in, or lien created by such Group Company or any Founder, with respect to any of such Group Company’s properties or assets, except liens for taxes not yet due or payable;

               (k) any debt, obligation, or liability incurred, assumed or guaranteed by such Group Company or any Founder, individually or in the aggregate, in excess of US$10,000, unless otherwise approved by the Investors in writing;

               (l) any declaration, setting aside or payment or other distribution in respect of any of such Group Company’s share capital, or any direct or indirect redemption, purchase or other acquisition of any of such share capital by such Group Company;

               (m) any failure to conduct business in the ordinary course, consistent with such Group Company’s past practices;

               (n) any material transactions with any of its officers, directors or employees, or any members of their immediate families, or any entity controlled by any of such individuals other than in the ordinary course of business of such Group Company;

               (o) any other event or condition of any character which could reasonably be expected to have a Material Adverse Effect; or

               (p) any agreement or commitment by such Group Company or any Founder to do any of the things described in this Section 3.17.

          3.18. Tax Matters. The provisions for taxes in the respective Financial Statements are sufficient for the payment of all accrued and unpaid applicable taxes of the covered Group Company, whether or not assessed or disputed as of the date of each such balance sheet. There have been no examinations or audits of any tax returns or reports by any applicable governmental agency. So far as each Group Company and each Founder is aware, each Group Company has duly filed all tax returns required to have been filed by it, all such tax returns are accurate, complete and

correct in all material respects, and paid all taxes shown to be due on such returns. None of the Group Companies is subject to any waivers of applicable statutes of limitations with respect to taxes for any year. Since Balance Sheet Date, none of the Group Companies has incurred any taxes, assessments or governmental charges other than in the ordinary course of business and each Group Company has made adequate provisions on its books of account for all taxes, assessments and governmental charges with respect to its business, properties and operations for such period.

          3.19. Interested Party Transactions. No Founder nor any officer or director of a Group Company or any “Affiliate” or “Associate” (as those terms are defined in Rule 405 promulgated under the Act) of any such person has any agreement (whether oral or written), understanding, proposed transaction with, or is indebted to, any Group Company, nor is any Group Company indebted (or committed to make loans or extend or guarantee credit) to any of such persons (other than for accrued salaries, reimbursable expenses or other standard employee benefits). No officer or director of a Group Company has any direct or indirect ownership interest in any firm or corporation with which a Group Company or Founder is affiliated or with which a Group Company or Founder has a business relationship, or any firm or corporation that competes with a Group Company. No Founder nor any Affiliate or Associate of any officer or director of a Group Company is directly or indirectly interested in any material contract with a Group Company. No Founder nor any officer or director of a Group Company or any Affiliate or Associate of any such person has had, either directly or indirectly, a material interest in: (a) any person or entity which purchases from or sells, licenses or furnishes to a Group Company any goods, property, intellectual or other property rights or services; or (b) any contract or agreement to which a Group Company or any Founder is a party or by which it may be bound or affected. There is no agreement between any Founder and any other shareholder with respect to the ownership or control of any Group Company.

          3.20. Employee Matters. Each of the Group Companies has complied in all material aspects with all applicable employment and labor laws. None of the Group Companies is aware that any officer or key employee intends to terminate their employment with any Group Company, nor does any Group Company have a present intention to terminate the employment of any officer or key employee. None of the Group Companies is a party to or bound by any currently effective employment contract, incentive plan, profit sharing plan, retirement agreement or other employee compensation agreement with any senior management personnel other than those set forth in the Disclosure Schedule. None of the Founders nor, to the knowledge of the Company, each Subsidiary and each Founder, any key employees of any Group Company are obligated under any contract (including licenses, covenants or commitments of any nature) or other agreement, or subject to any judgment, decree or order of any court or administrative agency, that would materially interfere with such Founder or employee’s ability to promote the interest of any Group Company or that would conflict with any Group Company’s business as proposed to be conducted. Neither the execution nor delivery of this Agreement, the Shareholders Agreement and the Ancillary Agreements, nor the carrying on of the Company’s business by the employees of the Company, nor the conduct of any Group Company’s business as now conducted and as presently proposed to be conducted, will conflict with or result in a breach of the terms, conditions, or provisions of, or constitute a default under, any contract, covenant or instrument under which any such employee is now obligated. Specifically, but not by way of limitation, the Company and Mr. Ma ▇▇▇▇▇ ▇▇▇▇ warrant and represent to the Investors that Mr. Ma ▇▇▇▇▇ ▇▇▇▇’▇ position with any Group Company, whether as a shareholder, a director, consultant or an employee, will not violate any of Mr. Ma ▇▇▇▇▇ ▇▇▇▇’▇ obligations under his previous employment agreement or other agreements with Chaoda Modern Agriculture (Holdings) Limited.

          3.21. Exempt Offering. The offer and sale of the Subscribed Shares under this Agreement are exempt from the registration or qualification requirements of all applicable securities laws and regulations, and the issuance of Ordinary Shares upon conversion of the Subscribed Shares

in accordance with the Company’s Restated Articles, will be exempt from such registration or qualification requirements.

          3.22. No Other Business. The Company was formed solely to form and hold, directly or indirectly, an equity interest in each of the Subsidiaries and since its formation has not engaged in any business and has not incurred any liability in the course of forming and holding its equity interest in the Subsidiaries. The Subsidiaries are engaged solely in the Principal Business and have no other activities.

          3.23. Minute Books. The minute books of each Group Company which have been made available to the Investors contain a complete summary of all meetings and major actions taken by directors and shareholders or owners of such Group Company since its time of formation, and reflect all transactions referred to in such minutes accurately in all material respects.

          3.24. Financial Advisor Fees. There exists no agreement or understanding between any Group Company or any of its affiliates and any investment bank or other financial advisor under which such Group Company may owe any brokerage, placement or other fees relating to the offer or sale of the Subscribed Shares.

          3.25. Other Representations and Warranties Relating to the PRC Subsidiaries.

               (a) The constitutional documents and certificates and related contracts and agreements of each of the PRC Subsidiaries are valid and have been duly approved or issued (as applicable) by the competent PRC authorities.

               (b) All material consents, approvals, authorizations or licenses required under PRC law for the due and proper establishment and operation of each of the PRC Subsidiaries have been duly obtained from the relevant PRC authorities and are in full force and effect.

               (c) So far as each Group Company and each Founder is aware, all material filings and registrations with the PRC governmental authorities required in respect of the establishment and operations of each of the PRC Subsidiaries and its operations, including but not limited to the registrations with the Ministry of Commerce, the State Administration of Industry and Commerce, the State Administration for Foreign Exchange, the State Administration of Taxation, the PRC state-owned Assets Supervision and Administration Commission and PRC customs authorities have been duly completed in accordance with the relevant rules and regulations.

               (d) Except as set forth in Section 3.25(d) of the Disclosure Schedule. the registered capital of each of the PRC Subsidiaries is fully paid up in accordance with Applicable Laws, and each capital contribution to each PRC Subsidiary has been duly verified by a certified accountant registered in the PRC and the accounting firm employing such accountant, and the report of the certified accountant evidencing such verification has been registered with the State Administration for Industry and Commerce, all in accordance with Applicable Law. HK Subsidiary A legally and beneficially owns 100% of the equity interest in each PRC Subsidiary (except for Fujian Land V, Land V. Limited (Huizhou), Land V. Limited (Zhangjiakou), Xiamen Land V. Group Co., Ltd, and Land V. Limited (Shantou), which are directly owned by the BVI Subsidiary). There are no outstanding rights, or commitments made by any of the PRC Subsidiaries to sell any of its equity interest.

               (e) None of the PRC Subsidiaries is in receipt of any letter or notice from any relevant authority notifying revocation of any permits or licenses issued to it for noncompliance or the need for compliance or remedial actions in respect of the activities carried out directly or indirectly by it.

               (f) Each of the PRC Subsidiaries has been conducting and will conduct its business activities within the permitted scope of business or is otherwise operating its business in compliance in all material respects with all relevant legal requirements and with all requisite licenses, permits and approvals granted by competent PRC authorities.

               (g) In respect of approvals, licenses or permits requisite for the conduct of any part of the business of each of the PRC Subsidiaries which are subject to periodic renewal, neither the Company or the Subsidiaries, nor any Founder has any reason to believe that such requisite renewals will not be timely granted by the relevant PRC authorities.

               (h) With regard to employment and staff or labor management, each of the PRC Subsidiaries has complied with all applicable PRC laws and regulations in all material respects, including without limitation, laws and regulations pertaining to welfare funds, social benefits, medical benefits, insurance, retirement benefits, and pensions.

     4. REPRESENTATIONS AND WARRANTIES OF THE INVESTORS

          Each Investor, severally and not jointly, represents and warrants to the Company as follows:

          4.1. Authorization. Such Investor has all requisite power, authority and capacity to enter into this Agreement and the Shareholders Agreement, and to perform its obligations under this Agreement and the Shareholders Agreement. This Agreement has been duly authorized, executed and delivered by such Investor. This Agreement and the Shareholders Agreement, when executed and delivered by such Investor, will constitute valid and legally binding obligations of the Investor, subject, as to enforcement of remedies, to applicable bankruptcy, insolvency, moratorium, reorganization and similar laws affecting creditors’ rights generally and to general equitable principles.

          4.2. Accredited Investor. Such Investor is an Accredited Investor within the definition set forth in Rule 501(a) under Regulation D of the Act.

          4.3. Purchase for Own Account. The Subscribed Shares and the Conversion Shares will be acquired for such Investor’s own account, not as a nominee or agent, and not with a view to or in connection with the immediate sale or distribution of any part thereof.

          4.4. Exempt from Registration; Restricted Securities. Such Investor understands that the Subscribed Shares and the Conversion Shares will not be registered under the Act or registered or listed publicly pursuant to any other applicable securities laws and regulations, on the ground that the sale provided for in this Agreement is exempt from registration under the Act or the registration or listing requirements of any other applicable securities laws and regulations, and that the reliance of the Company on such exemption is predicated in part on such Investor’s representations set forth in this Agreement. Such Investor understands that the Subscribed Shares and the Conversion Shares are restricted securities within the meaning of Rule 144 under the Act; that the Subscribed Shares and the Conversion Shares are not registered or listed publicly and must be held indefinitely unless they are subsequently registered or listed publicly or an exemption from such registration or listing is available.

     5. COVENANTS OF THE COMPANY, THE SUBSIDIARIES AND THE FOUNDERS.

          Each of the Company, the Subsidiaries and the Founders covenants to the Investors as follows:

          5.1. Business of the Company. The business of the Company shall be restricted to the holding, management and disposition of equity interest in the Subsidiaries.

          5.2. Business of the Subsidiaries. The business of each of the Subsidiaries shall be restricted to its respective scope of business as stated in its articles of association, business license and required for the carrying on of the Principal Business.

          5.3. Directors of the Subsidiaries. All directors (if any) of the Subsidiaries shall be appointed and removed only by the Company (or, where appropriate, as instructed by the Company) pursuant to action of the Board of Directors of the Company.

          5.4. Equity Compensation. The Company shall not directly or indirectly issue Ordinary Shares, share options or other forms of equity of the Company to employees, directors or consultants except in accordance with the employee equity compensation plans approved by the compensation committee of the Company.

          5.5. Confidentiality. Non-Competition and Invention Agreement. The Company shall cause all future key employees of the Company to enter into a Confidentiality, Non-Competition and Invention Agreement substantially in the form of EXHIBIT I of this Agreement, in form and substance satisfactory to the Investors.

          5.6. Employment Agreement. The Company shall cause all future key employees of the Company to enter into an Employment Agreement substantially in the term of EXHIBIT G of this Agreement, in form and substance satisfactory to the Investors.

          5.7. Use of Proceeds.

               (a) The proceeds from the sale of the Subscribed Shares hereunder shall be used for business expansion, research and development, production, capital expenditure and general working capital of the Company and the Subsidiaries in the Principal Business, and repayment of (a) RMB10,800,000 owed by Land V. Limited (Fujian) to Sun Jianguo, and (b) HK$10,800,000 owed by HK Subsidiary A to Ma ▇▇▇▇▇ ▇▇▇▇, and for no other purposes.

               (b) Without limiting the generality of the foregoing, the Company shall by the Closing maintain a U.S. Dollar interest-bearing account in its name with a reputable international bank in Hong Kong with an initial deposit consisting of the proceeds from the sale of the Subscribed Shares, less any expenses incurred in connection with the transactions contemplated by the Ancillary Agreements that are borne by the Company (the “Main Account”). The chief executive officer of the Company shall be the sole signatory with respect to the Main Account.

               (c) Subject to sub-Section 5.7(c)(iii) below, each payment out of the Main Account shall relate to a transaction described in the annual budget that the Board (including directors appointed by the holders of Preferred Shares) has approved of. The Main Account shall be operated as follows:

                    (i) The directors appointed by the holders of Preferred Shares need not be informed of any transaction in the Main Account of less than US$1,000,000 and that has been approved as part of the annual budget.

                    (ii) The directors appointed by the holders of Preferred Shares shall be. notified in writing by the Company of any transaction in the Main Account of US$1,000,000 or more (even If such a transaction was approved as part of the annual budget). Such transactions shall

not proceed until a director appointed by tie holders of Preferred Shares has received notification from the Company.

                    (iii) Any transaction in the Main Account that has not been approved as part of the annual budget may be carried out, provided that, the directors appointed by the holders of Preferred Shares shall be notified in writing by the Company of any such transaction. Such transactions shall not proceed until a director appointed by the holders of Preferred Shares has received notification from the Company.

          5.8. Enactment of PRC Laws and Regulations. In the event of an enactment of new PRC government policies, laws or regulations that prohibit non-PRC entities from investing in, holding or disposing of any securities in any Group Company, the Founders and the Company shall cause each relevant Group Company to enter into alternative arrangements permitted by all applicable laws and regulations in order to restructure the group structure in a manner (a) such that all or substantially all of the PRO Subsidiaries would be owned directly, or indirectly through one or more intermediaries, by a PRC joint stock company (or such other form of corporate entity), (b) such that each investor’s investment and economic interest in the Company will be adequately reflected, either directly or indirectly, in the shareholding of the PRC joint stock company (or such other form of corporate entity), and (c) that would permit a Qualified IPO.

          5.9. Post-Closing Covenants of the Warrantors. Each Warrantor shall cause the Company to, within three (3) months as of the date hereof, provide the Investors with:

               (a) evidence to the Investors’ satisfaction to prove legal title of the leases between (i) Shenzhen Land V and Zhang Qiaozhen, (ii) Liaoyang Land V and ▇▇▇ ▇▇▇▇▇, (iii) Fujian Land V and the Economic Commission of Hubei Town, (iv) Fujian Land V and the Grain Administration of Hubel Town (v) Fujian Land V and Tianjin Longtal Science and Technology Development Co., Ltd, (vi) Fujian Land V and the villager Committee of Qianyuan Village, and (vii) Fujian Land Varies Fuzhou Zhangjunlln Investment Co., Ltd;

               (b) copies of valid Hygiene Permit Certificate and Hygiene Registration Certificate issued by the relevant PRG authorities to each of the PRC Subsidiaries;

               (c) copies of valid Custom Registration Certificate and inspection Declaration Unit Registration Certificate issued by the relevant PRC authorities to each of the PRC Subsidiaries; and

               (d) evidence to the Investors’ satisfaction to prove that each of the PRC Subsidiaries has obtained all necessary examination and approval by the relevant PRC authorities: in relation to environmental protection regulations.

          5.10. Additional Covenants. Except as required by this Agreement, no resolution of the directors, owners, members, partners or shareholders of either the Company or any Subsidiaries shall be passed, nor shall any contract or commitment be entered into, in each case, prior to the Closing without the prior written consent of the Investors, except that the Company and the Subsidiaries may carry on its respective business in the same manner as heretofore and may pass resolutions and enter into contracts for so long as they are effected in the ordinary course of business.

          If at any time before the Closing, any Group Company or any Founder comes to know of any material fact or event which:

               (a) is in any way materially inconsistent with any of the representations and warranties given by the Company, the Subsidiaries or the Founders, and/or

               (b) suggests that any material fact warranted may not be as warranted or may be materially misleading, and/or

               (c) might affect the willingness of a prudent investor to purchase the Subscribed Shares or the amount of consideration which the Investors would be prepared to pay for the Subscribed Shares,

          such Group Company or such Founder shall give immediate written notice thereof to the Investors in which event each Investor may within fourteen (14) business days of receiving such notice terminate this Agreement by written notice without any penalty whatsoever and without prejudice to any rights that such investor may have under this Agreement or applicable law.

          5.11. Good Standing. Within thirty (30) calendar days after the Closing, the Company shall provide the Investors with a certificate of good standing issued by the Registry of Corporate Affairs of the British Virgin Islands certifying that the Company was duly constituted, paid all required fees and is in good legal standing.

     6. CONDITIONS TO INVESTORS’ OBLIGATIONS AT THE CLOSING.

          The obligation of each Investor to purchase its respective portion of the Subscribed Shares at the Closing as set forth opposite such Investor’s name in EXHIBIT C is subject to the fulfillment, to the satisfaction of such Investor on or prior to the Closing of the following conditions, unless waived in writing by such Investor prior to the Closing;

          6.1. Representations and Warranties True and Correct. The representations and warranties made by the Company, the Subsidiaries and the Founders herein, subject to the Disclosure Schedule, shall be true and correct and complete when made, and shall be true and correct and complete as of the date of the Closing with the same force and effect as if they had been made on and as of such date, subject to changes contemplated by this Agreement.

          6.2. Performance of Obligations. Each of the Company, the Subsidiaries and the Founders shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by it on or before the Closing:

          6.3. Proceedings and Documents. All corporate, legal and other proceedings in connection with the transactions contemplated hereby and all documents and instruments incident to such transactions shall be satisfactory in substance and form to such Investor, and such Investor shall have received all such counterpart originals or certified of other copies of such documents as it may reasonably request.

          6.4. Legal Action. No legal action is pending or have been threatened which seeks to impose liability upon any of the Group Companies by reason of the consummation of the transactions contemplated by the Ancillary Agreements to which it is a party.

          6.5 Approvals, Consents and Waivers. Each Group Company shall have obtained any and all approvals, consents and waivers necessary for consummation of the transactions contemplated by this Agreement, including, but not limited to, (i) all authorizations, approvals, consents or permits of any governmental authority or regulatory body, and (ii) the waiver by the existing shareholders of the Company of any anti-dilution rights, rights of first refusal, preemptive rights and all similar rights in connection with the issuance of the Subscribed Shares at the Closing.

          6.6. Authorisation of Un-issued Ordinary Shares. The Ordinary Shares issuable on conversion of the Series B Shares shall have been duly authorized.

          6.7 Compliance Certificate. At the Closing, the Company, each of the Subsidiaries and each Founder shall deliver to such Investor certificates, dated the date of the Closing, signed by the Company’s President or director, the respective legal representative of each of the Subsidiaries and each Founder certifying that the conditions specified in Sections 6.1, 6.2, 6.4, 6.5, and 6.6 have been fulfilled and stating that there shall have been no material adverse change in the business, affairs, prospects, operations, properties, assets or condition of the Company and the Subsidiaries, since the date of this Agreement.

          6.8. Securities Laws. The offer and sale of the Subscribed Shares to such Investors pursuant to this Agreement shall be exempt from the registration and/or qualification requirements of all applicable securities laws.

          6.9. Amendment to Constitutional Documents. The Restated Articles shall have been duly adopted by the Company by all necessary corporate action of its Board of Directors and its shareholders and duly filed with the Registry of Corporate Affairs in the British Virgin Islands. Such Investors shall have received a copy of the adopted Restated Articles, certified by a director of the Company as true and complete as of the date of Closing.

          6.10. Register of Members, Such Investors shall have received a copy of the Company’s register of members, certified by a director of the Company as true and complete as of the date of the Closing, updated to show such Investors as the holders of its respective number of Subscribed Shares as set forth opposite its name in EXHIBIT C as of the Closing.

          6.11. Appointment of Directors. As of the Closing, the Board of Directors of the Company shall consist of Ma ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇ ▇▇, ▇▇ ▇▇▇, ▇▇▇ ▇▇▇▇ Ho, ▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇ ▇. ▇▇▇▇, and ▇▇▇▇▇▇▇ ▇▇▇▇. The Investors shall have received a copy of the Company’s register of directors, certified by a director of the Company as true and complete as of the date of the Closing, reflecting the board composition set forth in this Section 6.11. Each Investor shall have received a deed of indemnity in substantially the form attached as EXHIBIT J, duly executed by the Company in favor of ▇▇▇ ▇. ▇▇▇▇ and ▇▇▇▇▇▇▇ ▇▇▇▇.

          6.12. Bank Account Signatories. The Company shall have caused all existing and shall cause all future bank signatory arrangements in respect of the Company’s Main Account to be established or amended to conform with the provisions of Section 5.7.

          6.13. Opinions of Company’s Counsels. Such Investors shall have received from British Virgin Islands, Hong Kong, and PRC counsels to the Group Companies opinions addressed to such Investors, dated the date of the Closing, in form and substance satisfactory to such Investors.

          6.14. Execution of Shareholders Agreement. The Company shall have delivered to the Investors the Shareholders Agreement, duly executed by the Company and all other parties thereto (except for the Investors).

          6.15. Employment Agreement. Each of Ma ▇▇▇▇▇ ▇▇▇▇ and ▇▇▇▇ ▇▇ shall have entered into an Employment Agreement substantially in the form of EXHIBIT G of this Agreement, in form and substance satisfactory to the Investors.

          6.16. Due Diligence. Such Investors shall have completed all business, legal, financial due diligence investigation of the Group Companies to its satisfaction and the Company shall have delivered to the Investors all due diligence materials requested by such Investors.

          6.17. No Material Adverse Effect. There shall have been no Material Adverse Effect since the date of this Agreement.

     7. CONDITIONS TO COMPANY’S OBLIGATIONS AT THE CLOSING

          The obligations of the Company under this Agreement to each such Investor are subject to the fulfillment by all investors at or before the Closing of the following conditions, unless waived in writing by the Company. For the avoidance of doubt, the obligations of the Company under this Agreement are subject to the fulfillment of these conditions by all the Investors on the Closing Date.

          7.1. Representations and Warranties. The representations and warranties of such Investor contained in Section 4 hereof shall be true and correct as of the Closing.

          7.2. Securities Exemptions. The offer and sale of the Subscribed Shares to such Investors pursuant to this Agreement shall be exempt from the registration and/or qualification requirements of all applicable securities laws.

          7.3. Execution of Shareholders Agreement. Each Investor shall have executed and delivered to the Company the Shareholder Agreement.

     8. MISCELLANEOUS

          8.1. Governing Law. This Agreement shall be governed by and construed under the substantive laws of the Hong Kong Special Administrative Region, without regard to the conflicts of laws rules thereof.

          8.2. Survival. The representations, warranties, covenants and agreements made herein shall survive any investigation made by any party hereto and the closing of the transactions contemplated hereby.

          8.3. Successors and Assigns. Except as otherwise expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto whose rights or obligations hereunder are affected by such amendments. This Agreement and the rights and obligations therein may not be assigned by any Investors without the written consent of the Company except that an Investor may assign its rights hereunder to a parent corporation, a subsidiary, an affiliate, its fund manager or other funds managed by its fund manager. This Agreement and the rights arid obligations therein may not be assigned by the Company, any Subsidiary or any Founder without the written consent of each Investor.

          8.4. Indemnity. Subject to Section 8.5 of this Agreement, the Company, each of the Subsidiaries and each Founder (each, an “indemnifying Party”), jointly and severally, hereby agree to indemnify and hold harmless each Investor, such Investor’s directors, officers, employees, Affiliates, agents and assigns (each, an “Indemnitee”), against any and all Indemnifiable Losses to such Indemnitee, directly or indirectly, as a result of, or based upon or arising from any inaccuracy in or breach or nonperformance of any of the representations, warranties, covenants or agreements made by the Company, each Subsidiaries or any of the Founders in or pursuant to this Agreement and any Ancillary Agreement. For purposes of this Section, “Indemnifiable Loss” means, with respect to any Indemnitee, any action, cost, damage, disbursement, expense, liability, loss, deficiency, obligation, penalty or settlement of any kind or nature, including, but not limited to, (i) interest or other carrying costs, penalties, legal, accounting and other professional fees and expenses reasonably incurred in the investigation, collection, prosecution and defense of claims and amounts paid in settlement, that may be imposed on or otherwise incurred or suffered by such Indemnitee and (ii) any taxes (other than income tax) that may be payable by such Indemnitee as a result of the indemnification of any Indemnifiable Loss hereunder. The amount of any payment to any such Indemnified Party shall be sufficient to make such Indemnified Party whole for any diminution in value of the Subscribed Shares. Each Indemnitee may elect to make a claim for indemnification under this Section against any Indemnifying Party in its sole discretion.

          8.5. Limitation of liabilities.

               (a) None of the Investors or any of their respective directors, officers, employees. Affiliates, agents or assigns (together, the “Claimants”) shall be entitled to claim that any fact causes any of the representations and warranties in section 3 of this Agreement to be breached or renders any inaccurate or misleading if it has been fully, fairly and specifically disclosed in the Disclosure Schedule in the absence of any fraud or dishonesty on the part of any of the Company, the Subsidiaries or the Founders.

               (b) Any liability on the part of the Company, the Subsidiaries or the Founders in respect of any claim for breach of any provision of (including, without limitation, any of the representations and warranties in section 3) or under any indemnity set out in this Agreement shall be subject to the following limitations:

                    (i) the aggregate liability of the Company, the Subsidiaries and the Founders for breach of this Agreement or under any indemnity set out in this Agreement shall not in any event exceed the aggregate Purchase Price set forth in EXHIBIT C plus all accrued or declared but unpaid dividends on the Series B Shares;

                    (ii) no matter shall be the subject of a claim to the extent that specific allowance, provision or reserve in respect of such matter shall have been made in the accounts of the Company for the accounting reference period ended on March 31, 2007;

                    (iii) where the matter or default giving rise to a claim is capable of remedy, no claim shall be initiated against any of the Company, the Subsidiaries or the Founders unless notice of the matter or default is given to the Company and the matter or default (where capable of being remedied) is not remedied to the reasonable satisfaction of such person within 30 calendar days after the date on which such notice is given; and

                    (iv) in respect of any matter which may give rise to a liability under any claim, no such liability shall be met more than once.

          8.6. Entire Agreement. This Agreement, the Shareholders Agreement, any Ancillary Agreements, and the schedules and exhibits hereto and thereto, which are hereby expressly incorporated herein by this reference constitute the entire understanding and agreement between the parties with regard to the subjects hereof and thereof; provided, however, that nothing in this Agreement or related agreements shall be deemed to terminate or supersede the provisions of any confidentiality and nondisclosure agreements executed by the parties hereto prior to the date hereof, which agreements shall continue in full force and effect until terminated in accordance with their respective terms.

          8.7. Notices. Except as may be otherwise provided herein, all notices, requests, waivers and other communications made pursuant to this Agreement shall be in writing and shall be conclusively deemed to have been duly given (a) when hand delivered to the other party, upon delivery; (b) when, sent by facsimile at the number set forth in EXHIBIT H hereto, upon receipt of confirmation of error-free transmission; (c) seven (7) business days after deposit in the mail as air mail or certified mail, receipt requested, postage prepaid and addressed to the other party as set forth in EXHIBIT H; or (d) three (3) business days after deposit with an overnight delivery service, postage prepaid, addressed to the parties as set forth in EXHIBIT H with next business-day delivery guaranteed, provided that the sending party receives a confirmation of delivery from the delivery service provider.

          Each person making a communication hereunder by facsimile shall promptly confirm by telephone to the person to whom such communication was addressed each communication made by it by facsimile pursuant hereto but the absence of such confirmation shall not affect the validity of any such communication. A party may change or supplement the addresses given above, or designate additional addresses, for purposes of this Section 8.7 by giving the other party written notice of the new address in the manner set forth above.

          8.8. Amendments and Waivers. Any term of this Agreement may be amended only with the written consent of the Company, the Subsidiaries, each Founder and each Investor.

          8.9. Delays or Omissions. No delay or omission to exercise any right, power or remedy accruing to the Company, any Subsidiary, any Founder or the Investors, upon any breach or default of any party hereto under this Agreement, shall impair any such right, power or remedy of the Company, such Subsidiary, such Founder or the Investors nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of any similar breach of default thereafter occurring; nor shall any waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind, or character on the part of the Company, any Subsidiary, any Founder or the Investors of any breach of default under this Agreement or any waiver on the part of the Company, any Subsidiary, any Founder or the investors of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement, or by law or otherwise afforded to the Company, the Subsidiaries, the Founders and the Investors shall be cumulative and not alternative.

          8.10. Interpretation; Titles and Subtitles. This Agreement shall be construed according to its fair language. The rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be employed in interpreting this Agreement. The titles of the sections and subsections of this Agreement are for convenience of reference only and are not to be considered in construing this Agreement. Unless otherwise expressly provided herein, all references to Sections and Exhibits herein are to Sections and Exhibits of this Agreement.

          8.11. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be an original, but all of which together shall constitute one instrument.

          8.12. Severability. If any provision of this Agreement is found to be invalid or unenforceable, then such provision shall be construed, to the extent feasible, so as to render the provision enforceable and to provide for the consummation of the transactions contemplated hereby on substantially the same terms as originally set forth herein, and if no feasible interpretation would save such provision, it shall be severed from the remainder of this Agreement, which shall remain in full force and effect unless the severed provision is essential to the rights or benefits intended by the parties. In such event, the parties shall use best efforts to negotiate, in good faith, a substitute, valid and enforceable provision or agreement which most nearly effects the parties’ intent in entering into this Agreement.

          8.13. Confidentiality and Non-Disclosure. The parties hereto agree to be bound by the confidentiality and non-disclosure provisions of Section 6 of the Shareholders Agreement.

          8.14. Further Assurances. Each party shall from time to time and at all times hereafter make, do, execute, or cause or procure to be made, done and executed such further acts, deeds, conveyances, consents and assurances without further consideration, which may reasonably be required to effect the transactions contemplated by this Agreement.

          8.15. Dispute Resolution.

               (a) Negotiation Between Parties. The parties agree to negotiate in good faith to resolve any dispute between them regarding this Agreement. If the negotiations do not resolve the dispute to the reasonable satisfaction of all parties within thirty (30) calendar days after the commencement of the negotiation, Section 8.15(b) shall apply.

               (b) Arbitration. In the event the parties are unable to settle a dispute between them regarding this Agreement in accordance with subsection (a) above, such dispute shall he referred to and finally settled by arbitration at the Hong Kong International Arbitration Centre in accordance with the UNCITRAL Arbitration Rules (the “UNCITRAL Rules”) in effect, which rules are deemed to be incorporated by reference into this subsection (b). The arbitration tribunal shall consist of three arbitrators to be appointed according to the UNCITRAL Rules. The language of the arbitration shall be English.

          8.16. Expenses. At the Closing, the Company shall reimburse the Investors the legal expenses of up to a total amount of US$100,000 in aggregate incurred by the Investors, which payment shall be made directly to the legal adviser to the Investors at the Closing. In default of which, the investors may effect such reimbursement at the Closing by withholding from the payment of the Purchase Price the amount to which they are each entitled to reimbursement pursuant to the preceding sentence. Notwithstanding the withholding of such amount, the investors shall be deemed to have paid to the Company the full amount of the Purchase Price, including the amount so withheld.

          8.17. Termination. The obligations of any Investor pursuant to this Agreement may be terminated by such Investor and the transactions contemplated hereunder abandoned by such Investor, at any time on or after June 30, 2008, by written notice to the Company, if the Closing has not occurred on or prior to such date. Any termination under this Section 8.17 shall be without prejudice to any claims for damages or other remedies that the parties may have under this Agreement or applicable law.

[Remainder of this page intentionally left blank]

     IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

[Signature Page to Series B Share Subscription Agreement]

     IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

By the Founders:
/s/ Ma ▇▇▇▇▇ ▇▇▇▇
Ma ▇▇▇▇▇ ▇▇▇▇		▇▇▇▇ ▇▇

[Signature Page to Series B Share Subscription Agreement]

     IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

By the Founders:
		/s/ Luan ▇▇
▇▇ ▇▇▇▇▇ ▇▇▇▇		▇▇▇▇ ▇▇

[Signature Page to Series B Share Subscription Agreement]

     IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

By the BVI Subsidiary and HK Subsidiaries:

Land V. Group Limited

Land V. Limited

By:

/s/ Ma ▇▇▇▇▇ ▇▇▇▇

By:

/s/ Ma ▇▇▇▇▇ ▇▇▇▇

Name:

Ma ▇▇▇▇▇ ▇▇▇▇

Name:

Ma ▇▇▇▇▇ ▇▇▇▇

Title:

Director

Title:

Director

[Signature Page to Series B Share Subscription Agreement]

      IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

By the PRC Subsidiaries:
Land V. Limited (Fujian)				Land V. Limited (Shenzhen)
By:		/s/ ▇▇▇▇ ▇▇		By:		/s/ ▇▇▇▇ ▇▇
		Name: ▇▇▇▇ ▇▇				Name: ▇▇▇▇ ▇▇
		Title: Legal Representative				Title: Legal Representative
Land V. Limited (Hangzhou)				Land V. Limited (Tianjin)
By:		/s/ ▇▇▇▇ ▇▇		By:		/s/ ▇▇▇▇ ▇▇
		Name: ▇▇▇▇ ▇▇ Title: Legal Representative				Name: ▇▇▇▇ ▇▇ Title: Legal Representative
(Welfang) Land V. Limited				Land V. Limited (Liaoyang)
By:		/s/ ▇▇▇▇ ▇▇		By:		/s/ ▇▇▇▇ ▇▇
		Name: ▇▇▇▇ ▇▇ Title: Legal Representative				Name: ▇▇▇▇ ▇▇ Title: Legal Representative
Land V. Limited (Huizhou)				Land V. Limited (Zhangjiakou)
By:				By:
		Name:				Name:
		Title:				Title:
Xiamen Land V. Group Co., Ltd.				Land V. Limited (Shantou)
By:				By:
		Name:				Name:
		Title:				Title:

[Signature Page to Series B Share Subscription Agreement]

      IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

By the PRC Subsidiaries:
Land V. Limited (Fujian)				Land V. Limited (Shenzhen)
By:				By:
		Name:				Name:
		Title:				Title:
Land V. Limited (Hangzhou)				Land V. Limited (Tianjin)
By:				By:
		Name:				Name:
		Title:				Title:
(Welfang) Land V. Limited				Land V. Limited (Liaoyang)
By:				By:
		Name:				Name:
		Title:				Title:
Land V. Limited (Huizhou)				Land V. Limited (Zhangjiakou)
By:		/s/ Ma ▇▇▇▇▇ ▇▇▇▇		By:		/s/ Ma ▇▇▇▇▇ ▇▇▇▇
		Name: Ma ▇▇▇▇▇ ▇▇▇▇				Name: Ma ▇▇▇▇▇ ▇▇▇▇
		Title: Legal Representative				Title: Legal Representative
Xiamen Land V. Group Co., Ltd.				Land V. Limited (Shantou)
By:		/s/ Ma ▇▇▇▇▇ ▇▇▇▇		By:		/s/ Ma ▇▇▇▇▇ ▇▇▇▇
		Name: Ma ▇▇▇▇▇ ▇▇▇▇				Name: Ma ▇▇▇▇▇ ▇▇▇▇
		Title: Legal Representative				Title: Legal Representative

[Signature Page to Series B Share Subscription Agreement]

     IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

By the Investors:

[Signature Page to Series B Share Subscription Agreement]

     IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

By the Investors:

[Signature Page to Series B Share Subscription Agreement]

     IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

By the Investors:

[Signature Page to Series B Share Subscription Agreement]

     IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

By the Investors:

[Signature Page to Series B Share Subscription Agreement]

LIST OF EXHIBITS

Exhibit A		Schedule of PRC Subsidiaries
Exhibit B		Schedule of Founders
Exhibit C		Schedule of Investors
Exhibit D		Restated Articles
Exhibit E		Disclosure Schedule
Exhibit F		Shareholders Agreement
Exhibit G		Employment Agreement
Exhibit H		Notices
Exhibit I		Confidentiality, Non-Competition and Invention Agreement
Exhibit J		Deed of Indemnity

[Series B Share Subscription Agreement]

EXHIBIT A

SCHEDULE OF PRC SUBSIDIARIES

1.		Land V. Limited (Fujian)
2.		Land V. Limited (Shenzhen)
3.		Land V Limited (Hangzhou)
4.		Land V Limited (Tianjin)
5.		Land V. Limited (Liaoyang)
6.		(Weifang) Land V. Limited
7.		Land V. Limited (Zhangjiakou)
8.		Land V. Limited (Huizhou)
9.		Xiamen Land V. Group Co., Ltd.
10.		Land V. Limited (Shantou)

[Series B Share Subscription Agreement]

EXHIBIT B

SCHEDULE OF FOUNDERS

1.		Ma ▇▇▇▇▇ ▇▇▇▇
2.		▇▇▇▇ ▇▇

[Series B Share Subscription Agreement]

EXHIBIT C

SCHEDULE OF INVESTORS

Investor		No. of Series B Shares				Purchase Price (US$)
SIG China Investments One, Ltd.			130,270			US$	9,500,344
▇▇▇▇▇▇ International			95,990			US$	7,000,368
Pacven ▇▇▇▇▇▇ Ventures VI, L.P.			89,056			US$	6,494,685
Pacven ▇▇▇▇▇▇ Ventures Parallel VI, L.P.			6,934			US$	505,683
Sequoia Capital China Growth Fund I, L.P.			75,420			US$	5,500,237
PreIPO Capital Partners Limited			27,420			US$	1,999,688
TOTAL			329,100			US$	24,000,637

[Series B Share Subscription Agreement]

EXHIBIT D

RESTATED ARTICLES

[ATTACHED]

[Series B Share Subscription Agreement]

BVI COMPANY NUMBER: 1017713

TERRITORY OF THE BRITISH VIRGIN ISLANDS
▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇, ▇▇▇▇

AMENDED AND RESTATED
MEMORANDUM AND ARTICLES

OF ASSOCIATION

OF

A COMPANY LIMITED BY SHARES

Incorporated on the 24th day of March, 2006

INCORPORATED IN THE BRITISH VIRGIN ISLANDS

TERRITORY OF THE BRITISH VIRGIN ISLANDS
THE BVI BUSINESS COMPANIES ACT, 2004

AMENDED AND RESTATED
MEMORANDUM OF ASSOCIATION

OF

China Linong International Limited

A COMPANY LIMITED BY SHARES

1.		DEFINITIONS AND INTERPRETATION
1.1.		In this Memorandum of Association and the attached Articles of Association, if not inconsistent with the subject or context:

“Act” means the BVI Business Companies Act, 2004 (No. 16 of 2004) and includes the regulations made under the Act;

“Articles” means the attached Articles of Association of the Company;

“BVI Subsidiary” means Land V. Group Limited;

“Capital” means the sum of the aggregate par value of all outstanding shares with par value of the Company and shares with par value held by the Company as treasury shares plus (a) the aggregate of the amounts designated as capital of all outstanding shares without par value of the Company and shares without par value held by the Company as treasury shares, and (b) the amounts as are from time to time transferred from surplus to capital by a resolution of directors;

“Chairman of the Board” has the meaning specified in Regulation 12;

“Distribution” in relation to a distribution by the Company to a Shareholder means the direct or indirect transfer of an asset, other than Shares, to or for the benefit of the Shareholder, or the incurring of a debt to or for the benefit of a Shareholder, in relation to Shares held by a Shareholder, and whether by means of the purchase of an asset, the purchase, redemption or other acquisition of Shares, a transfer of indebtedness or otherwise, and includes a dividend;

“Eligible Person” means individuals, corporations, trusts, the estates of deceased individuals, partnerships and unincorporated associations of persons;

“Existing Ordinary Shareholders” means Grow Grand Limited, Magnetic Star Holdings Limited, Limewater Limited, Natural Eternity Limited, Valuetrue Investments Limited., Win Seasons Finance Ltd., Honeycomb Assets Management Limited., Natural Scent Limited.

“Group Companies” means the Company and its Subsidiaries, and each a “Group Company”;

“HK Subsidiary A” means Land V. Limited;

“HK Subsidiary B” means Hong Kong Linong Limited;

“HK Subsidiaries” means HK Subsidiary A and HK Subsidiary B;

“Investors” means members holding Preferred Shares;

“majority” means 50% or more votes of each class of shares or 50% or more votes of the directors;

“Major Subsidiary” means any subsidiary of the Company (i) whose net asset value exceeds 25% of the net asset value of the Company on a consolidated basis, or (ii) whose net profit after tax accounts for more than 25% of the net profit after tax of the Company on a consolidated basis, in either case, to be determined by reference to the then latest audited financial statements of such subsidiary and the Company;

“Memorandum” means this Memorandum of Association of the Company;

“Ordinary Shares” mean the ordinary shares with the par value of US$0.001 each in the capital of the Company;

“person” means an individual, a corporation, a trust, the estate of a deceased individual, a partnership or an unincorporated or association of persons;

“PRC Subsidiaries” mean Land V. Limited (Fujian), Land V. Limited (Shenzhen), Land V. Limited (Hangzhou), Land V. Limited (Tianjin); Land V. Limited (Liaoyang), (Weifang) Land V. Limited, Land V. Limited (Zhangjiakou), Land V. Limited (Huizhou), Xiamen Land V. Group Co., Ltd., Land V. Limited (Shantou);

“Preferred Shares” mean Series A Shares, Series A1 Shares and Series B Shares, collectively;

“Registrar” means the Registrar of Corporate Affairs appointed under section 229 of the Act;

“Resolution of Directors” means either:

	(a)		a resolution approved at a duly convened and constituted meeting of directors of the Company or of a committee of directors of the Company by the affirmative vote of a majority of the directors present at the meeting who voted except that where a director is given more than one vote, he shall be counted by the number of votes he casts for the purpose of establishing a majority; or
	(b)		a resolution consented to in writing by all directors of by all members of a committee of directors of the Company, as the case may be;

“Resolution of Shareholders” means either;

	(a)		Unless otherwise provided by the Memorandum or the Articles, a resolution approved at a duly convened and constituted meeting of the Shareholders of the Company by the affirmative vote of (i) a majority of the votes of the shares entitled to vote thereon which were present at the meeting and were voted and not abstained, or (ii) a majority of the votes of each class or series of shares which were present at the meeting and entitled to vote thereon as a class or series and were voted and not abstained and of a simple majority of the votes of the remaining shares entitled to vote thereon which were present at the meeting and were voted and not abstained; or
	(b)		a resolution consented to in writing by (i) an absolute majority of the votes of shares entitled to vote thereon, or (ii) an absolute majority of the votes of each class or series of shares entitled to vote thereon as a class or series and of an absolute majority of the votes of the remaining shares entitled to vote thereon;

“Seal” means any seal which has been duly adopted as the common seal of the Company;

“Securities” mean Shares and debt obligations of every kind of the Company, and including without limitation options, warrants and rights to acquire Shares or debt obligations;

“Series A issue Price” means US$18.59950 per Series A Share;

“Series A Original Issue Date” means the date of the first sale and issuance of Series A Shares;

“Series A Shares” mean Series A preferred shares with a par value of US$0.001 each in the capital of the Company having the rights set forth in the Memorandum and the Articles;

“Series A1 Issue Price” means US$49.56015 per Series A1 Share;

“Series A1 Original Issue Date” means the date of the first sale and issuance of Series A1 Shares;

“Series A1 Shares” mean Series A1 preferred shares with a par value of US$0.001 each in the capital of the Company having the rights set forth in the Memorandum and the Articles;

“Series B Issue Price” means US$72.9281 per Series B Share;

“Series B Original Issue Date” means the date of the first sale and issuance of Series B Shares;

“Series B Shares” mean Series B preferred shares with a par value of US$0.001 each in the capital of the Company having the rights set forth in the Memorandum and the Articles;

“Share” means a share issued or to be issued by the Company;

“Shareholder” means an Eligible Person whose name is entered in the register of members of the Company as the holder of one or more Shares or fractional Shares;

“Special Resolution” means a resolution passed by the holders of at least seventy-five percent (75%) of the then outstanding Shares, on an as converted basis;

“Subsidiaries” mean the BVI Subsidiary, the PRC Subsidiaries and the HK Subsidiaries;

“surplus” means the excess, if any, at the time of the determination of the total assets of the Company over the aggregate of its total liabilities, as shown in its books of account, plus the Company’s capital;

“Treasury Share” means a Share that was previously issued but was repurchased, redeemed or otherwise acquired by the Company and not cancelled; and

“Written” or any term of like import includes information generated, sent, received or stored by electronic, electrical, digital, magnetic, optical, electromagnetic, biometric or photonic means; including electronic data interchange, electronic mail, telegram, telex or telecopy, and “in writing” shall be construed accordingly.

1.2.

In the Memorandum and the Articles, unless the context otherwise requires a reference to:

	(a)		a “Regulation” is a reference to a regulation of the Articles;
	(b)		a “Clause” is a reference to a clause of the Memorandum;
	(c)		voting by Shareholders is a reference to the casting of the votes attached to the Shares held by the Shareholder voting;
	(d)		the Act, the Memorandum or the Articles is a reference to the Act or those documents as amended or; in the case of the Act, any re-enactment thereof; and
	(e)		the singular includes the plural and vice versa.

1.3.		Any words or expressions defined in the Act unless the context otherwise requires bear the same meaning in the Memorandum and the Articles unless otherwise defined herein.
1.4.		Headings are inserted for convenience only and shall be disregarded in interpreting the Memorandum and the Articles.
2.		NAME

        The name of the Company is China Linong international Limited.

3.

STATUS

        The Company is a company limited by Shares.

4.		REGISTERED OFFICE AND REGISTERED AGENT
4.1.		The registered office of the Company is at P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands, the office of the first registered agent.
4.2.		The registered agent of the Company is Offshore Incorporations Limited of P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands.
4.3.		The Company may by Resolution of Shareholders or by Resolution of Directors change the location of its registered office or change its registered agent.
4.4.		Any change of registered office or registered agent will take effect on the registration by the Registrar of a notice of the change filed by the existing registered agent or a legal practitioner in the British Virgin Islands acting on behalf of the Company.
5.		CAPACITY AND POWERS
5.1.		Subject to the Act and any other British Virgin Islands legislation, the Company has, irrespective of corporate benefit:

	(a)		full capacity to carry on or undertake any business or activity, do any act or enter into any transaction; and
	(b)		for the purposes of paragraph (a) full rights, powers, and privileges,

5.2.		For the purposes of section 9(4) of the Act, there are no limitations on the business that the Company may carry on.
6.		NUMBER AND CLASSES OF SHARES
6.1.		Shares in the company shall be issued in the currency of the United States of America.
6.2.		The Company is authorised to issue a maximum of 50,624,870 shares divided into 50,000,000 Ordinary Shares with a par value of US$0.001 each, 215,060 Series A Shares with a par value of US$0.001 each, 80,710 Series A1 Shares with a par value of US$0.001 each, and 329,100 Series B Shares with a par value of US$0.001 each.
6.3.		The Company may issue fractional Shares and a fractional Share shall have the corresponding fractional rights, obligations and liabilities of a whole Share of the same class or series of Shares.
6.4.		Shares may be issued in one or more series of Shares as the directors may by Resolution of Directors determine from time to time.
7.		RIGHTS OF SHARES
7.1.		Each Ordinary Share in the Company confers upon the Shareholder:

	(a)		the right to one vote at a meeting of the Shareholders of the Company or on any Resolution of Shareholders;
	(b)		subject to the rights of the Preferred Shares, the right to an equal share in any dividend paid by the Company; and
	(c)		subject to the rights of the Preferred Shares, the right to an equal share in the distribution of the surplus assets of the Company on its liquidation.

7.2.		The Company may by Resolution of Directors redeem, purchase or otherwise acquire all or any of the Shares in the Company subject to Regulation 3 of the Articles.
7.3.		The Preferred Shares shall have the following rights:-

	(a)		Dividends. The holders of the Preferred Shares shall be entitled to receive out of any funds legally available therefor, if and when declared by the Board of Directors of the Company (the “Board”), dividends at the rate or in the amount as the Board considers appropriate in preference to any dividend on any other class or series of shares of the Company; provided that no dividend shall be paid on any other class or series of shares of the Company unless and until a dividend in like amount is first paid in full on the Series B Shares (on an as-converted basis). Holders of the Preferred Shares shall also be entitled to receive any non-cash dividends declared by the Board on an as-converted basis.
	(b)		liquidation Preference.

(1) in the event of any liquidation, dissolution or winding up of any Group Company (other than a liquidation, dissolution or winding up of a Subsidiary that has been approved by the Shareholders as part of a restructuring for the benefit of the Company), either voluntary or involuntary, the holders of the Series B Shares shall be entitled to receive, prior to any distribution to other holders of Preferred Shares and holders of the Ordinary Shares or any other class or series of shares, an amount per Series B Share equal to 100% of the Series B Issue Price (as adjusted for share dividends, splits, combinations, recapitalizations or similar events) plus all accrued or declared but unpaid dividends thereon (the “Series B Preference Amount”). After the full distribution of the Series B Preference Amount, holders of Series A1 Shares shall be entitled to receive, prior to any distribution to holders of Series A Shares and holders of the Ordinary Shares or any other

class or series of shares, an amount per Series A1 Share equal to 100% of the Series A1 Issue Price (as adjusted for share dividends, splits, combinations, recapitalizations or similar events) plus all accrued or declared but unpaid dividends thereon (the “Series A1 Preference Amount”). After the full distribution of the Series B Preference Amount and Series A1 Preference Amount, holders of Series A Shares shall be entitled to receive prior to any distribution to holders of the Ordinary Shares or any other class or series of shares, an amount per Series A Share equal to 100% of the Series A Issue Price (as adjusted for share dividends, splits, combinations, recapitalizations or similar events) plus all accrued or declared but unpaid dividends thereon (the “Series A Preference Amount”, and collectively with Series B Preference Amount and Series A1 Preference Amount, the “Preference Amount”). After the full liquidation Preference Amount on all outstanding Preferred Shares has been paid, any remaining funds or assets of the Company legally available for distribution to Shareholders shall be distributed pro rata among the holders of the Preferred Shares (on an as-converted basis) together with the holders of the Ordinary Shares. If the Company has insufficient assets to permit payment of the Preference Amount in full to all holders of Preferred Shares, then the assets of the Company shall be distributed as follows:

	(A)		the holders of Series B Shares shall receive an amount equal to the applicable Series B Preference Amount that would be payable to such holders pursuant to paragraph 7.3(b)(1) in the circumstances set forth therein. If the value of the assets of the company is less than the Series B Preference Amount, then the remaining assets of the Company shall be distributed pro rata amongst the holders of all outstanding Series B Shares;
	(B)		after payment in accordance with paragraph 7.3(b)(1)(A) above, the holders of Series A-1 Shares shall receive an amount equal to the applicable Series A-1 Preference Amount that would be payable to such holders pursuant to paragraph 7.3(b)(1) in the circumstances set forth therein. If the value of the assets of the Company is less than the Series A-1 Preference Amount, then the remaining assets of the Company shall be distributed pro rata amongst the holders of all outstanding Series A-1 Shares;
	(C)		after payment in accordance with paragraphs 7.3(b)(1)(A) and 7.3(b)(1)(B) above, the holders of Series A Shares shall receive an amount equal to the applicable Series A Preference Amount that would be payable to such holders pursuant to paragraph 7.3(b)(1) in the circumstances set forth therein. If the value of the assets of the Company is less than the Series A Preference Amount, then the remaining assets of the Company shall be distributed pro rata amongst the holders of all outstanding Series A Shares;
	(D)		the remainder (after payment in accordance with paragraphs 7.3(b)(1)(A), 7.3(b)(1)(B) and 7.3(b)(1)(C) above), if any, shall be distributed to the holders of Preferred Shares and Ordinary Shares, on a pro rata basis, based on the number of Ordinary Shares then held by each holder on an as-converted basis.

(2) Other than a sale, conveyance or disposition of all or substantially all of the assets of a Subsidiary or, a consolidation or merger of a Subsidiary that has been approved by the Shareholders as part of a restructuring for the benefit of the Company in the event of (i) a sale, conveyance or disposition of all or substantially all of the assets of any Group Company, or (ii) a consolidation or merger of any Group Company with or into any other company or companies in which the Existing Shareholders of the Company, at the time immediately before such consolidation or merger takes place, do not retain a majority of the voting power in the surviving company, the Company shall, to the extent legally entitled to do so, distribute to its Shareholders the amount received on such sale, disposition or consolidation in either the same form of consideration received by the Company or in cash, as the Company may determine, whether such payment is in the form of a dividend or other legally permissible form (the “Compulsory Payment”). The Compulsory Payment will be distributed to the Shareholders of the Company as follows:

	(A)		to the holders of Series B Shares, an amount equal to the applicable Series B Preference Amount that would be payable to such holders pursuant to paragraph 7.3(b)(1) in the circumstances set forth therein (collectively, the “Series B Compulsory Payment Preference”). If the value of the Compulsory Payment is less than the Series B Compulsory Payment Preference, then the Compulsory Payment shall be distributed pro rata amongst the holders of all outstanding Series B Shares;
	(B)		after payment in accordance with paragraph 7.3(b)(2)(A) above, to the holders of Series A1 Shares, an amount equal to the applicable Series A1 Preference Amount that would be payable to such holders pursuant to paragraph 7.3(b)(1) in the circumstances set forth therein (collectively, the “Series A1 Compulsory Payment Preference”). After payment in accordance with paragraph 7.3(b)(2)(A) above, if the remaining value of the Compulsory Payment is less than the Series A1 Compulsory Payment Preference, then the remaining Compulsory Payment shall be distributed pro rata amongst the holders of all outstanding Series A1 Shares;
	(C)		after payment in accordance with paragraphs 7.3(b)(2)(A) and 7.3(b)(2)(B) above, to the holders of Series A Shares, an amount equal to the applicable Series A Preference Amount that would be payable to such holders pursuant to paragraph 7.3(b)(1) in the circumstances set forth therein (collectively, the “Series A Compulsory Payment Preference”). After payment in accordance with paragraphs 7.3(b)(2)(A) and 7.3(b)(2)(B) above, if the remaining value of the Compulsory Payment is less than the Series A Compulsory Payment Preference, then the remaining Compulsory Payment shall be distributed pro rata amongst the holders of all outstanding Series A Shares;
	(D)		the remainder (after payment in accordance with paragraphs 7.3(b)(2)(A), 7.3(b)(2)(B) and 7.3(b)(2)(C) above), if any, to the holders of Preferred Shares and Ordinary Shares on a pro rata basis, based on the number of Ordinary Shares then held by each holder on an as-converted basis.

(3) Notwithstanding any other provision of this paragraph 7.3(b), the Company may at any time, out of funds legally available therefor, repurchase Ordinary Shares of the Company issued to or held by employees, officers or consultants of the Company or its subsidiaries upon termination of their employment or services, or pursuant to any bona fide agreement providing for such right of repurchase, whether or not dividends on the Preferred Shares shall have been declared.

(4) In the event the Company proposes to distribute assets other than cash in connection with any liquidation, dissolution or winding up of the Company, the value of the assets to be distributed to the holder of Preferred Shares and Ordinary Shares shall be determined in good faith by the liquidator (or, in the case of any proposed distribution in connection with a transaction which is a deemed liquidation hereunder, by the Board, which decision shall include the affirmative vote of at least one (1) director appointed by Sequoia Capital China I, L.P.), and at least one (1) director appointed by holders of Series B Shares. Any securities not subject to investment letter or similar restrictions on free marketability shall be valued as follows:

	(i)		If traded on a securities exchange, the value shall be deemed to be the average of the security’s closing prices on such exchange over the thirty (30) day ending one (1) day prior to the distribution;
	(ii)		If actively traded over-the-counter, the value shall be deemed to be the average of the closing bid prices over the thirty (30) day period ending three (3) days prior to the distribution; and
	(iii)		If there is no active public market, the value shall be the fair market value thereof as determined in good faith by the liquidator (or, in the case of any

proposed distribution in connection with a transaction which is a deemed liquidation hereunder, by the Board).

(5) The method of valuation of securities subject to restrictions on free marketability shall be adjusted to make an appropriate discount from the market value determined as above in clauses (i), (ii) or (iii) to reflect the fair market value thereof as determined in good faith by the liquidator (or, in the case of any proposed distribution in connection with a transaction which is a deemed liquidation hereunder, by the Board). The holders of at least a majority of the outstanding Preferred Shares shall have the right to challenge any determination by the liquidator or the Board, as the case may be, of fair market value pursuant to this paragraph 7.3(b), in which, case the determination of fair market value shall be made by an independent appraiser selected jointly by the liquidator or the Board, as the case may be, and the challenging parties, the cost of such appraisal to be borne equally by the challenging parties and the Company.

(c)

Conversion Rights. Unless converted earlier pursuant to paragraph 7.3(d) below, each holder of Preferred Shares shall have the right, at such holder’s sole discretion, to convert all or any portion of the Preferred Shares into Ordinary Shares at any time. The conversion rate for the Series A Shares shall be determined by dividing the Series A1 Issue Price for each of the Series A Shares by its conversion price provided that in the event of any share splits, share combinations, share dividends, recapitalisations and similar events, the initial Series A Conversion Price shall be adjusted accordingly. The conversion rate for the Series A1 Shares shall be determined by dividing the Series A1 Issue Price for each of the Series A1 Shares by its conversion price provided that in the event of any share splits, share combinations, share dividends, recapitalisations and similar events, the initial Series A1 Conversion Price shall be adjusted accordingly. The conversion rate for the Series B Shares shall be determined by dividing the Series B Issue Price for each of the Series B Shares by its conversion price provided that in the event of any share splits, share combinations, share dividends, recapitalisations and similar events, the initial Series B Conversion Price shall be adjusted accordingly.

The conversion price for each of the Series A Shares, subject to adjustments from time to time in the event of any share splits, share combinations, share dividends, recapitalisations and similar events in accordance with the provisions hereof, is referred hereinafter as Series A Conversion Price. The initial Series A Conversion Price for each of the Series A Shares, subject to adjustments from time to time in the event of any share splits, share combinations, share dividends, recapitalisations and similar events in accordance with the provisions hereof, shall be its Series A Issue Price. The conversion price for each of the Series A1 Shares, subject to adjustments from time to time in the event of any share splits, share combinations, share dividends, recapitalisations and similar events in accordance with the provisions hereof, is referred hereinafter as Series A1 Conversion Price. The initial Series A1 Conversion Price for each of the Series A1 Shares shall be its Series A1 Issue Price. The conversion price for each of the Series B Shares, subject to adjustments from time to time in the event of any share splits, share combinations, share dividends, recapitalisations and similar events in accordance with the provisions hereof, is referred hereinafter as Series B Conversion Price. The Initial Series B Conversion Price for each of the Series B Shares shall be its Series B Issue Price.

	(d)		Automatic Conversion. The Series A Shares and Series A1 Shares would automatically be converted into Ordinary Shares, at the then applicable conversion price, upon (i) the date specified by written consent or agreement of the holders of at least 50% of the Series A Shares and Series A1 Shares then outstanding, or (ii) the closing of an underwritten public offering of the Ordinary Shares of the Company in the United States, that has been registered under the Securities Act of 1933, as amended (the “Securities Act”), with gross proceeds to the Company in excess of US$70,000,000 (prior to underwriters’ discounts and commissions) and a pre-public offering market capitalization of at least US$300,000,000, or in a similar public offering of the Ordinary Shares of the Company in another jurisdiction which results in the Ordinary Shares trading publicly on a recognized regional or national securities exchange; provided that such offering satisfies the foregoing gross proceeds and pre-public offering market capitalization requirements (a “Qualified Public Offering”). The Series B Shares would automatically be converted into Ordinary Shares, at the then applicable conversion price upon the closing of a Qualified Public Offering. In the event of the automatic conversion of the Preferred Shares upon a Qualified Public Offering as aforesaid, the person(s) entitled to receive the Ordinary Shares issuable upon such conversion of Preferred Shares shall not be deemed to have converted such Preferred Shares until immediately prior to the closing of such Qualified Public Offering.
	(e)		Mechanics of Conversion. No fractional Ordinary Share shall be issued upon conversion of the Preferred Shares. In lieu of any fractional shares to which the holder would otherwise be entitled, the Company shall pay cash equal to such fraction multiplied by the then effective respective Series A Conversion Price, Series A1 Conversion Price, or Series B Conversion Price, as the case may be. Before any holder of Preferred Shares shall be entitled to convert the same into full Ordinary Shares and to receive certificates therefor, he shall surrender the certificate or certificates therefor, duly endorsed, at the office of the Company or of any transfer agent for the Preferred Shares and shall give written notice to the Company at such office that he elects to convert the same. The Company shall, as soon as practicable thereafter, issue and deliver at such office to such holder of Preferred Shares a certificate or certificates for the number of Ordinary Shares to which he shall be entitled as aforesaid and a check payable to the holder in the amount of any cash amounts payable as the result of a conversion into fractional Ordinary Shares. Such conversion shall be deemed to have been made immediately prior to the close of business on the date of such surrender of the shares of Preferred Shares to be converted, and the person or persons entitled to receive the Ordinary Shares issuable upon such conversion shall be treated for all purposes as the record holder or holders of such Ordinary Shares on such date. The directors may effect conversion in any matter permitted by law including, without prejudice to the generality of the foregoing, repurchasing or redeeming the relevant Preferred Shares and applying the proceeds towards the issue of the relevant number of new Ordinary Shares.

Reservation of Shares Issuable Upon Conversion. The Company shall at all times reserve and keep available out of its authorized but unissued Ordinary Shares solely for the purpose of effecting the conversion of the shares of the Preferred Shares such number of its Ordinary Shares as shall from time to time be sufficient to effect the conversion of all outstanding shares of the Preferred Shares, and if at any time the number of authorized but unissued Ordinary shares shall not be sufficient to effect the conversion of all then outstanding shares of the Preferred Shares, in addition to such other remedies as shall be available to the holder of such Preferred Shares, the Company will take such corporate action as may, in the opinion of its legal counsel, be necessary to increase its authorized but unissued Ordinary Shares to such number of shares as shall be sufficient for such purposes.

(f)

Adjustments to Series A Conversion Price, Series A1 Conversion Price and Series B Conversion Price.

(1)

Special Definitions. For purposes of this paragraph 7.3(f), the following definitions shall apply:

	(i)		“Options” mean rights, options or warrants to subscribe for, purchase or otherwise acquire either Ordinary Shares or Convertible Securities.
	(ii)		“Convertible Securities” shall mean any evidences of indebtedness, shares (other than the Preferred Shares and Ordinary Shares) or other securities directly or indirectly convertible into or exchangeable for Ordinary Shares.
	(iii)		“Additional Ordinary Shares” shall mean all Ordinary Shares (including reissued shares) issued (or, pursuant to paragraph 7.3(f)(3), deemed to be issued) by the Company after the Series B Original Issue Date, other than:

	(A)		Ordinary Shares issued upon conversion of the Preferred Shares authorized herein;
	(B)		66,580 Ordinary Shares reserved for issuance upon the exercise of the option currently held by Winsome Group Limited on behalf of Ma ▇▇▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ Ho, Ma Wen Lie, ▇▇▇▇ Lo Yin, Li Jin and other officers, employees and advisors of the Company, and up to 151,430 Ordinary Shares (and/or options or warrants therefor) reserved for issuance pursuant to employee equity incentive plans approved by the Compensation Committee (as defined in the Articles), and any other Ordinary Shares held by officers, directors, employees, and consultants which are repurchased at cost subsequent to the Series B Original Issue Date;
	(C)		as a dividend or distribution on Preferred Shares or any event for which adjustment is made pursuant to paragraph 7.3(f)(7) or 7.3(f)(8) hereof;
	(D)		any securities issued pursuant to the acquisition of another corporation or entity by the Company by consolidation, merger, purchase of assets, or other reorganization in which the Company acquires, in a single transaction or series of related transactions, all or substantially all assets of such other corporation or entity, or 50% or more of the equity ownership or voting power of such other corporation or entity; and
	(E)		pursuant to a Qualified Public Offering.

	(2)		No Adjustment to Series A Conversion Price, Series A1 Conversion Price, and Series B Conversion Price. No adjustment in the Series A Conversion Price, Series A1 Conversion Price, or Series B Conversion Price shall be made in respect of the issuance of Additional Ordinary Shares unless the consideration per share for an Additional Ordinary Share issued or deemed to be issued by the Company is less than the Series A Conversion Price, Series A1 Conversion Price, or Series B Conversion Price, as the case may be, of such series in effect on the date of and immediately prior to such issuance.
	(3)		Deemed Issuance of Additional Ordinary Shares. In the event the Company at any time or from time to time after the Series B Original Issue Date shall issue any Options or Convertible Securities or shall fix a record date for the determination of holders of any class of securities entitled to receive any such Options or Convertible Securities, then the maximum number (as set forth in the instrument relating thereto without regard to any provisions contained therein for a subsequent adjustment of such number that would result in an adjustment pursuant to clause (ii) below) of Ordinary Shares issuable upon the exercise of such Options or, in the case of Convertible Securities and Options therefor, the conversion or exchange of such Convertible Securities, shall be deemed to be Additional Ordinary Shares issued as of the time of such issuance or, in case such a record date shall have been fixed, as of the close of business on such record date, provided that Additional Ordinary Shares shall not be deemed to have been issued unless the

consideration per share (determined pursuant to paragraph 7.3(f)(5) hereof) of such Additional Ordinary Shares would be less than the Series A Conversion Price, Series A1 Conversion Price, or the Series B Conversion Price, as the case may be, in effect on the date of and immediately prior to such issuance, or such record date, as the case may be, and provided further that in any such case in which Additional Ordinary Shares are deemed to be issued:

	(i)		no further adjustment to the Series A Conversion Price, the Series A1 Conversion Price, or the Series B Conversion Price, shall be made upon the subsequent issuance of Convertible Securities or Ordinary Shares upon the exercise of such options or conversion or exchange of such Convertible Securities;
	(ii)		if such Options or Convertible Securities by their terms provide, with the passage of time or otherwise, for any increase or decrease in the consideration payable to the Company, or increase or decrease in the number of Ordinary Shares issuable, upon the exercise, conversion or exchange thereof, the Series A Conversion Price, the Series A1 Conversion Price, or the Series B Conversion Price computed upon the original issuance thereof (or upon the occurrence of a record date with respect thereto), and any subsequent adjustments based thereon, shall, upon any such increase or decrease becoming effective be recomputed to reflect such increase or decrease insofar as it affects such Options or the rights of conversion or exchange under such Convertible Securities;
	(iii)		upon the expiration of any such Options or any rights of conversion or exchange under such Convertible Securities which shall not have been exercised, the Series A Conversion Price, the Series A1 Conversion Price, or the Series B Conversion Price, computed upon the original issuance thereof (or upon the occurrence of a record date with respect thereto), and any subsequent adjustments based thereon, shall, upon such expiration be recomputed as if:

	(A)		in the case of Convertible Securities or Options for Ordinary Shares, the only Additional Ordinary Shares issued were Ordinary Shares, if any, actually issued upon the exercise of such Options or the conversion or exchange of such Convertible Securities and the consideration received therefor was the consideration actually received by the Company for the issuance of all such Options, whether or not exercised, plus the consideration actually received by the Company upon such exercise, or for the issuance of all such Convertible Securities which were actually converted or exchanged, plus the additional consideration, if any, actually received by the Company upon such conversion or exchange, and
	(B)		in the case of Options for Convertible Securities, only the Convertible Securities, if any, actually issued upon the exercise thereof were issued at the time of issuance of such Options, and the consideration received by the Company for the Additional Ordinary Shares deemed to have been then issued was the consideration actually received by the Company for the issuance of all such Options, whether or not exercised, plus the consideration deemed to have been received by the Company upon the issuance of the Convertible Securities with respect to which such Options were actually exercised;

(i)

no readjustment pursuant to clause (ii) or (iii) above shall have the effect of increasing the Series A Conversion Price, the Series A1 Conversion Price, or the Series B Conversion Price, to an amount which exceeds the lower of (i) the Series A Conversion Price, the Series A1 Conversion Price, or the Series B Conversion Price, as the case may be, on the original adjustment date, or

(ii) the Series A Conversion Price, the Series A1 Conversion Price, or the Series B Conversion Price, as the case may be, that would have resulted from any issuance of Additional Ordinary Shares between the original adjustment date and such readjustment date; and

(ii)

in the case of any Options which expire by their terms not more than 30 days after the date of issuance thereof, no adjustment of the Series A Conversion Price, the Series A1 Conversion Price, or the Series B Conversion Price, shall be made until the expiration or exercise of all such Options, whereupon such adjustment shall be made in the manner provided in clause (iii) above.

(4)

Issuance of Additional Ordinary Shares below Series A Conversion Price, the Series A1 Conversion Price, or the Series B Conversion Price. In the event that the Company shall issue any Additional Ordinary Shares (including those deemed to be issued pursuant to paragraph 7.3(f)(3)) at a subscription price per Ordinary Share (on an as-converted basis) less than the Series A Conversion Price, the Series A1 Conversion Price, or the Series B Conversion Price (as adjusted from time to time) in effect on the date of and immediately prior to such issuance, the Series A Conversion Price, the Series A1 Conversion Price, of the Series B Conversion Price, as the case may be, shall be reduced, concurrently with such issuance, to a price (calculated to the nearest one hundredth of a cent) to be determined as set forth below. The mathematical formula for determining the adjusted Series A Conversion Price, the Series A1 Conversion Price, or the Series B Conversion Price, as the case may be, is as follows and is subject to the more detailed textual description set forth thereafter:

AP = OP * (OS + (NP/OP))/(OS + NS)

WHERE:

AP = adjusted Series A Conversion Price, adjusted Series A1 Conversion Price, or adjusted Series B Conversion Price, as the case may be

OP = old Series A Conversion Price, old Series A1 Conversion Price, or old Series B Conversion Price, as the case may be

OS = the number of outstanding Ordinary Shares immediately before the Additional Ordinary Shares are issued or sold

NP = the total consideration received for the issuance or sale of Additional Ordinary Shares

NS = the number of Additional Ordinary Shares issued or sold

The newly adjusted Series A Conversion Price, Series A1 Conversion Price, or Series B Conversion Price, shall be the amount equal to the price determined by multiplying the old Series A Conversion Price, the old Series A1 Conversion Price, or the old Series B Conversion Price, as the case may be, by a fraction:

	(i)		the numerator of which shall be the number of Ordinary Shares outstanding immediately prior to such issuance plus the number of Ordinary Shares which the aggregate consideration received by the Company for the total number of Additional Ordinary Shares would purchase at the old Series A Conversion Price, the old Series A1 Conversion Price, or the old Series B Conversion Price, as the case may be; and
	(ii)		the denominator of which shall be the number of Ordinary Shares outstanding immediately prior to such issuance plus the number of such Additional Ordinary Shares so issued;

provided that for the purposes of this paragraph 7.3(f)(4), all Ordinary Shares issuable upon conversion of outstanding Series A Shares, Series A1 Shares, or Series B Shares and outstanding Convertible Securities or exercise of outstanding Options (excluding Options issued pursuant to the Company’s employee equity incentive plans approved by the Board of Directors) shall be deemed to be outstanding.

(5)

One-time Adjustment of Series A Shares based on 2006 Accounts. Upon the delivery by the Company to the holders of Series A Shares of the Company’s audited consolidated financial statements for the fiscal year commencing from April 1, 2006 and ending on March 31, 2007 (the “2006 Accounts”) prepared by a “Big 4” accounting firm in accordance with the United States generally accepted accounting principles,

	(i)		if the Net income of the Company as reflected in the 2006 Accounts is less than US$5,000,000, then the number of Series A Shares then in issue shall be increased as of April 1, 2007 to a number obtained by dividing the number of Series A Shares in issue immediately before such adjustment by a factor of 0.8192; or
	(ii)		if the Net Income of the Company as reflected in the 2006 Accounts is more than US$5,500,000, then the number of Series A Shares then in issue shall be reduced as of April 1, 2007 to a number obtained by dividing the number of Series A Shares in issue immediately before such adjustment by a factor of 1.0753.

Any increase in the number of Series A Shares pursuant to this paragraph 7.3(f)(5) shall be accomplished by a mandatory transfer of Ordinary Shares pro rata by the holders of Ordinary Shares to the holders of Series A Shares ratably within 45 days of delivery of the 2006 Accounts, provided that such Ordinary Shares shall be re-designated as Series A Shares in connection with such transfer. Any decrease in the number of Series A Shares pursuant to this paragraph 7.3(f)(5) shall be accomplished by a mandatory transfer of Series A Shares pro rata by the holders of Series A Shares to the holders of Ordinary Shares ratably within 45 days of delivery of the 2006 Accounts, provided that such Series A Shares shall be re-designated as Ordinary Shares in connection with such transfer.

For the purpose of calculation of the Net Income under this paragraph, the legal, accounting and public relation expenses incurred to the Company in connection with Sequoia Capital China I, L.P.’s Series A investment in the Company shall be excluded; provided that the incurrence of any public relation expense by the Company shall be subject to Sequoia Capital China I, L.P.’s prior written approval. Any adjustment to the Series A Conversion Price made pursuant to this paragraph 7.3(f)(5) shall be in addition to, and not in substitution for, any other prior or subsequent adjustments made to the Series A Conversion Price pursuant to this Article 7.3.

(6)

Determination of Consideration. For purposes of this paragraph 7.3(f), the consideration received by the Company for the issuance of any Additional Ordinary Shares shall be computed as follows:

(i)

Cash and Property. Except as provided in clause (ii) below, such consideration shall:

	(A)		insofar as it consists of cash, be computed at the aggregate amount of cash received by the Company excluding amounts paid or payable for accrued interest for accrued dividends;
	(B)		insofar as it consists of property other than cash, be computed at the fair value thereof at the time of such issuance, as determined in good

faith by the Board; provided, however, that no value shall be attributed to any services performed by any employee, officer or director of the Company; and

(C)

in the event Additional Ordinary Shares are issued together with other shares or securities or other assets of the Company for consideration which covers both, be the proportion of such consideration so received with respect to such Additional Ordinary Shares, computed as provided in clauses (A) and (B) above, as determined in good faith by the Board.

(ii)

Options and Convertible Securities. The consideration per share received by the Company for Additional Ordinary Shares deemed to have been issued pursuant to paragraph 7.3(f)(3), relating to Options and Convertible Securities, shall be determined by dividing

	(A)		the total amount, if any, received or receivable by the Company as consideration for the issuance of such Options or Convertible Securities, plus the minimum aggregate amount of additional consideration (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such consideration) payable to the Company upon the exercise of such Options or the conversion or exchange of such Convertible Securities, or in the case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities by
	(B)		the maximum number of Ordinary Shares (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such number) issuable upon the exercise of such Options or the conversion exchange of such Convertible Securities.

	(7)		Adjustments for Share Dividends, Subdivisions, Combinations or Consolidations of Ordinary Shares. In the event the outstanding Ordinary Shares shall be subdivided (by share dividend, share split, or otherwise), into a greater number of Ordinary Shares, the Series A Conversion Price, the Series A1 Conversion Price, or the Series B Conversion Price, then in effect shall, concurrently with the effectiveness of such subdivision, be proportionately decreased. In the event the outstanding Ordinary Shares shall be combined or consolidated, by reclassification or otherwise, into a lesser number of ordinary shares the Series A Conversion Price, the Series A1 Conversion Price, or the Series B Conversion Price, then in effect shall, concurrently with the effectiveness of such combination or consolidation, be proportionately increased.
	(8)		Adjustments for Other Distributions. In the event the Company at any time or from time to time makes, or files a record date for the determination of holders of Ordinary Shares entitled to receive any distribution payable in securities or assets of the Company other than Ordinary Shares, then and in each such event provision shall be made so that the holders of Series A Shares, Series A1 Shares and Series B Shares shall receive upon conversion thereof, in addition to the number of Ordinary Shares receivable thereupon, the amount of securities or assets of the Company which they would have received had their Series A Shares, Series A1 Shares or Series B Shares been converted into Ordinary Shares on the date of such event and had they thereafter, during the period from the date of such event to and including the date of conversion, retained such securities or assets receivable by them as aforesaid during such period, subject to all other adjustment called for during such period under this paragraph 7.3(f) with respect to the rights of the holders of the Series A Shares, Series A1 Shares and Series B Shares.

	(9)		Adjustments for Reclassification, Exchange and Substitution. If the Ordinary Shares issuable upon conversion of the Series A Shares, the Series A1 Shares and Series B Shares shall be changed into the same or a different number of shares of any other class or classes of shares, whether by capital reorganization, reclassification or otherwise (other than a subdivision or combination of shares provided for above), then and in each such event the holder of each share of Series A Shares, Series A1 Shares or Series B Shares shall have the right thereafter to convert such share into the kind and amount of shares and other securities and property receivable upon such reorganization or reclassification or other change by holders of the number of Ordinary Shares that would have been subject to receipt by the holders upon conversion of the Series A Shares, Series A1 Shares or Series B Shares immediately before that change, all subject to further adjustment as provided herein.
	(10)		No Impairment. The Company will not, by the amendment of its Memorandum and the Articles of Association or through any reorganization, transfer of assets, consolidation, merger, dissolution issuance or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Company but will at all times in good faith assist in the carrying out of all the provisions of paragraph 7.3(f) and in the taking of all such action as may be necessary or appropriate in order to protect the Conversion Rights of the holders of the Series A Shares, the Series A1 Shares and the Series B Shares against impairment.
	(11)		Certificate as to Adjustments. Upon the occurrence of each adjustment or readjustment of the Series A Conversion Price, the Series A1 Conversion Price, or the Series B Conversion Price pursuant to paragraph 7.3(f), the Company at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to each holder of Series A Shares, Series A1 Shares or Series B Shares a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Company shall, upon the written request at any time of any holder of Series A Shares, Series A1 Shares, or Series B Shares, furnish or cause to be furnished to such holder a like certificate setting forth (i) such adjustments and readjustments, (ii) the Series A Conversion Price, the Series A1 Conversion Price, or the Series B Shares, as the case may be, at the time in effect, and (iii) the number of ordinary shares and the amount, if any, of other property which at the time would be received upon the conversion of Series A Shares, Series A1 Shares or Series B Shares.
	(12)		Miscellaneous.

	(i)		All calculations under this paragraph 7.3(f) shall be made to the nearest one hundredth (1/100) of a cent or to the nearest one hundredth (1/100) of a share, as the case may be.
	(ii)		The holders of at least a majority of the outstanding Series A Shares, Series A1 Shares or Series B Shares shall have the right to challenge any determination by the Board of fair value pursuant to this paragraph 7.3(f), in which case such determination of fair value shall be made by an independent appraiser selected jointly by the Board and the challenging parties, the cost of such appraisal to be borne equally by the Company and the challenging holders of Series A Shares, Series A1 Shares or Series B Shares, as the case may be.
	(iii)		No adjustment in the Series A Conversion Price, the Series A1 Conversion Price or the Series B Conversion Price need be made if such adjustment would result in a change in such Series A Conversion Price, the Series A1 Conversion Price, or the Series B Conversion Price of less than US$0.001. Any adjustment of less than US$0.001 which is not made shall be carried

forward and shall be made at the time of and together with any subsequent adjustment which, on a cumulative basis, amounts to an adjustment of US$0.001 or more in such Series A Conversion Price, the Series A1 Conversion Price or the Series B Conversion Price.

	(g)		Voting Rights. Each Preferred Share shall carry a number of votes equal to the number of Ordinary Shares then issuable upon its conversion into Ordinary Shares at the record date for determination of the Shareholders entitled to vote on such matters, or, if no such record date is established, at the date such vote is taken or any written consent of Shareholders is solicited. The Preferred Shares shall generally vote together with the Ordinary Shares and not as a separate class, except as provided in paragraph (h) below or as expressly provided in this Memorandum and in the Articles of Association.
	(h)		Protective Provisions.

In addition to such other limitations as may be provided in the Memorandum and Articles and the BVI Business Companies ▇▇▇ ▇▇▇▇, the Company shall not, and shall cause the other Group Companies to not, and the holders of Ordinary Shares shall exercise all of their rights with respect to such Ordinary Shares so as to cause the Group Companies to not, effect or otherwise consummate any of the following acts without first obtaining,

     (1) the prior written approval of (i) the holder(s) of at least 75% of the outstanding Series A Shares and Series A1 Shares (in aggregate and on an as-converted basis), and (ii) the holder(s) of at least 50% of the outstanding Series B Shares (on an as converted basis); provided that such requirement shall terminate upon a Qualified Public Offering:

          i. any amendment or change of the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Preferred Shares of the Company;

          ii. any action to authorize, create or issue shares of any class or series of the Company having preferences superior to or on a parity with the Preferred Shares in any aspects including without limitation, dividend rights, redemption rights and/or liquidation rights;

          iii. any new issuance of any equity securities of the Company, including any change in the total number of authorized Series B Shares, but excluding (i) any issuance of the Series B Shares authorized under the Purchase Agreement, (ii) any issuance of Ordinary Shares upon conversion of the Preferred Shares, and (iii) the issuance of 66,580 Ordinary Shares reserved for issuance upon the exercise of the option currently held by Winsome Group Limited on behalf of Ma ▇▇▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ Ho, Ma Wen Lie, ▇▇▇▇ Lo Yin and other officers, employees and advisors of the Company, and (iv) the issuance of up to 151,430 Ordinary Shares (and/or options or warrants therefor) reserved for issuance pursuant to the employee equity incentive plans approved by the Compensation Committee (as defined in the Articles);

          iv. any action of the Company to reclassify any outstanding shares into shares having preferences or priority as to dividends or assets senior to or on a parity with the preference of the Preferred Shares;

          v. any increase or decrease of the authorized number of Ordinary

Shares or Preferred Shares of the Company;

          vi. any amendment of the Memorandum and Articles of Association or other charter documents of the Company (including any Major Subsidiary);

          vii. any merger or consolidation of the Company (including any Subsidiary) with or into any other business entity in which the shareholders of the Company (including any Subsidiary) immediately after such merger or consolidation held shares representing less than a majority of the voting power of the outstanding share capital of the surviving business entity;

          viii. any transaction or series of transactions that would result in a change of control of the Company (including any Subsidiary);

          ix. the sale, lease, transfer or other disposition of all or substantially all of the assets of the Company (including any Subsidiary), except for intra-group transactions among the Company and any Subsidiaries;

          x. any licensing or other transfer of the patents, copyrights, trademarks or other intellectual property of the Company (including any Subsidiary) other than in the ordinary course of its business, except for intra-group transactions among the Company and any Subsidiaries;

          xi. any increase or decrease of the authorized number of the Board (including any committees of the Board) of the Company;

          xii. effect a liquidation, dissolution or winding up of the Company (including any Subsidiary)

          xiii. the declaration or payment of a dividend or other distribution on Ordinary Shares or Preferred Shares of the Company;

          xiv. any increase of the number of Ordinary Shares of the Company reserved under any employee equity incentive plan;

          xv. any increase in compensation of any employee of the Company (including any Subsidiary) with an annual salary of US$50,000 or more by more than 20% in a twelve (12) month period;

          xvi. the extension by the Company of any loan or guarantee for indebtedness to any director, officer, employee or affiliate of the Company (Including any Subsidiary), except for intra-group transactions among the Company and any Subsidiaries;

          xvii. any incurrence of indebtedness in excess of US$1,000,000 in the aggregate to the Company (Including any Subsidiary), or creation of any encumbrance whatsoever upon the assets, patents, copyrights, trademarks or other intellectual property of the Company (including any Subsidiary);

          xviii. any purchase by the Company (including any Subsidiary) of real

property with a value of US$1,000,000 or more, or any purchase of production facilities with a value of US$500,000 or more, individually or in the aggregate;

          xix. any transaction or series of transactions that are not in the ordinary course of the Company’s business where the value involved exceeds US$1,000,000, individually or in the aggregate, during any twelve (12) month period;

          xx. approval of the annual consolidated budget of the Company;

          xxi. the appointment and removal of any key officer of the Company (including any Major Subsidiary), including the Chief Executive Officer and the Chief Financial Officer;

          xxii. the appointment and/or reappointment of auditors of the Company; or

          xxiii. any transaction involving both the Company (including any Subsidiary) and a shareholder of any Group Company or any of the Company’s employees, officers, directors or shareholders or any affiliate of a shareholder of any Group Company or any of such affiliate’s officers, directors or shareholders, except for intra-group transactions among the Company and any Subsidiaries and employment contracts between a Group Company and its employees that are not otherwise subject to this paragraph 7.3(h), and

     (2) the prior written approval of the holder(s) as at the date hereof (taking no account of any share issuances after the date hereof) of at least 96% of the aggregate of Ordinary Shares and preferred Shares (on an as-converted basis), provided that such requirement shall terminate upon a Qualified IPO, any repurchase or redemption of any equity securities of the Company other than (A) pursuant to contractual rights to repurchase Ordinary Shares from the employees, directors or consultants of the Company upon termination of their employment or services or (B) pursuant to a contractual right of first refusal held by the Company.

     Provided, however that, to the extent that the applicable laws prevent the Company from being bound by any of the above provisions, such provisions shall be binding as amongst the holders of Ordinary Shares and holders of Preferred Shares and such parties shall take all actions necessary to give effect to such provisions.

8.

VARIATION OF RIGHTS

Subject to Clause 7.3(h) hereof, if at any time the Shares are divided into different classes, the rights attached to any class may only be varied, whether or not the Company is in liquidation, with the consent in writing of or by a resolution passed at a meeting by the holders of at least a majority of the issued Shares in that class.

9.

RIGHTS NOT VARIED BY THE ISSUE OF SHARES PARI PASSU

The rights conferred upon the holders of the Shares of any class shall not, unless otherwise expressly provided by the terms of issue of the Shares of that class, be deemed to be varied by the creation or issue of further Shares ranking pari passu therewith.

10.

REGISTERED SHARES

10.1.		The Company shall issue Registered Shares only.
10.2.		The Company is not authorised to issue Bearer Shares, convert Registered Shares to Bearer Shares or exchange Registered Shares for Bearer Shares.
11.		TRANSFER OF SHARES
11.1.		Subject to Clause 13, the Company shall, on receipt of an instrument of transfer complying with Sub-Regulation 6.1 of the Articles, enter the name of the transferee of a Share in the register of members unless the directors resolve to refuse or delay the registration of the transfer for reasons that shall be specified in a Resolution of Directors.
11.2.		The directors may not resolve to refuse or delay the transfer of a Share unless the Shareholder has failed to pay an amount due in respect of the Share.
12.		AMENDMENT OF THE MEMORANDUM AND THE ARTICLES
12.1.		Subject to Clauses 7.3(h) and 8, the Company may amend the Memorandum or the Articles by Resolution of Shareholders or by Resolution of Directors, save that no amendment may be made by Resolution of Directors:

	(a)		to restrict the rights or powers of the Shareholders to amend the Memorandum or the Articles;
	(b)		to change the percentage of Shareholders required to pass a Resolution of Shareholders to amend the Memorandum or the Articles;
	(c)		in circumstances where the Memorandum or the Articles cannot be amended by the Shareholders; or
	(d)		to Clauses 7, 8, 9 or this Clause 12.

12.2.		Any amendment of the Memorandum or the Articles will take effect on the registration by the Registrar of a notice of amendment, or restated Memorandum and Articles, filed by the registered agent.
13.		PRIVATE COMPANY

         The Company is a private company, and accordingly:

	(a)		any invitation to the public to subscribe for any Shares or debentures of the Company is prohibited;
	(b)		the number of the Shareholders of the Company (not including persons who are in the employment of the Company, and persons who, having been formerly in the employment of the Company, were, while in such employment, and have continued after the determination of such employment to be, Shareholders of the Company) shall be limited to fifty PROVIDED that where two (2) or more persons hold one or more Shares in the Company jointly they shall, for the purposes of this Clause 13, be treated as a single Shareholder;
	(c)		the right to transfer the Shares of the Company shall be restricted in manner herein prescribed; and
	(d)		the Company shall not have power to issue Share Warrants to Bearer.

TERRITORY OF THE BRITISH VIRGIN ISLANDS
▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇, ▇▇▇▇

AMENDED AND RESTATED
ARTICLES OF ASSOCIATION

OF

China Linong International Limited

A COMPANY LIMITED BY SHARES

1.		REGISTERED SHARES
1.1.		Every Shareholder is entitled to a certificate signed by a director or officer of the Company, or any other person authorised by Resolution of Directors, or under the Seal specifying the number of Shares held by him and the signature of the director, officer or authorised person and the Seal may be facsimiles.
1.2.		Any Shareholder receiving a certificate shall indemnify and hold the Company and its directors and officers harmless from any loss or liability which it or they may incur by reason of any wrongful or fraudulent use or representation made by any person by virtue of the possession thereof. If a certificate for Shares is worn out or lost it may be renewed on production of the worn out certificate or on satisfactory proof of its loss together with such indemnity as may be required by Resolution of Directors.
1.3.		If several Eligible Persons are registered as joint holders of any Shares, any one of such Eligible Persons may give an effectual receipt for any Distribution.
2.		SHARES
2.1.		Shares and other Securities may be issued at such times, to such Eligible Persons, for such consideration and on such terms as the directors may by Resolution of Directors determine.
2.2.		Section 46 of the Act (Pre-emptive rights) does not apply to the Company.
2.3.		A Share may be issued for consideration in any form, including money, a promissory note, or other written obligation to contribute money or property, real property, personal property (including goodwill and know-how), services rendered or a contract for future services.
2.4.		The consideration for a Share with par value shall not be less than the par value of the Share. If a Share with par value is issued for consideration less than the par value, the person to whom the Share is issued is liable to pay to the Company an amount equal to the difference between the issue price and the par value.
2.5.		No Shares may be issued for a consideration other than money, unless a Resolution of Directors has been passed stating:

(a)

the amount to be credited for the issue of the Shares;

	(b)		the determination of the directors of the reasonable present cash value of the non-money consideration for the issue; and
	(c)		that, in the opinion of the directors, the present cash value of the non-money consideration for the issue is not less than the amount to be credited for the issue of the Shares.

2.6.

The consideration paid for any Share, whether a par value Share or a no par value Share, shall not be treated as a liability or debt of the Company for the purposes of

	(a)		the solvency test in Regulations 3 and 18; and
	(b)		sections 197 and 209 of the Act,

2.7.

The Company shall keep a register (the “register of members”) containing:

	(a)		the names and addresses of the Eligible Persons who hold Shares;
	(b)		the number of each class and series of Shares held by each Shareholder;
	(c)		the date on which the name of each Shareholder was entered in the register of members; and
	(d)		the date on which any Eligible Person ceased to be a Shareholder.

2.8.		The register of members may be in any such form as the directors may approve, but if it is in magnetic, electronic or other data storage form, the Company must be able to produce legible evidence of its contents. Until the directors otherwise determine, the magnetic, electronic or other data storage form shall be the original register of members.
2.9.		A Share is deemed to be issued when the name of the Shareholder is entered in the register of members
3.		REDEMPTION OF SHARES AND TREASURY SHARES
3.1.		Subject to receipt of all approvals required under the Memorandum or elsewhere in the Articles, the Company may purchase, redeem or otherwise acquire and hold its own Shares save that the Company may not purchase, redeem or otherwise acquire its own Shares without the consent of Shareholders whose Shares are to be purchased, redeemed or otherwise acquired unless the Company is permitted by the Act or any other provision in the Memorandum or Articles to purchase, redeem or otherwise acquire the Shares without their consent.
3.2.		The Company may only offer to purchase, redeem or otherwise acquire Shares if the Resolution of Directors authorising the purchase, redemption or other acquisition contains a statement that the directors are satisfied, on reasonable grounds, that immediately after the acquisition the value of the Company’s assets will exceed its liabilities and the Company will be able to pay its debts as they fall due.
3.3.		Sections 60 (Process for acquisition of own Shares), 61 (Offer to one or more shareholders) and 62 (Shares redeemed otherwise than at the option of company) of the Act shall not apply to the Company.
3.4.		Shares that the Company purchases, redeems or otherwise acquires pursuant to this Regulation may be cancelled or held as Treasury Shares except to the extent that such Shares are in excess of 50% of the issued Shares in which case they shall be cancelled but they shall be available for reissue.

3.5.		All rights and obligations attaching to a Treasury Share are suspended and shall not be exercised by the Company while it holds the Share as a Treasury Share.
3.6.		Treasury Shares may be transferred by the Company on such terms and conditions (not otherwise inconsistent with the Memorandum and the Articles) as the Company may by Resolution of Directors determine.
3.7.		Where Shares are held by another body corporate of which the Company holds, directly or indirectly, Shares haying more than 50% of the votes in the election of directors of the other body corporate, all rights and obligations attaching to the Shares held by the other body corporate are suspended and shall not be exercised by the other body corporate.
4.		MORTGAGES AND CHARGES OF SHARES
4.1.		Subject to the Company and the Shareholders’ contractual obligations in connection with restrictions on the transfer of shares, Shareholders may mortgage or charge their Shares.
4.2.		There shall be entered in the register of members at the written request of the Shareholder:

	(a)		a statement that the Shares held by him are mortgaged or charged;
	(b)		the name of the mortgagee or chargee; and
	(c)		the date on which the particulars specified in subparagraphs (a) and (b) are entered in the register of members.

4.3.

Where particulars of a mortgage or charge are entered in the register of members, such particulars may be cancelled:

	(a)		with the written consent of the named mortgagee or chargee or anyone authorised to act on his behalf; or
	(b)		upon evidence satisfactory to the directors of the discharge of the liability secured by the mortgage or charge and the issue of such indemnities as the directors shall consider necessary or desirable.

4.4.

Whilst particulars of a mortgage or charge over Shares are entered in the register of members pursuant to this Regulation:

	(a)		no transfer of any Share the subject of those particulars shall be effected;
	(b)		the Company may not purchase, redeem or otherwise acquire any such Share; and
	(c)		no replacement certificate shall be issued in respect of such Shares,

            without the written consent of the named mortgagee or chargee.

5.		FORFEITURE
5.1.		Shares that are not fully paid on issue are subject to the forfeiture provisions set forth in this Regulation and for this purpose Shares issued for a promissory note, other written obligation to contribute money or property or a contract for future services are deemed to be not fully paid.
5.2.		A written notice of call specifying the date for payment to be made shall be served on the Shareholder who defaults in making payment in respect of the Shares.

5.3.		the written notice of call referred to in Sub-Regulation 5.2 shall name a further date not earlier than the expiration of 14 days from the date of service of the notice on or before which the payment required by the notice is to be made and shall contain a statement that in the event of non-payment at or before the time named in the notice the Shares, or any of them, in respect of which payment is not made will be liable to be forfeited.
5.4.		Where a written notice of call has been issued pursuant to Sub-Regulation 5.3 and the requirements of the notice have not been complied with, the directors may, at any time before tender of payment, forfeit and cancel the Shares to which the notice relates.
5.5.		The Company is under no obligation to refund any moneys to the Shareholder whose Shares have been cancelled pursuant to Sub-Regulation 5.4 and that Shareholder shall be discharged from any further obligation to the Company.
6.		TRANSFER OF SHARES
6.1.		Subject to the Memorandum and the Articles, Shares may be transferred by a written instrument of transfer signed by the transferor and containing the name and address of the transferee, which shall be sent to the Company for registration.
6.2.		The transfer of a Share is effective when the name of the transferee is entered on the register of members.
6.3.		If the directors of the Company are satisfied that an instrument of transfer relating to Shares has been signed but that the instrument has been lost or destroyed, they may resolve by Resolution of Directors:

	(a)		to accept such evidence of the transfer of Shares as they consider appropriate; and
	(b)		that the transferee’s name should be entered in the register of members notwithstanding the absence of the instrument of transfer.

6.4.		If a director refuses to register a transfer they shall notify the transferee within sixty (60) days of such refusal,
6.5.		Subject to the Memorandum, the personal representative of a deceased Shareholder may transfer a Share even though the personal representative is not a Shareholder at the time of the transfer.
7.		MEETINGS AND CONSENTS OF SHAREHOLDERS
7.1.		Any director of the Company may convene meetings of the Shareholders at such times and in such manner and places within or outside the British Virgin Islands as the director considers necessary or desirable.
7.2.		Upon the written request of Shareholders entitled to exercise 20% or more of the voting rights in respect of the matter for which the meeting is requested the directors shall convene a meeting of Shareholders.
7.3.		The director convening a meeting shall give not less than seven (7) days’ notice of a meeting of Shareholders to:

	(a)		those Shareholders whose names on the date the notice is given appear as Shareholders in the register of members of the Company and are entitled to vote at the meeting; and
	(b)		the other directors.

7.4.		The director convening a meeting of Shareholders may fix as the record date for determining those Shareholders that are entitled to vote at the meeting the date notice is given of the meeting, or such other date as may be specified in the notice, being a date not earlier than the date of the notice.
7.5.		A meeting of Shareholders held in contravention of the requirement to give notice is valid if Shareholders holding at least 90% of the total voting rights on all the matters to be considered at the meeting have waived notice of the meeting and, for this purpose, the presence of a Shareholder at the meeting shall constitute waiver in relation to all the Shares which that Shareholder holds.
7.6.		The inadvertent failure of a director who convenes a meeting to give notice of a meeting to a Shareholder or another director, or the fact that a Shareholder or another director has not received notice, does not invalidate the meeting.
7.7.		A Shareholder may be represented at a meeting of Shareholders by a proxy who may speak and vote on behalf of the Shareholder.
7.8.		The instrument appointing a proxy shall be produced at the place designated for the meeting before the time for holding the meeting at which the person named in such instrument proposes to vote. The notice of the meeting may specify an alternative or additional place or time at which the proxy shall be presented.
7.9.		The instrument appointing a proxy shall be in substantially the following form or such other form as the chairman of the meeting shall accept as properly evidencing the wishes of the Shareholder appointing the proxy.

[COMPANY NAME]

I/We being a Shareholder of the above Company HEREBY APPOINT                      of                                          or failing him                                           of                                          to be my/our proxy to vote for me/us at the meeting of Shareholders to be held on the                      day of                                         , 20      and at any adjournment thereof.

(Any restrictions on voting to be inserted here.)

Signed this                     day of                     , 20     

                                                            
Shareholder

7.10.

The following applies where Shares are jointly owned:

	(a)		if two (2) or more persons hold Shares jointly each of them may be present in person or by proxy at a meeting of Shareholders and may speak as a Shareholder;
	(b)		if only one (1) of the joint owners is present in person or by proxy he may vote on behalf of all joint owners; and
	(c)		if two (2) or more of the joint owners are present in person or by proxy they must vote as one.

7.11.

A Shareholder shall be deemed to be present at a meeting of Shareholders if he participates by telephone or other electronic means and all shareholders participating in the meeting are able to hear each other.

7.12.		A meeting of Shareholders is duly constituted if, at the commencement of the meeting, there are present in person or by proxy (i) not less than a majority of the votes of the Shares entitled to vote on Resolutions of Shareholders to be considered at the meeting, and (ii) holders of not less than a majority of the Preferred Shares (on an as-converted basis).
7.13.		If within two (2) hours from the time appointed for the meeting a quorum is not present, the meeting, if convened upon the requisition of Shareholders, shall be dissolved; in any other case it shall stand adjourned to the sixth (6th) business day in the Jurisdiction in which the meeting was to have been held at the same time and place or to such other time and place as the directors may determine, and if at the adjourned meeting there are present within one hour from the time appointed for the meeting in person or by proxy not less than two (2) Shareholders entitled to vote on the matters to be considered by the meeting, those present shall constitute a quorum but otherwise the meeting shall be dissolved.
7.14.		At every meeting of Shareholders, the Chairman of the Board shall preside as chairman of the meeting. If there is no Chairman of the Board or if the Chairman of the Board is not present at the meeting, the Shareholders present shall choose one of their number to be the chairman. If the Shareholders are unable to choose a chairman for any reason, then the person representing the greatest number of voting Shares present in person or by proxy at the meeting shall preside as chairman failing which the oldest individual Shareholder or representative of a Shareholder present shall take the chair.
7.15.		The chairman may, with the consent of the meeting, adjourn any meeting from time to time, and from place to place, but no business shall be transacted at any adjourned meeting other than the business left unfinished at the meeting from which the adjournment took place;
7.16.		At any meeting of the Shareholders the chairman is responsible for deciding in such manner as he considers appropriate whether any resolution proposed has been carried or not and the result of his decision shall be announced to the meeting and recorded in the minutes of the meeting. If the chairman has any doubt as to the outcome of the vote on a proposed resolution, he shall cause a poll to be taken of all votes cast upon such resolution. If the chairman fails to take a poll then any Shareholder present in person or by proxy who disputes the announcement by the chairman of the result of any vote may immediately following such announcement demand that a poll be taken and the chairman shall cause a poll to be taken. If a poll is taken at any meeting, the result shall be announced to the meeting and recorded in the minutes of the meeting.
7.17.		Subject to the specific provisions contained in this Regulation for the appointment of representatives of Eligible Persons other than individuals the right of any individual to speak for or represent a Shareholder shall be determined by the law of the jurisdiction where, and by the documents by which, the Eligible Person is constituted or derives its existence. In case of doubt, the directors may in good faith seek legal advice from any qualified person and unless and until a court of competent jurisdiction shall otherwise rule, the directors may rely and act upon such advice without incurring any liability to any Shareholder or the Company.
7.18.		Any Eligible Person other than an individual which is a Shareholder may by resolution of its directors or other governing body authorise such individual as it thinks fit to act as its representative at any meeting of Shareholders or of any class of Shareholders, and the individual so authorised shall be entitled to exercise the same rights on behalf of the Shareholder which he represents as that Shareholder could exercise if it were an individual.
7.19.		The chairman of any meeting at which a vote is cast by proxy or on behalf of any Eligible Person other than an individual may call for a notarially certified copy of such proxy or authority which shall be produced within 7 days of being so requested or the votes cast by such proxy or on behalf of such Eligible Person shall be disregarded.
7.20.		Directors of the Company may attend and speak at any meeting of Shareholders and at any separate meeting of the holders of any class or series of Shares.

7.21.		An action that may be taken by the Shareholders at a meeting may also be taken by a resolution consented to in writing, without the need for any notice, but If any Resolution of Shareholders is adopted otherwise than by the unanimous written consent of all Shareholders, a copy of such resolution shall forthwith be sent to all Shareholders not consenting to such resolution. The consent may be in the form of counterparts, each counterpart being signed by one or more Shareholders. If the consent is in one or more counterparts, and the counterparts bear different dates, then the resolution shall take effect on the earliest date upon which Shareholders holding a sufficient number of votes of Shares to constitute a Resolution of Shareholders have consented to the resolution by signed counterparts.
8.		DIRECTORS
8.1.		The first directors of the Company shall be appointed by the first registered agent within six (6) months of the date of incorporation of the Company; and thereafter, the directors shall be elected by Resolution of Shareholders. The Company shall be managed by a Board of Directors consisting of no more than seven (7) members, which number of members may not be increased without the Investors’ prior written consent and shall not be changed except pursuant to an amendment to the Memorandum and Articles. So long as Sequoia Capital China I, L.P. and its affiliates (“Sequoia”), whether individually or in the aggregate, hold or remain beneficially interested in at least 20% of the total number of Series A Shares and Series A1 Shares (in aggregate and on an as-converted basis), Sequoia shall be entitled to exclusively nominate, appoint, remove and replace one (1) director (the “Sequoia Representative”). In addition, the Series B Holders shall be entitled to nominate, appoint, remove and replace two (2) directors; provided that SIG China Investments One, Ltd. and its affiliates (“SIG”) shall have the sole and irrevocable right to exercise such rights of nomination, appointment, removal and replacement of one (1) director (the “SIG Representative”), and provided that Pacven ▇▇▇▇▇▇ Ventures VI, LP, and its affiliates (“▇▇▇▇▇▇”) shall have the sole and irrevocable right to exercise such rights of nomination, appointment, removal and replacement of one (1) director (the “▇▇▇▇▇▇ Representative”, and together with the SIG Representative and Sequoia Representative, the “Investor Representatives” and each an “Investor Representative”), so long as SIG and ▇▇▇▇▇▇ hold or remain beneficially interested in at least 50% or more of their respective original number of Series B Shares. An Investor Representative shall have the right to appoint alternates or proxies to attend any meeting of the Board. The holders of Ordinary Shares shall be entitled to nominate, appoint, remove and replace the remaining four (4) directors; the Existing Shareholders and the holders of Preferred Shares shall vote all their respective Shares to give effect to any such nomination, appointment, removal or replacement. Upon a Qualified Public Offering, the SIG Representative and ▇▇▇▇▇▇ Representative shall both resign as directors of the Company.
		All resolutions of the Board of Directors shall be adopted by a majority of the directors present, except as otherwise provided by law or in the Memorandum of the Articles.
8.2.		No person shall be appointed as a director, or nominated as a reserve director, of the Company unless he has consented in writing to be a director or to be nominated as a reserve director.
8.3.		Subject to Sub-Regulation 8.1 the minimum number of directors shall be one and there shall be no maximum number.
8.4.		Each director holds office for the term, if any, fixed by the Resolution of Shareholders or the Resolution of Directors appointing him, or until his earlier death, resignation or removal. If no term is fixed on the appointment of a director, the director serves indefinitely until his earlier death, resignation or removal.
8.5.		Subject to Article 8.1 above, a director may be removed from office.

(a)

with or without cause, by Resolution of Shareholders passed at a meeting of Shareholders called for the purposes of removing the director or for purposes including the removal of the director or by a written resolution passed by a least 75% of the Shareholders of the Company entitled to vote; or

(b)

with cause, by Resolution of Directors passed at a meeting of directors called for the purpose of removing the director or for purposes including the removal of the director.

8.6.		A director may resign his office by giving written notice of his resignation to the Company and the resignation has effect from the date the notice is received by the Company or from such later date as may be specified in the notice. A director shall resign forthwith as a director if he is, or becomes, disqualified from acting as a director under the Act.
8.7.		The directors may at any time appoint any person to be a director either to fill a vacancy or as an addition to the existing directors. Where the directors appoint a person as director to fill a vacancy, the term shall not exceed the term that remained when the person who has ceased to be a director ceased to hold office.
8.8.		A vacancy in relation to directors occurs if a director dies or otherwise ceases to hold office prior to the expiration of his term of office.
8.9.		Where the Company only has one Shareholder who is an individual and that Shareholder is also the sole director of the Company, the sole Shareholder/director may, by instrument in writing, nominate a person who is not disqualified from being a director of the Company as a reserve director of the Company to act in the place of the sole director in the event of his death.
8.10.		The nomination of a person as a reserve director of the Company ceases to have effect if:

(a)

before the death of the sole Shareholder/director who nominated him,

	(i)		he resigns as reserve director, or
	(ii)		the sole Shareholder/director revokes the nomination In writing; or

(b)

the sole Shareholder/director who nominated him ceases to be able to be the sole Shareholder/director of the Company for any reason other than his death.

8.11.

The Company shall keep a register of directors containing:

	(a)		the names and addresses of the persons who are directors of the Company or who have been nominated as reserve directors of the Company;
	(b)		the date on which each person whose name is entered in the register was appointed as a director, or nominated as a reserve director, of the Company;
	(c)		the date on which each person named as a director ceased to be a director of the Company;
	(d)		the date on which the nomination of any person nominated as a reserve director ceased to have effect; and
	(e)		such other information as may be prescribed by the Act.

8.12.		The register of directors may be kept in any such form as the directors may approve, but if it is in magnetic, electronic or other data storage form, the Company must be able to produce legible evidence of its contents. Until a Resolution of Directors determining otherwise is passed, the magnetic, electronic or other data storage shall be the original register of directors.
8.13.		Subject to all other approvals required under the Memorandum or the Articles, the Shareholders may, by Resolution of Directors, fix the emoluments of directors with respect to services to be rendered in any capacity to the Company.
8.14.		A director is not required to hold a Share as a qualification to office.

8.15.		The Board shall establish a compensation committee (the “Compensation Committee”) comprising three (3) members to manage certain compensation affairs of the Company, including implementing salary and equity guidelines for the Company, approving compensation packages, severance agreements and employment agreements for all senior managers (including but not limited to the chief executive officer and the chief financial officer) as well as administering the Company’s employee equity incentive plans, subject to the Company’s contractual obligations and any limitations in the Memorandum and the Articles; provided that, subject to Clause 8.1. (i) holders of Ordinary Shares shall be entitled to appoint one (1) director to sit on the Compensation Committee, (ii) Series A Holders shall be entitled to appoint one (1) director to sit on the Compensation Committee, (iii) subject to Clause 8.16(iv), Series B Holders shall be entitled to appoint one (1) director to sit on the Compensation Committee, and (iv) any allocation of shares under the Company’s employee equity incentive plans shall be subject to the Compensation Committee’s prior approval.
8.16.		The Board shall establish an audit committee of the Board (the “Audit Committee”) comprising three (3) members to establish a framework for and monitor financial accountability, and to review and supervise the financial reporting process and internal control procedures of the Company; provided that, subject to Clause 8.1. (i) holders of Ordinary Shares shall be entitled to appoint one (1) director to sit on the Audit Committee, (ii) Series A Holders shall be entitled to appoint one (1) director to sit on the Audit Committee (iii) Series B Holders shall be entitled to appoint one (1) director to sit on the Audit Committee, and (iv) the director appointed by Series B Holders to sit on the Compensation Committee will not be elected to sit on the Audit Committee, and vice versa.
8.17.		The company shall bear the reasonable cost associated with a director attending the meetings of the Board, including all reasonable travel and lodging expenses, provided that the prior approval of the Company be obtained before incurrence in excess of US$5,000.
8.18.		Each Investor shall have the right to designate an observer to attend all meetings of the Board (whether in person, by telephone or otherwise) in the capacity of a non-voting observer. Such right shall terminate upon a Qualified Public Offering. Any such non-voting observer shall not have the right to vote on matters tabled before the Board.
9.		POWERS OF DIRECTORS
9.1.		The business and affairs of the Company shall be managed by, or under the direction or supervision of, the directors of the Company. The directors of the Company have all the powers necessary for managing, and for directing and supervising, the business and affairs of the Company. The directors may pay all expenses incurred preliminary to and in connection with the incorporation of the Company and may exercise all such powers of the Company as are not by the Act or by the Memorandum or the Articles required to be exercised by the Shareholders.
9.2.		Each director shall exercise his powers for a proper purpose and shall not act or agree to the Company acting in a manner that contravenes the Memorandum, the Articles or the Act. Each director in exercising his powers or performing his duties, shall act honestly and in good faith in what the director believes to be the best interests of the Company.
9.3.		If the Company is the wholly owned subsidiary of a holding company, a director of the Company may, when exercising power or performing duties as a director, act in a manner which he believes is in the best interests of the holding company even though it may not be in the best interests of the Company.
9.4.		Any director which is a body corporate may appoint any individual as its duly authorised representative for the purpose of representing it at meetings of the directors, with respect to the signing of consents or otherwise.
9.5.		The continuing directors may act notwithstanding any vacancy in their body.

9.6.		The directors may by Resolution of Directors exercise all the powers of the Company to incur Indebtedness, liabilities or obligations and to secure indebtedness, liabilities or obligations whether of the Company or of any third party.
9.7.		All cheques, promissory notes, drafts, bills of exchange and other negotiable instruments and all receipts for moneys paid to the Company shall be signed, drawn, accepted, endorsed or otherwise executed, as the case may be, in such manner as shall from time to time be determined by Resolution of Directors.
9.8.		For the purposes of Section 175 (Disposition of assets) of the Act, the directors may by Resolution of Directors determine that any sale, transfer, lease, exchange or other disposition is in the usual or regular course of the business carried on by the Company and such determination is, in the absence of fraud, conclusive.
10.		PROCEEDINGS OF DIRECTORS
10.1.		Any one director (including, without limitation, any one director appointed by the holders of Preferred Shares) of the Company may call a meeting of the directors by sending a written notice to each other director.
10.2.		The directors of the Company or any committee thereof may meet at Such times and in such manner and places within or outside the British Virgin Islands as the directors may determine to be necessary or desirable.
10.3.		A director is deemed to be present at a meeting of directors if he participates by telephone or other electronic means and all directors participating in the meeting are able to hear each other.
10.4.		A director shall be given not less than seven (7) days’ notice, of meetings of directors, but a meeting of directors held without seven (7) days’ notice having been given to all directors shall be valid if all the directors entitled to vote at the meeting who do not attend waive notice of the meeting, and for this purpose the presence of a director at a meeting shall constitute waiver by that director The inadvertent failure to give notice of a meeting to a director, or the fact that a director has not received the notice, does not invalidate the meeting.
10.5.		A director may by a written instrument appoint an alternate who need not be a director and the alternate shall be entitled to attend meetings in the absence of the director who appointed him and to vote in place of the director until the appointment lapses or is terminated.
10.6.		A meeting of directors is duly constituted for all purposes if at the commencement of the meeting there are present in person or by alternate not less than three (3) directors, at least one (1) of which shall be a director appointed by Sequoia Capital China I, L.P., and at least one (1) of which shall be a director appointed by holders of Series B Shares. If within two (2) hours from the time appointed for the meeting a quorum is not present, the meeting shall stand adjourned to the sixth (6th) business day at the same time and place, and if at the adjourned meeting there are present within one hour from the time appointed for the meeting in person or by proxy not less than three (3) directors, those present shall constitute a quorum but otherwise the meeting shall be dissolved.
10.7.		If the Company has only one director the provisions herein contained for meetings of directors do not apply and such sole director has full power to represent and act for the Company in all matters as are not by the Act, the Memorandum or the Articles required to be exercised by the Shareholders. In lieu of minutes of a meeting the sole director shall record in writing and sign a note or memorandum of all matters requiring a Resolution of Directors. Such a note or memorandum constitutes sufficient evidence of such resolution for all purposes.

10.8.		At meetings of directors at which the Chairman of the Board is present, he shall preside as chairman of the meeting. If there is no Chairman of the Board or if the Chairman of the Board is not present, the directors present shall choose one of their number to be chairman of the meeting.
10.9.		An action that may be taken by the directors or a committee of directors at a meeting may also be taken by a Resolution of Directors or a resolution of a committee of directors consented to in writing by all directors or by all members of the committee, as the case may be without the need for any notice. The consent may be in the form of counterparts each counterpart being signed by one or more directors. If the consent is in one or more counterparts, and the counterparts bear different dates, then the resolution shall take effect on the date upon which the last director has consented to the resolution by Signed counterparts.
11.		COMMITTEES
11.1.		The directors may, by Resolution of Directors, designate one or more committees, each consisting of one or more directors, and delegate one or more of their powers, including the power to affix the Seal to the committee. All resolutions of each of the committees of the board of directors shall be adopted by a majority of the members of such committee.
11.2.		The directors have no power to delegate to a committee of directors any of the following powers:

	(a)		to amend the Memorandum or the Articles;
	(b)		to designate committees of directors;
	(c)		to delegate powers to a committee of directors;
	(d)		to appoint or remove directors;
	(e)		to appoint or remove an agent;
	(f)		to approve a plan of merger, consolidation or arrangement;
	(g)		to make a declaration of solvency or to approve a liquidation plan; or
	(h)		to make a determination that immediately, after a proposed Distribution the value of the Company’s assets will exceed its liabilities and the Company will be able to pay its debts as they fall due.

11.3.		Sub-Regulation 11.2(b) and (c) do not prevent a committee of directors, where authorised by the Resolution of Directors appointing such committee or by a subsequent Resolution of Directors, from appointing a sub-committee and delegating powers exercisable by the committee to the sub-committee.
11.4.		The meetings and proceedings of each committee of directors consisting of two (2) or more directors shall be governed mutatis mutandis by the provisions of the Articles regulating the proceedings of directors so far as the same are not superseded by any provisions in the Resolution of Directors establishing the committee.
11.5.		Where the directors delegate their powers to a committee of directors they remain responsible for the exercise of that power by the committee, unless they believed on reasonable grounds at all times before the exercise of the power that the committee would exercise the power in conformity with the duties imposed on directors of the Company under the Act.
12.		OFFICERS AND AGENTS

12.1.		The Company may by Resolution of Directors appoint officers of the Company at such times as may be considered necessary or expedient. Such officers may consist of a Chairman of the Board of Directors, a president and one (1) or more vice-presidents, secretaries and treasurers and such other officers as may from time to time be considered necessary or expedient. Any number of offices may be held by the same person.
12.2.		The officers shall perform such duties as are prescribed at the time of their appointment subject to any modification in such duties as may be prescribed thereafter by Resolution of Directors. In the absence of any specific prescription of duties it shall be the responsibility of the Chairman of the Board to preside at meetings of directors and Shareholders, the president to manage the day to day affairs of the Company, the vice-presidents to act in order of seniority in the absence of the president but otherwise to perform such duties as may be delegated to them by the president, the secretaries to maintain the register of members, minute books and records (other than financial records) of the Company and to ensure compliance with all procedural requirements imposed on the Company by applicable law, and the treasurer to be responsible for the financial affairs of the Company.
12.3.		The emoluments of all officers shall be fixed by Resolution of Compensation Committee.
12.4.		The officers of the Company shall hold office until their successors are duly appointed, but any officer elected or appointed by the directors may be removed at any time, with or without cause, by Resolution of Directors. Any vacancy occurring in any office of the Company may be filled by Resolution of Directors.
12.5.		The directors may, by Resolution of Directors, appoint any person, including a person who is a director, to be an agent of the Company.
12.6.		An agent of the Company shall have such powers and authority of the directors, including the power and authority to affix the Seal, as are set forth in the Articles or in the Resolution of Directors appointing the agent, except that no agent has any power or authority with respect to the following:

	(a)		to amend the Memorandum or the Articles;
	(b)		to change the registered office or agent;
	(c)		to designate committees of directors;
	(d)		to delegate powers to a committee of directors;
	(e)		to appoint or remove directors;
	(f)		to appoint or remove an agent;
	(g)		to fix emoluments of directors;
	(h)		to approve a plan of merger, consolidation or arrangement;
	(i)		to make a declaration of solvency or to approve a liquidation plan;
	(j)		to make a determination that immediately after a proposed Distribution the value of the Company’s assets will exceed its liabilities and the Company will be able to pay its debts as they fall due; or
	(k)		to authorise the Company to continue as a company incorporated under the laws of a jurisdiction outside the British Virgin Islands.

12.7.		The Resolution of Directors appointing an agent may authorise the agent to appoint one or more substitutes of delegates to exercise some or all of the powers conferred on the agent by the Company.
12.8.		The directors may remove an agent appointed by the Company and may revoke or vary a power conferred on him.
13.		CONFLICT OF INTERESTS
13.1.		A director of the Company shall, forthwith after becoming aware of the fact that he is interested in a transaction entered into or to be entered into by the Company, disclose interest to all other directors of the Company.
13.2.		For the purposes of Sub-Regulation 13.1, a disclosure to all other directors to the effect that a director is a member, director or officer of another named entity or has a fiduciary relationship with respect to the entity or a named individual and is to be regarded as interested in any transaction which may, after the date of the entry into the transaction or disclosure of the interest, be entered into with that entity or individual, is a sufficient disclosure of interest in relation to that transaction.
13.3.		A director of the Company who is interested in a transaction entered into or to be entered into by the Company may:

	(a)		vote on a matter relating to the transaction;
	(b)		attend a meeting of directors at which a matter relating to the transaction arises and be included among the directors present at the meeting for the purposes of a quorum; and
	(c)		sign a document on behalf of the Company, or do any other thing in his capacity as a director, that relates to the transaction,

		and, subject to compliance with the Act shall not, by reason of his office be accountable to the Company for any benefit which he derives from such transaction and no such transaction shall be liable to be avoided on the grounds of any such interest or benefit.
14.		INDEMNIFICATION
14.1.		Subject to the limitations hereinafter provided the Company shall indemnify against all expenses, including legal fees, and against all judgments; fines and amounts paid in settlement and reasonably incurred in connection with legal, administrative or investigative proceedings any person who:

	(a)		is or was a party or is threatened to be made a party to any threatened, pending or completed proceedings, whether civil, criminal, administrative or investigative, by reason of the fact that the person is or was a director of the Company; or
	(b)		is or was, at the request of the Company, serving as a director of, or in any other capacity is or was acting for another body corporate or a partnership, joint venture, trust or other enterprise.

14.2.		The indemnity in Sub-Regulation 14.1 only applies if the person acted honestly and in good faith with a view to the best interests of the Company and, in the case of criminal proceedings, the person had no reasonable cause to believe that their conduct was unlawful
14.3.		For the purposes of Sub-Regulation 14.2, a director acts in the best interests of the Company if he acts in the best interests of

(a)

the Company’s holding company; or

(b)

a Shareholder or Shareholders of the Company;

		in either case, in the circumstances specified in Sub-Regulation 9.3 or the Act, as the case may be.
14.4.		The decision of the directors as to whether the person acted honestly and in good faith and with a view to the best interests of the Company and as to whether the person had no reasonable cause to believe that his conduct was unlawful is, in the absence of fraud, sufficient for the purposes of the Articles, unless a question of law is involved.
14.5.		The termination of any proceedings by any judgment, order, settlement, conviction or the entering of a nolle prosequi does not, by itself, create a presumption that the person did not act honestly and in good faith and with a view to the best interests of the Company or that the person had reasonable cause to believe that his conduct was unlawful.
14.6.		Expenses, including legal fees, incurred by a director in defending any legal, administrative or investigative proceedings may be paid by the Company in advance of the final disposition of such proceedings upon receipt of an undertaking by or on behalf of the director to repay the amount if it shall ultimately be determined that the director is not entitled to be indemnified by the Company in accordance with Sub-Regulation 14.1.
14.7.		Expenses, including legal fees, incurred by a former director in defending any legal, administrative or investigative proceedings may be paid by the Company in advance of the final disposition of such proceedings upon receipt of an undertaking by or on behalf of the former director to repay the amount if it shall ultimately be determined that the former director is not entitled to be indemnified by the Company in accordance with Sub-Regulation 14.1 and upon such terms and conditions, if any, as the Company deems appropriate.
14.8.		The indemnification and advancement of expenses provided by, or granted pursuant to, this Article is not exclusive of any other rights to which the person seeking indemnification or advancement of expenses may be entitled under any agreement, Resolution of Shareholders, resolution of disinterested directors or otherwise, both as acting in the person’s official capacity and as to acting in another capacity while serving as a director of the Company.
14.9.		If a person referred to in Sub-Regulation 14.1 has been successful in defence of any proceedings referred to in Sub-Regulation 14.1, the person is entitled to be indemnified against all expenses, Including legal fees, and against all judgments, fines and amounts paid in settlement and reasonably incurred by the person in connection with the proceedings.
14.10.		The Company may purchase and maintain insurance in relation to any person who is or was a director, officer or liquidator of the Company, or who at the request of the Company is or was serving as a director, officer or liquidator of, or in any other capacity is or was acting for, another company or a partnership, joint venture, trust or other enterprise, against any liability asserted against the person and incurred by the person in that capacity, whether or not the Company has or would have had the power to indemnify the person against the liability as provided in the Articles.
15.		RECORDS
15.1.		The Company shall keep the following documents at the office of its registered agent:

	(a)		the Memorandum and the Articles;
	(b)		the register of members, or a copy of the register of members;
	(c)		the register of directors, or a copy of the register of directors; and
	(d)		copies of all notices and other documents filed by the Company with the Registrar of Corporate Affairs in the previous ten (10) years.

15.2.		Until the directors determine otherwise by Resolution of Directors the Company shall keep the original register of members and original register of directors at the office of its registered agent.
15.3.		If the Company maintains only a copy of the register of members or a copy of the register of directors at the office of its registered agent it shall:

	(a)		within fifteen (15) days of any change in either register, notify the registered agent in writing of the change; and
	(b)		provide the registered agent with a written record of the physical address of the place or places at which the original register of members or the original register of directors is kept.

15.4.

The Company shall keep the following records at the office of its registered agent or at such other place or places, within or outside the British Virgin Islands, as the directors may determine:

	(a)		minutes of meetings and Resolutions of Shareholders and classes of Shareholders;
	(b)		minutes of meetings and Resolutions of Directors and committees of directors; and
	(c)		an impression of the Seal.

15.5.		Where any original records referred to in this Regulation are maintained other than at the office of the registered agent of the Company, and the place at which the original records is changed, the Company shall provide the registered agent with the physical address of the new location of the records of the Company within fourteen (14) days of the change of location.
15.6.		The records kept by the Company under this Regulation shall be in written form or either wholly or partly as electronic records complying with the requirements of the Electronic Transactions Act, 2001 (No. 5 of 2001) as from time to time amended or re-enacted.
16.		REGISTER OF CHARGES
		The Company shall maintain at the office of its registered agent a register of charges in which there shall be entered the following particulars regarding each mortgage charge and other encumbrance created by the Company:

	(a)		the date of creation of the charge;
	(b)		a short description of the liability secured by the charge;
	(c)		a short description of the property charged;
	(d)		the name and address of the trustee for the security or, if there is no such trustee, the name and address of the chargee;
	(e)		unless the charge is a security to bearer, the name and address of the holder of the charge; and
	(f)		details of any prohibition or restriction contained in the instrument creating the charge on the power of the Company to create any future charge ranking in priority to or equally with the charge.

17.

SEAL

		The Company shall have a Seal and may have more than one Seal and references herein to the Seal shall be references to every Seal which shall have been duly adopted by Resolution of Directors. The directors shall provide for the safe custody of the Seal and for an imprint thereof to be kept at the registered office. Except as otherwise expressly provided herein the Seal when affixed to any written instrument shall be witnessed and attested to by the signature of any one director or other person so authorised from time to time by Resolution of Directors. Such authorisation may be before or after the Seal is affixed, may be general or specific and may refer to any number of sealings. The directors may provide for a facsimile of the Seal and of the signature of any director or authorised person which may be reproduced by printing or other means on any instrument and it shall have the same force and validity as if the Seal had been affixed to such instrument and the same had been attested to as hereinbefore described.
18.		DISTRIBUTIONS BY WAY OF DIVIDEND
18.1.		Subject to receipt of all approval required under the Memorandum or elsewhere in the Articles, the directors of the Company may, by Resolution of Directors, authorise a Distribution by way of dividend at a time and of an amount they think fit if they are satisfied, on reasonable grounds, that, immediately after the Distribution, the value of the Company’s assets will exceed its liabilities and the Company will be able to pay its debts as they fail due.
18.2.		Dividends may be paid in money, Shares, or other property.
18.3.		Notice of any dividend that may have been declared shall be given to each Shareholder as specified in Sub-Regulation 20.1 and all dividends unclaimed for three (3) years after having been declared may be forfeited by Resolution of Directors for the benefit of the Company.
18.4.		No dividend shall bear interest as against the Company and no dividend shall be paid on Treasury Shares.
19.		ACCOUNTS AND AUDIT
19.1.		The Company shall keep records that are sufficient to show and explain the Company’s transactions and that will, at any time, enable the financial position of the Company to be determined with reasonable accuracy.
19.2.		The Company may by Resolution of Shareholders call for the directors to prepare periodically and make available a profit and loss account and a balance sheet. The profit and loss account and balance sheet shall be drawn up so as to give respectively a true and fair view of the profit and loss of the Company for a financial period and a true and fair view of the assets and liabilities of the Company as at the end of a financial period.
19.3.		The Company may by Resolution of Shareholders call for the accounts to be examined by auditors.
19.4.		The first auditors shall be appointed by Resolution of Directors; subsequent auditors shall be appointed by Resolution of shareholders or by Resolution of Directors.
19.5.		The auditors may be Shareholders, but no director or other officer shall be eligible to be an auditor of the Company during their continuance in office.
19.6.		The remuneration of the auditors of the Company may be fixed by Resolution of Directors.
19.7.		The auditors shall examine each profit and loss account and balance sheet required to be laid before a meeting of the Shareholders or otherwise given to Shareholders and shall state in a written report whether or not:

(a)

in their opinion the profit and loss account and balance sheet give a true and fair view respectively of the profit and loss for the period covered by the accounts, and of the assets and liabilities of the Company at the end of that period; and

(b)

all the information and explanations required by the auditors have been obtained.

19.8.		The report of the auditors shall be annexed to the accounts and shall be read at the meeting of Shareholders at which the accounts are laid before the Company or shall be otherwise given to the Shareholders.
19.9.		Every auditor of the Company shall have a right of access at all times to the books of account and vouchers of the Company, and shall be entitled to require from the directors and officers of the Company such information and explanations as he thinks necessary for the performance of the duties of the auditors.
19.10.		The auditors of the Company shall be entitled to receive notice of, and to attend any meetings of Shareholders at which the Company’s profit and loss account and balance sheet are to be presented.
20.		NOTICES
20.1.		Any notice, information or written statement to be given by the Company to Shareholders may be given by personal service or by mail addressed to each Shareholder at the address shown in the register of members.
20.2.		Any summons, notice, order, document, process, information or written statement to be served on the Company may be served by leaving it, or by sending it by registered mail addressed to the Company at its registered office, or by leaving it with, or by sending it by registered mail to, the registered agent of the Company.
20.3.		Service of any summons, notice, order, document, process,; information or written statement to be served on the Company may be proved by showing that the summons, notice, order, document, process, information or written statement was delivered to the registered office or the registered agent of the Company or that it was mailed in such time as to admit to its being delivered to the registered office or the registered agent of the Company in the normal course of delivery within the period prescribed for service and was correctly addressed and the postage was prepaid.
21.		VOLUNTARY LIQUIDATION
		Subject to the provisions of the Memorandum and the Act, the Company may by Resolution of Shareholders appoint a voluntary liquidator.
22.		CONTINUATION
		The Company may by Resolution of Shareholders or by a resolution passed unanimously by all directors of the Company continue as a company incorporated under the laws of a jurisdiction outside the British Virgin Islands in the manner provided under those laws.
23.		THE PROVISIONS SET OUT IN THE APPENDIX
		All provisions set out in the main body of these Articles shall be subject to the terms set out in the Appendix hereto, which provide further details on the rights agreed among the holders of Series A Shares, holders of Series A1 Shares, and holders of Series B Shares. In the event of any difference between the provisions set out in the main body of these Articles and the provisions set out in the Appendix, the Appendix shall prevail.

APPENDIX

SPECIAL PROVISIONS

     1. INFORMATION RIGHTS; BOARD REPRESENTATION.

     (a) Information Rights. The Company covenants and agrees that, commencing on the date of the shareholders agreement entered into by, among others, the Company, the Existing Shareholders, the holders of Series A Shares (the “Series A Holders”), the holders of Series A1 Shares (the “Series A1 Holders”) and the holders of Series B Shares (the “Series B Holders”) (the “Shareholders Agreement”), for so long as (1) 20% of the Series A Shares together with Series A1 Shares (on an as converted basis) are outstanding, or (2) 20% of the Series B Shares (on an as converted basis) are outstanding, the Company will deliver, unless such rights are waived by each holder of the relevant class of outstanding Preferred Shares, to each holder of the relevant class of outstanding Preferred Shares:

          (i) audited annual consolidated financial statements, within one hundred and twenty (120) days after the end of each fiscal year, prepared in accordance with the Hong Kong generally accepted accounting principles (the “Hong Kong GAAP”) or international Financial Reporting Standards (“IFRS”) and audited by a “Big 4” accounting firm selected by the board of directors of the Company;

          (ii) unaudited monthly consolidated financial statements, within thirty (30) days of the end of each month, prepared in accordance with the PRC generally accepted accounting principles (the “PRC GAAP”) or IFRS which shall indicate variances from the annual budget of the Company with respect to key line items;

          (iii) an annual consolidated budget for the following fiscal year, within thirty (30) days prior to the end of each fiscal year; and

          (iv) copies of all documents or other information sent to any shareholder (the above rights, collectively, the “Information Rights”). All financial statements to be provided pursuant to Section 1(a) of this Appendix shall include an income statement, a balance sheet and a cash flow statement for the relevant period and shall be prepared in conformance with Hong Kong GAAP except for item (ii) above, which shall be prepared in accordance with PRC GAAP.

     (b) Inspection Rights. The Company further covenants and agrees that commencing on the date of the Shareholders Agreement, for so long as any Preferred Shares are outstanding, each holder of Preferred Shares shall have (i) the right to inspect facilities, records and books of the Company and any of its subsidiaries (including any Subsidiary) at any time during regular working hours on reasonable prior notice to the Company, and (ii) the right to discuss the business, operations and conditions of the Company and any of its subsidiaries (including any Subsidiary) with its directors, officers, employees, accountants, legal counsel and investment bankers (the “Inspection Rights”). All such Inspection Rights must be exercised in good faith and reasonably.

     (c) Termination of Rights. The information Rights and Inspection Rights shall terminate upon consummation of a firm underwritten public offering of the ordinary shares, with a par value of US$0.001 per share, of the Company (the “Ordinary Shares”) in the United States, that has been registered under the United States Securities Act of 1933, as amended from time to time, including any successor statutes (the “Securities Act”), with gross proceeds to the Company in excess of US$70,000,000 (prior

to underwriters’ discounts and commissions) and at a pre-public offering market capitalization of at least US$300,000,000, or in a similar public offering of the Ordinary Shares of the Company in another jurisdiction which results in the Ordinary Shares trading publicly on a recognized regional or national securities exchange; provided that such offering satisfies the foregoing gross proceeds and pre-public offering market capitalization requirements (a “Qualified IPO”).

     2. REGISTRATION RIGHTS.

          2.1 Applicability of Rights. The holders of Preferred Shares shall be entitled to the following rights with respect to any potential public offering of the Company’s Ordinary Shares in the United States.

          2.2 Definitions. For purposes of Section 2 of this Appendix:

               (a) Registration. The terms “register,” “registered,” and “registration” refer to a registration effected by preparing and filing a registration statement which is in a form which complies with, and is declared effective by the SEC (as defined below) in accordance with, the Securities Act.

               (b) Registrable Securities. The term “ Registrable Securities” shall mean: (1)any Ordinary Shares of the Company issued or to be issued pursuant to conversion of any Preferred Shares, (2) any Ordinary Shares of the Company issued (or issuable upon the conversion or exercise of any warrant, right or other security which is issued) as a dividend or other distribution with respect to, or in exchange for or in replacement of, any Preferred Shares, and (3) any other Ordinary Shares of the Company owned or hereafter acquired by a holder of Preferred Shares. Notwithstanding the foregoing, “Registrable Securities” shall exclude any Registrable Securities sold by a person in a transaction in which rights under Section 2 of this Appendix are not assigned in accordance with the Shareholders Agreement, and any Registrable Securities which are sold in a registered public offering under the Securities Act or analogous statute of another jurisdiction, or sold pursuant to Rule 144 promulgated under the Securities Act or analogous rule of another jurisdiction.

               (c) Registrable Securities Then Outstanding. The number of shares of “Registrable Securities then outstanding” shall mean the number of Ordinary Shares of the Company that are Registrable Securities and are then issued and outstanding, issuable upon conversion of Preferred Shares then issued and outstanding or issuable upon conversion or exercise of any warrant, right or other security then outstanding.

               (d) Holder. For purposes of Section 2 of this Appendix the term “Holder” shall mean any person owning or having the rights to acquire Registrable Securities or any permitted assignee of record of such Registrable Securities to whom rights under Section 2 of this Appendix have been duly assigned in accordance with the Shareholders Agreement.

               (e) Form F-3. The term “Form F-3” shall mean such respective form under the Securities Act as is in effect on the date hereof or any successor registration form under the Securities Act subsequently adopted by the SEC which permits inclusion or incorporation of substantial information by reference to other documents filed by the Company with the SEC.

               (f) SEC. The term “SEC” or “Commission” shall mean the U.S. Securities and Exchange Commission.

               (g) Registration Expenses The term “Registration Expenses shall mean all expenses incurred by the Company in complying with Sections 2.3, 2.4 and 2.5 of this Appendix, including, without limitation, all registration and filing fees, printing expenses, fees, and disbursements of counsel for the Company, reasonable fees and disbursements of counsel for the Holders, Blue Sky fees and expenses and the expense of any special audits incident to or required by any such registration (but excluding the compensation of regular employees of the Company which shall be paid in any event by the Company).

               (h) Selling Expenses. The term “Selling Expenses” shall mean all underwriting discounts and selling commissions applicable to the sale of Registrable Securities pursuant to Sections 2.3, 2.4 and 2.5 of this Appendix.

               (i) Exchange Act. The term “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and any successor statute.

          2.3 Demand Registration.

               (a) Request by Holders. If the Company shall, at any time after the earlier of (1) two (2) years after the date of the Shareholders Agreement or (ii) six (6) months following a Qualified IPO, receive a written request from Series B Holders of at least 50% of the Series B Shares then outstanding, or the Holders of at least 50% of the Registrable Securities then outstanding, that the Company file a registration statement under the Securities Act covering the registration of such Holders Registrable Securities pursuant to Section 2.3 of this Appendix, then the Company shall, within ten (10) business days of the receipt of such written request, give written notice of such request (“Request Notice”) to all Holders, and use its best efforts to effect, as soon as practicable, the registration under the Securities Act of all Registrable Securities that the Holders request to be registered and included in such registration by written notice given by such Holders to the Company within twenty (20) days after receipt of the Request Notice, subject only to the limitations of Section 2.3 of this Appendix; provided that the Company shall not be obligated to effect any such registration If the Company has, within the six (6) month period preceding the date of such request, already effected a registration under the Securities Act pursuant to Section; 2.3 or Section 2.5 of this Appendix or in which the Holders had an opportunity to participate pursuant to the provisions of Section 2.4 of this Appendix, other than a registration from which the Registrable Securities of the Holders have been excluded (with respect to all or any portion of the Registrable Securities the Holders requested be included in such registration) pursuant to the provisions of Section 2.4(a) of this Appendix.

               (b) Underwriting. If the Holders initiating the registration request under Section 2.3 of this Appendix (the “Initiating Holders”) intend to distribute the Registrable Securities covered by their request by means of an underwriting, then they shall so advise the Company as a part of their request made pursuant to Section 2.3 of this Appendix and the Company shall include such information in the Request Notice. In such event the right of any Holder to include its Registrable Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting (unless otherwise mutually agreed by a majority in interest of the Initiating Holders and such Holder) to the extent provided herein. All Holders proposing to distribute their securities through such underwriting shall enter into an underwriting agreement in customary form with the managing underwriter or underwriters selected for such underwriting by the Holders of a majority of the Registrable Securities being registered and reasonably acceptable to the Company. Notwithstanding any other provision of Section 2.3 of this Appendix, if the underwriter(s) advise(s) the Company in writing that marketing factors require a limitation of the number of securities to be underwritten, then the Company shall so advise all Holders of

Registrable Securities which would otherwise be registered and underwritten pursuant hereto, and the number of Registrable Securities that may be included in the underwriting shall be reduced as required by the underwriter(s) and allocated among the Holders of Registrable Securities on a pro rata basis according to the number of Registrable Securities then outstanding held by each Holder requesting registration (including the Initiating Holders); provided, however, that the number of shares of Registrable Securities to be included in such underwriting and registration shall not be reduced unless all other securities are first entirely excluded from the underwriting and registration including, without limitation, all shares that are not Registrable Securities and are held by any other person, including, without limitation, any person who is an employee, officer or director of the Company or any subsidiary of the Company; provided further, that at least 25% of shares of Registrable Securities requested by the Holders to be included in such underwriting and registration shall be so included. If any Holder disapproves of the terms of any such underwriting, such Holder may elect to withdraw therefrom by written notice to the Company and the underwriter(s), delivered at least ten (10) business days prior to the effective date of the registration statement. Any Registrable Securities, excluded or withdrawn from such underwriting shall be excluded and withdrawn from the registration.

               (c) Maximum Number of Demand Registrations. The Company shall not be obligated to effect more than two (2) demand registrations initiated by any Series B Holder and two (2) demand registrations initiated by the Holders of at least 50% of the Registrable Securities referred to under Section 2.3 of the Series A1 Shareholders Agreement then outstanding.

               (d) Deferral. Notwithstanding the foregoing, if the Company shall furnish to Holders requesting registration pursuant to Section 2.3 of this Appendix, a certificate signed by the President or Chief Executive Officer of the Company stating that in the good faith judgment of the Board, it would be materially detrimental to the Company and its shareholders for such registration statement to be filed at such time, then the Company shall have the right to defer such filing for a period of not more than ninety (90) days after receipt of the request of the Initiating Holders; provided, however, that the Company may not utilize this right more than once in, any twelve (12) month period; provided further, that the Company shall not register any other of its shares during such twelve (12) month period. A demand right shall not be deemed to have been exercised until such deferred registration shall have been effected.

          2.4 Piggyback Registrations.

               (a) The Company shall notify all Holders of Registrable Securities in writing at least thirty (30) days prior to filing any registration statement under the Securities Act for purposes of effecting a public offering of securities of the Company (including, but not limited to, registration statements relating to secondary offerings of securities of the Company, but excluding registration statements relating to any registration under Section 2.3 or Section 2.5 of the Shareholders Agreement or to any employee benefit plan or a corporate reorganization or other Rule 145 transaction, an offer and sale of debt securities, or a registration on any registration form that does not permit secondary sales), and shall afford each such Holder an opportunity to include in such registration statement all or any part of the Registrable Securities then held by such Holder. Each Holder desiring to include in any such registration statement all or any part of the Registrable Securities held by it shall within twenty (20) days after receipt of the above-described notice from the Company, so notify the Company in writing, and in such notice shall inform the Company of the number of Registrable Securities such Holder wishes to include in such registration statement. If a Holder decides not to include all of its Registrable Securities in any registration statement thereafter filed by the Company, such Holder shall nevertheless continue to have the right to include any Registrable Securities in any subsequent

registration statement or registration statements as may be filed by the Company with respect to offerings of its securities, all upon the terms and conditions set forth herein.

               (b) Underwriting. If a registration statement under which the Company gives notice under Section 2.4 of this Appendix is for an underwritten offering, then the Company shall so advise the Holders of Registrable Securities. In such event, the right of any such Holder’s Registrable Securities to be included in a registration pursuant to Section 2.4 of this Appendix shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders proposing to distribute their Registrable Securities through such underwriting shall enter into an underwriting agreement in customary form with the managing underwriter or underwriters selected for such underwriting. Notwithstanding any other provision of the Shareholders Agreement but subject to Section 2.12, if the managing underwriter(s) determine(s) in good faith that marketing factors require a limitation of the number of shares to be underwritten, then the managing underwriter(s) may exclude shares from the registration and the underwriting, and the number of shares that may be included in the registration and the underwriting shall be allocated, first, to the Company, second, to each of the Holders requesting inclusion of their Registrable Securities in such registration statement on a pro rata basis based on the total number of shares of Registrable Securities then held by each such Holder, and third, to holders of other securities of the Company; provided, however, that the right of the underwriter(s) to exclude shares (including Registrable Securities) from the registration and underwriting as described above shall be restricted so that (i) except for the case of an initial public offering of the Ordinary Shares of the Company, the number of Registrable Securities included in any such registration is not reduced below 25% of the aggregate number of shares of Registrable Securities for which inclusion has been requested; and (ii) all shares that are not Registrable Securities and are held by any other person, including, without limitation, any person who is an employee, officer or director of the Company (or any subsidiary of the Company) shall first be excluded from such registration and underwriting before any Registrable Securities are so excluded unless otherwise approved by the majority of the Holders of the Registrable Securities in writing. if any Holder disapproves of the terms of any such underwriting, such Holder may elect to withdraw therefrom by written notice to the Company and the underwriter(s), delivered at least ten (10) business days prior to the effective date of the registration statement Any Registrable Securities excluded or withdrawn from such underwriting shall be excluded and withdrawn from the registration.

               (c) Not Demand Registration. Registration pursuant to Section 2.4 of this Appendix shall not be deemed to be a demand registration as described in Section 2.3 of this Appendix. There shall be no limit on the number of times the Holders may request registration of Registrable Securities under Section 2.4 of this Appendix.

          2.5 Form F-3 Registration. In case the Company shall receive from (i) any investor, or (ii) any Holder or Holders of a majority of all Registrable Securities then outstanding a written request or requests that the Company effect a registration on Form F-3 and any related qualification or compliance with respect to all or a part of the Registrable Securities owned by such Holder or Holders, then the Company will;

               (a) Notice. Promptly give written notice of the proposed registration and the Holder’s of Holders’ request therefor, and any related qualification or compliance, to all other Holders of Registrable Securities; and

               (b) Registration. As soon as practicable, effect such registration and all such qualifications and compliances as may be so requested and as would permit or facilitate the sale

and distribution of all or such portion of such Holders or Holders’ Registrable Securities as are specified in such request, together with all or such portion of the Registrable Securities of any other Holder or Holders joining in such request as are specified in a written request given within twenty (20) days after the Company provides the notice contemplated by Section 2.5(a) of this Appendix; provided, however, that the Company shall not be obligated to effect any such registration, qualification or compliance pursuant to Section 2.5 of this Appendix;

                    (i) if Form F-3 is not available for such offering by the Holders;

                    (ii) if the Holders, together with the holders of any other securities of the Company entitled to inclusion in such registration, propose to sell Registrable Securities and such other securities (if any) at an aggregate price to the public of less than US$500,000;

                    (iii) if the Company shall furnish to the Holders a certificate signed by the President or Chief Executive Officer of the Company stating that in the good faith judgment of the Board of Directors of the Company, it would be materially detrimental to the Company and its shareholders for such Form F-3 Registration to be effected at such time, in which event the Company shall have the right to defer the filing of the Form F-3 registration statement no more than once during any twelve (12) month period for a period of not more than sixty (60) days after receipt of the request of the Holder or Holders under Section 2.5 of this Appendix; provided that the Company shall not register any of its other shares during such sixty (60) day period;

                    (iv) if the Company has, within the six (6) month period preceding the date of such request, already effected a registration under the Securities Act other than a registration from which the Registrable Securities of Holders have been excluded (with respect to all or any portion of the Registrable Securities the Holders requested be included in such registration) pursuant to the provisions of Sections 2.3(b) and 2.4(b) of this Appendix; or

                    (v) in any particular jurisdiction in which the Company would be required to qualify to do business or to execute a general consent to service of process in effecting such registration, qualification or compliance.

               (c) Not Demand Registration. Form F-3 registrations shall not be deemed to be demand registrations as described in Section 2.3 of this Appendix. Except as otherwise provided herein, there shall be no limit on the number of times the Holders may request registration of Registrable Securities under Section 2.5 of this Appendix.

               (d) Underwriting. If the Holders of Registrable Securities requesting registration under Section 2.5 of this Appendix intend to distribute the Registrable Securities covered by their request by means of an underwriting, the provisions of Section 2.3(b) of this Appendix shall apply to such registration.

          2.6 Expenses. All Registration Expenses incurred in connection with any registration pursuant to Sections 2.3, 2.4 or 2.5 of this Appendix (but excluding Selling Expenses) shall be borne by the Company. Each Holder participating in a registration’ pursuant to Sections 2.3, 2.4 or 2.5 of this Appendix shall bear such Holder’s proportionate share (based on the total number of shares sold in such registration other than for the account of the Company) of all Selling Expenses or other amounts payable to underwriter(s) or brokers, in connection with such offering by the Holders. Notwithstanding the foregoing the Company shall not be; required to pay for any expenses of any registration proceeding begun pursuant to Section 2.3 of this Appendix if the registration request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered, unless the Holders

of a majority of the Registrable Securities then outstanding agree that such registration constitutes the use by the Holders of one (1) demand registration pursuant to Section 2.3 of this Appendix (in which case such registration shall also constitute the use by all Holders of Registrable Securities of one (1) such demand registration); provided further, however, that if at the time of such withdrawal, the Holders have learned of a material adverse change in the condition, business, or prospects of the Company not known to the Holders at the time of their request for such registration and have withdrawn their request for registration with reasonable promptness after learning of such material adverse change, then the Holders shall not be required to pay any of such expenses and such registration shall not constitute the use of a demand registration pursuant to Section 2.3 of this Appendix.

          2.7 Obligations of the Company. Whenever required to effect the registration of any Registrable Securities under the Shareholders Agreement the Company shall, as expeditiously as reasonably possible.

               (a) Registration Statement. Prepare and file with the SEC a registration statement with respect to such Registrable Securities and use its best efforts to cause such registration statement to become effective, and, upon the request of the Holders of a majority of the Registrable Securities registered thereunder, keep such registration statement effective for a period of up to ninety (90) days or, in the case of Registrable Securities registered under Form F-3 in accordance with Rule 415 under the Securities Act or a successor rule, until the distribution contemplated in the registration statement has been completed; provided, however, that (i) such ninety (90) day period shall be extended for a period of time equal to the period any Holder refrains from selling any securities included in such registration at the request of the underwriter(s), and (ii) in the case of any registration of Registrable Securities on Form F-3 which are intended to be offered on a continuous or delayed basis, such ninety (90) day period shall be extended, if necessary, to keep the registration statement effective until all such Registrable Securities are sold.

               (b) Amendments and Supplements. Prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such registration statement.

               (c) Prospectuses. Furnish to the Holders such number of copies of a prospectus, including a preliminary prospectus, in conformity with the requirements of the Securities Act, and such other documents as they may reasonably request in order to facilitate the disposition of the Registrable Securities owned by them that are included in such registration.

               (d) Blue Sky. Use its best efforts to register and qualify the securities covered by such registration statement under such other securities or Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders; provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of process in any such states or jurisdictions, unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act.

               (e) Underwriting. In the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement in usual and customary form, with the managing underwriter(s) of such offering.

               (f) Notification. Notify each Holder of Registrable Securities covered by such registration statement at any time when a prospectus relating thereto is required to be delivered under the Securities Act of (i) the issuance of any stop order by the SEC in respect of such registration

statement, or (ii) the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing.

               (g) Opinion and Comfort Letter. Furnish, at the request of any Holder requesting registration of Registrable Securities, on the date that such Registrable Securities are delivered to the underwater(s) for sale, if such securities are being sold through underwriters, or, if such securities are not being sold through underwriters, on the date that the registration statement with respect to such securities becomes effective, (i) an opinion, dated as of such date, of the counsel representing the Company for the purposes of such registration, in form and substance as is customarily given to underwriters in an underwritten public offering and reasonably satisfactory to a majority in interest of the Holders requesting registration, addressed to the underwriters, if any, and (ii) letters dated as of (x) the effective date of the registration statement covering such Registrable Securities and (y) the closing date of the offering from the independent certified public accountants of the Company, in form and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering and reasonably satisfactory to a majority in interest of the Holders requesting registration, addressed to the underwriters, if any.

          2.8 Furnish Information. It shall be a condition precedent to the obligations of the Company to take any action pursuant to Sections 2.3, 2.4 or 2.5 of this Appendix that the selling Holders shall furnish to the Company such information regarding themselves, the Registrable Securities held by them and the intended method of disposition of such securities as shall be required to timely effect the Registration of their Registrable Securities.

          2.9 Indemnification. In the event any Registrable Securities are included in a registration statement under Section 2.3, 2.4 or 2.5 of this Appendix:

               (a) By the Company. To the extent permitted by law, the Company will indemnify and hold harmless each Holder, its partners, officers, directors, legal counsel, any underwriter (as defined in the Securities Act) for such Holder and each person, if any, who controls such Holder or underwriter within the meaning of the Securities Act or the Exchange Act, against arty losses, claims, damages, or liabilities (joint or several) to which they may become subject under the Securities Act, the Exchange Act, or other United States federal or state law, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a “Violation”):

                     (i) any untrue statement or alleged untrue statement of a material fact contained in such registration statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto;

                     (ii) the omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading; or

                    (iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any United States federal or state securities law, or any rule or regulation promulgated under the Securities Act, the Exchange Act, or any United States federal or state securities law in connection with the offering covered by such registration statements;

and the Company will reimburse each such Holder, its partner, officer, director, legal counsel, underwriter

or controlling person for any legal or other expenses reasonably incurred by them, as incurred, in connection with investigating or defending any such loss, claim, damage, liability or action: provided, however, that the indemnity agreement contained in Section 2.9(a) of this Appendix shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable in any such case for any such loss, claim, damage, liability or action to the extent that it arises out of or is based upon a Violation which occurs in reliance upon and in conformity with written information furnished expressly for use in connection with such registration by such Holder, or any partner, officer, director, legal counsel, underwriter or controlling person of such Holder.

               (b) By Selling Holders. To the extent permitted by law, each selling Holder will, if Registrable Securities held by Holder are included in the securities as to which such registration qualifications or compliance is being effected, indemnify and hold harmless the Company, each of its directors, each of its officers who has signed the registration statement, each person, if any, who controls the Company within the meaning of the Securities Act, any underwriter and any other Holder selling securities under such registration statement or any of such other Holder’s partners, directors, officers, legal counsel or any person who controls such Holder within the meaning of the Securities Act or the Exchange Act, against any losses, claims, damages or liabilities (joint or several) to which the Company or any such director, officer, legal counsel, controlling person, underwriter or other such Holder, partner or director, officer or controlling person of such other Holder may become subject under the Securities Act, the Exchange Act or other United States federal or state law, insofar as such losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such Holder expressly for use in connection with such registration; and each such Holder will reimburse any legal or other expenses reasonably incurred by the Company or any such director, officer, controlling person, underwriter or other Holder, partner, officer, director or controlling person of such other Holder in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the indemnity agreement contained in Section 2.9(b) of this Appendix shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action If such settlement is effected without the consent of the Holder, which consent shall not be unreasonably withheld; and provided, further, that in no event shall any indemnity under Section 2.9(b) of this Appendix exceed the net proceeds received by such Holder in the registered offering out of which the applicable Violation arises.

               (c) Notice. Promptly after receipt by an indemnified party under Section 2.9 of this Appendix of notice of the commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under Section 2.9 of this Appendix, deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party shall have the right to retain its own counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential conflict of interests between such indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action shall relieve such indemnifying party of liability to the indemnified party under Section 2.9 of this Appendix to the extent the indemnifying party is prejudiced as a result thereof, but the omission to so deliver written notice to the indemnifying party will not relieve it of any liability that if may have to any indemnified party otherwise than under Section 2.9 of this Appendix.

               (d) Contribution. In order to provide for just and equitable contribution to joint liability under the Securities Act in any case in which either (i) any indemnified party makes a claim for indemnification pursuant to Section 2.9 of this Appendix but it is judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal of the denial of the last right of appeal) that such indemnification may not be enforced in such case notwithstanding the fact that Section 2.9 of this Appendix provides for indemnification in such case, or (ii) contribution under the Securities Act may be required on the part of any indemnified party in circumstances for which indemnification is provided under Section 2.9 of this Appendix; then, and in each such case, the indemnified party and the indemnifying party will contribute to the aggregate losses, claims, damages or liabilities to which they may be subject (after contribution from others) in such proportion so that a Holder (together with its related persons is responsible for the portion represented by the percentage that the public offering price of its Registrable Securities offered by and sold under the registration statement bears to the public offering price of all securities offered by and sold under such registration statement, and the Company and other selling Holders are responsible for the remaining portion. The relative fault of the indemnifying party and of the indemnified party shall be determined by a court of law by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission; provided, however, that, in any such case; (A) no Holder will be required to contribute any amount in excess of the net proceeds to such Holder from the sale of all such Registrable Securities offered and sold by such Holder pursuant to such registration statement; and (B) no person or entity guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any person or entity who was not guilty of such fraudulent misrepresentation.

               (e)  Survival; Consents to Judgments and Settlements. The obligations of the Company and Holders under Section 2.9 of this Appendix shall survive the completion of any offering of Registrable Securities in a registration statement, regardless of the expiration of any statutes of limitation or extensions of such statutes. No indemnifying party, in the defense of any such claim or litigation, shall, except with the consent of each indemnified party, consent to entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

          2.10 Termination of the Company’s Obligations. The Company’s obligations under Sections 2.3, 2.4 and 2.5 of this Appendix with respect to any Registrable Securities proposed to be sold by a Holder in a registration pursuant to Sections 2.3, 2.4 or 2.5 of this Appendix shall terminate on the seventh (7^th) anniversary of a Qualified IPO of the Company.

          2.11 No Registration Rights to Third Parties. Without the prior written consent of the Holders of a majority in interest of the Registrable Securities then outstanding, the Company covenants and agrees that it shall not grant, or cause of permit to be created, for the benefit of any person or entity any registration rights of any kind (whether similar to the demand, “piggyback” or Form F-3 registration rights described in Section 2 of this Appendix, or otherwise) relating to any securities of the Company which are senior to, or on a party with, those granted to the Holders of Registrable Securities.

          2.12 Market Stand-Off. Each Holder agrees that, so long as it holds any voting securities of the Company, upon request by the Company or the underwriters managing the initial public offering of the Company’s securities, it will not sell or otherwise transfer or dispose of any securities of

the Company (other than those permitted to be included in the registration and other transfers to affiliates permitted by the Shareholders Agreement) without the prior written consent of the Company or such underwriters, as the case may be, for a period of time specified by the representative of the underwriters not to exceed one hundred and eighty (180) days from the effective date of the registration statement covering such initial public offering or the pricing date of such offering as may be requested by the underwriters. The foregoing provision of Section 2.12 of this Appendix shall not apply to the sale of any securities of the Company to an underwriter pursuant to any underwriting agreement, and shall only be applicable to the Holders if all officers, directors and holders of 1% or more of the Company’s outstanding share capital enter into similar agreements, and if the Company or any underwriter releases any officer, director or holder of 1% or more of the Company’s outstanding share capital from his or her sale restrictions so undertaken, then each Holder shall be notified prior to such release and shall itself be simultaneously released to the same proportional extent. The Company shall require all future acquirers of the Company’s securities holding at least 1% of the then outstanding share capital of the Company to execute prior to a Qualified IPO a market stand-off agreement containing substantially similar provisions as those contained in Section 2.12 of this Appendix.

          2.13 Listing in Hong Kong. Without limiting the generality of the foregoing provisions in Section 2 of this Appendix, in the event of a listing of the Company’s Ordinary Shares in Hong Kong (the “Listing”):

               (a) The selection of Hong Kong as the jurisdiction, and the relevant exchange as the exchange, for the Listing shall be subject to the prior written approval of Holders of at least a majority of the Registrable Securities;

               (b) The selection of the sponsor and/or lead manager (and any co-managers) for the Listing shall be subject to the prior written approval of Holders of at least a majority of the Registrable Securities;

               (c) Each Holder of Registrable Securities shall have the right to include and sell all of the Ordinary Shares (as-converted) held by it in such Listing;

                (d) Each Holder of Registrable Securities shall have the right to attend all meetings in connection with the Listing where the Company is present;

               (e)  The determination of the price at which the Ordinary Shares are to be listed in such Listing shall be subject to the prior written approval of Holders of at least a majority of the Registrable Securities;

               (f) At any time after the third anniversary of the date of the Shareholders Agreement, at the written request from Holders of at least a majority of the Registrable Securities for a Listing, the Company shall use its best efforts to effect such Listing on terms and subject to conditions as agreed upon between the Company and such Holder; and

               (g) The Company shall not require any Holder to hold, or refrain from transferring, any of its shares in the Company beyond the specific period(s) set forth in the listing rules applicable to such Listing, or as requested by the Company or the underwriters pursuant to Section 2.12 of this Appendix.

          2.14 Rule 144 Reporting. With a view to making available to the Holders the benefits of certain rules and regulations of the SEC which may at any time permit the sale of the Registrable

Securities to the public without registration or pursuant to a registration on Form F-3, after such time as a public market exists for the Ordinary Shares, the Company agrees to:

                (a) Make and keep public information available, as those terms are understood and defined in Rule 144 under the Securities Act at all times after the effective date of the first registration under the Securities Act filed by the Company for an offering of its securities to the general public;

               (b) File with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act (at any time after it has become subject to such reporting requirements); and

               (c) So long as a Holder owns any Registrable Securities, to furnish to such Holder forthwith upon request (i) a written statement by the Company as to its compliance with the reporting requirements of Rule 144 (at any time after ninety (90) days after the effective date of the Company’s initial public offering), the Securities Act and the Exchange Act (at any time after it has become subject to such reporting requirements), or its qualification as a registrant whose securities may be resold pursuant to Form F-3 (at any time after it so qualifies), (ii) a copy of the most recent annual or quarterly report of the Company; and (iii) such other reports and documents of the Company as a Holder may reasonably request in availing itself of any rule or regulation of the SEC that permits the selling of any such securities without registration or pursuant to Form F-3.

     3. RIGHT OF PARTICIPATION.

          3.1 General. The holders of Preferred Shares, the holders of Ordinary Shares and their permitted transferees to which rights under Section 3 of this Appendix have been duly assigned in accordance with the terms of the Shareholders Agreement (each a “Participation Rights Holder”) shall have the right of first refusal to purchase such Participation Rights Holder’s Pro Rata Share (as defined below), of all (or any part) of any New Securities (as defined in Section 3.3 of this Appendix) that the Company may from time to time issue after the date of the Shareholders Agreement (the “Right of Participation”).

          3.2 Pro Rata Share. A Participation Rights Holder’s “Pro Rata Share” for purposes of the Right of Participation is the ratio of (a) the number of Ordinary Shares (calculated on a fully-diluted and as-converted basis) held by such Participation Rights Holder, to (b) the total number of Ordinary Shares (calculated on a fully-diluted and as-converted basis) then outstanding immediately prior to the issuance of New Securities giving rise to the Right of Participation.

          3.3 New Securities. “New Securities” shall mean any Preferred Shares, any other shares of the Company designated as “preferred shares”, Ordinary Shares or other voting shares of the Company, whether now authorized or not, and rights, options or warrants to purchase such Preferred Shares, other preferred shares, Ordinary Shares and securities of any type whatsoever that are, or may become, convertible or exchangeable into such Preferred Shares, other preferred shares, Ordinary Shares or other voting shares, provided, however, that the term “New Securities” shall not include.

                (a) 66,580 Ordinary Shares reserved for issuance upon the exercise of the option currently held by Winsome Group Limited on behalf of Ma ▇▇▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ Ho, Ma Wen Lie, ▇▇▇▇ Lo Yin, Li Jin and other officers, employees and advisors of the Company, and up to 151,430 Ordinary Shares (and/or options or warrants therefor) reserved for issuance pursuant to the Company’s employee equity incentive plans approved by the compensation committee of the Company;

               (b) any Series B Shares issued under the Purchase Agreement, as such agreement may be amended and any Ordinary Shares issued pursuant to the conversion thereof;

               (c) any securities issued in connection with any share split, share dividend or other similar event in which all Participation Rights Holders are entitled to participate on a pro rata basis;

               (d) any securities issued upon the exercise, conversion or exchange of any outstanding security if such outstanding security constituted a New Security;

               (e) any securities issued pursuant to a Qualified IPO; or

               (f) any securities issued pursuant to the acquisition of another corporation or entity by the Company by consolidation, merger, purchase of assets, or other reorganization in which the Company acquires, in a single transaction or series of related transactions, all or substantially all assets of such other corporation or entity, or 50% or more of the equity ownership or voting power of such other corporation or entity.

          3.4 Procedures.

               (a)  First Participation Notice. In the event that the Company proposes to undertake an issuance of New Securities (in a single transaction or a series of related transactions), it shall give to each Participation Rights Holder written notice of its intention to issue New Securities (the “First Participation Notice”), describing the amount and type of New Securities, the price and the general terms upon which the Company proposes to issue such New Securities. Each Participation Rights Holder shall have fifteen (15) days from the date of receipt of any such First Participation Notice to agree in writing to purchase such Participation Rights Holder’s Pro Rata Share of such New Securities for the price and upon the terms and conditions specified in the First Participation Notice by giving written notice to the Company and stating therein the quantity of New Securities to be purchased (not to exceed such Participation Rights Holder’s Pro Rate Share). If any Participation Rights Holder fails to so agree in writing within such fifteen (15) day period to purchase such Participation Rights Holder’s full Pro Rata Share of an offering of New Securities, then such Participation Rights Holder shall forfeit the right hereunder to purchase that part of its Pro Rata Share of such New Securities that it did not agree to purchase.

               (b)  Second Participation Notice; Oversubscription. If any Participating Rights Holder fails or declines to exercise its Right of Participation in accordance with Section 3.4(a) of this Appendix, the Company shall promptly give notice (the “Second Participation Notice”) to other Participating Rights Holders who exercised their Right of Participation (the “Right Participants”) in accordance with Section 3.4(a) of this Appendix. Each Right Participant shall have five (5) business days from the date of the Second Participation Notice (the “Second Participation Period”) to notify the Company of its desire to purchase more than its Pro Rata Share of the New Securities, stating the number of the additional New Securities it proposes to buy (the “Additional Number”). Such notice may be made by telephone if confirmed in writing within two (2) business days. If, as a result thereof, such oversubscription exceeds the total number of the remaining New Securities available for purchase, each oversubscribing Right Participant will be cut back by the Company with respect to its oversubscription to that number of remaining New Securities equal to the lesser of (x) the Additional Number and (y) the product obtained by multiplying (i) the number of the remaining New Securities available for subscription by (ii) a fraction, the numerator of which the number of Ordinary Shares (calculated on a fully-diluted

and as-converted basis) held by such oversubscribing Right Participant and the denominator of which is the total number of Ordinary Shares (calculated on a fully-diluted and as-converted basis) held by all the oversubscribing Right Participants. Each Right Participant shall be obligated to buy such number of New Securities as determined by the Company pursuant to Section 3.4 of this Appendix and the Company shall so notify the Right Participants within fifteen (15) business days following the date of the Second Participation Notice.

          3.5 Failure to Exercise. Upon the expiration of the Second Participation Period, or in the event no Participation Rights Holder exercises the Right of Participation within fifteen (15) days following the issuance of the First Participation Notice, the Company shall have one hundred and twenty (120) days thereafter to sell the New Securities described in the First Participation Notice (with respect to which the Right of Participation hereunder were not exercised) at the same or higher price and upon non-price terms not materially more favorable to the purchasers thereof than specified in the First Participation Notice. In the event that the Company has not issued and sold such New Securities within such one hundred and twenty (120) day period, then the Company shall not thereafter issue or sell any New Securities without again first offering such New Securities to the Participation Rights Holders pursuant to Section 3 of this Appendix.

          3.6 Termination. The Right of Participation for each Participation Rights Holder shall terminate upon a Qualified IPO.

     4. TRANSFER RESTRICTIONS.

          4.1 Certain Definitions., For purposes of Section 4 of this Appendix, “Ordinary Holder” means a holder of the Company’s outstanding Ordinary Shares and its permitted assignees to whom their rights under Section 4 of this Appendix have been duly assigned in accordance with the Shareholders Agreement; provided that Ordinary Shares issued upon conversion of any Preferred Shares shall not be considered Ordinary Shares for the purposes of Section 4 of this Appendix with respect to Ordinary Shares; “Preferred Holder” means each of the holders of Preferred Shares and its permitted assignees to whom its rights under Section 4 of this Appendix have been duly assigned in accordance with the Shareholders Agreement; “Restricted Shares” means any of the Company’s securities now owned or subsequently acquired by an Ordinary Holder;

          4.2 Sale of Restricted Shares; Notice of Sale. Subject to Section 4.7 of the Shareholder Agreement, if any Ordinary Holder (the “Selling Shareholder”) receives a bona fide third party offer to acquire any Restricted Shares held by it (the “Offered Shares”), then the Selling Shareholder shall promptly give written notice (the “Transfer Notice”) to the Company, each other Ordinary Holder and each Preferred Holder prior to the sale or transfer of such Offered Shares. If any Preferred Holder (the “Selling Preferred Holder”) receives a bona fide third party offer to acquire any Preferred Shares held by it or any Ordinary Shares issued upon conversion of any Preferred Shares held by it (together, the “Preferred Offered Shares”), such Selling Preferred Holder shall promptly give a Transfer Notice to each other Preferred Holder prior to the sale or transfer of such Preferred Offered Shares (the “Preferred Offer”). The Transfer Notice shall describe in reasonable detail the proposed sale or transfer including, without limitation, the number of Offered Shares to be sold or transferred, or the number of Preferred Offered Shares to be sold or transferred (in the event of a Preferred Offer), the nature of such sale or transfer, the consideration to be paid, and the name and address of each prospective purchaser or transferee.

          4.3 Right of First Refusal and Co-Sale Rights.

               (a) Company’s Option. The Company shall have the right, exercisable upon written notice to the Selling Shareholder, the Ordinary Holders and Preferred Holders, within forty-five (45) days after receipt of the Transfer Notice (the “Company Refusal Period”), to elect to purchase all or part of the Offered Shares; provided that the Company’s right under Section 4.3(a) of this Appendix shall expire on the first anniversary of this Agreement.

               (b) Preferred Holders’ Option.

                    (i) If and to the extent that any Offered Shares have not been purchased pursuant to Section 4.3(a) of this Appendix, each Preferred Holder shall have the right, exercisable upon written notice to the Selling Shareholder, the Company and each other Ordinary Holder and Preferred Holder, within forty-five (45) days after the Company Refusal Period (the “First Refusal Period”), to elect to purchase all or any part of its pro rata share of the Offered Shares equivalent to the product obtained by multiplying the aggregate number of the Offered Shares by a fraction, the numerator of which is the number of Ordinary Shares (calculated on an as-converted basis) held by such Preferred Holder on the date of the Transfer Notice and the denominator of which is the total number of Ordinary Shares (calculated on an as-converted basis) owned by all the Preferred Holders on the date of the Transfer Notice, at the same price and subject to the same material terms and conditions as described in the Transfer Notice;

                    (ii) Each Preferred Holder shall also have the right, exercisable upon written notice to the Selling Preferred Holder, the Company and each other Preferred Holder, within forty-five (45) days after receipt of the Transfer Notice (the “Preferred First Refusal Period”), to elect to purchase all or any part of its pro rata share of the Preferred Offered Shares equivalent to the product obtained by multiplying the aggregate number of the Preferred Offered Shares by a fraction, the numerator of which is the number of Ordinary Shares (calculated on an as-converted basis) held by such Preferred Holder on the date of the Transfer Notice and the denominator of which is the total number of Ordinary Shares (calculated on an as-converted basis) owned by all the Preferred Holders on the date of the Transfer Notice, at the same price and subject to the same material terms and conditions as described in the Transfer Notice; and

                    (iii) To the extent that any Preferred Holder does not exercise its right of first refusal to the full extent of its pro rata share of the Offered Shares, or the Preferred Offered Shares (in the event of a Preferred Offer), (x) the Selling Shareholder or Selling Preferred Holder (in the event of a Preferred Offer) shall, promptly upon expiration of the First Refusal Period or Preferred First Refusal Period (in the event of a Preferred Offer), notify each Preferred Holder that has exercised in full its pro rata right of first refusal to the Offered Shares or the Preferred Offered Shares (in the event of a Preferred Offer) during the First Refusal Period or the Preferred First Refusal Period (in the event of a Preferred Offer) (each such Preferred Holders, a “First Refusal Participant”) of the number of Offered Shares or Preferred Offered Shares (in the event of a Preferred Offer) with respect to which the first refusal rights of Preferred Holders were not exercised (such shares, the “Excess Shares”), and (y) each First Refusal Participant shall have the right, exercisable by delivery of written notice (the “Excess Shares Notice”) to the Selling Shareholder or Preferred Selling Holder within fifteen (15) days after receipt of the notice required under sub-section (x) of Section 4.3(b) of this Appendix (the “First Refusal Adjustment Period”), to purchase part or all of the Excess Shares. If the total number of Excess Shares which all of the First Refusal Participants desire to purchase as set forth in the Excess Shares Notices is greater than the number of Excess Shares available for purchase, then each First Refusal Participant that has delivered an Excess Shares Notice to the Selling Shareholder or the Selling Preferred Holder shall have the right to purchase such number of Excess Shares that is equal to the product of (as) the total number of Excess Shares, multiplied by (bb) a fraction, the numerator of which is

the Ordinary Shares owned by such First Refusal Participant (calculated on an as-converted basis) and the denominator of which is the total number of Ordinary Shares owned by all First Refusal Participants (on an as-converted basis).

               (c) Ordinary Holders’ Option. If and to the extent that any Offered Shares have not been purchased pursuant to Section 4.3(b) of this Appendix, each Ordinary Holder shall have the right, exercisable upon written notice to the Selling Shareholder, the Company and each other Ordinary Holder and Preferred Holder, within forty-five (45) days following the expiration of the First Refusal Adjustment Period (the “Ordinary First Refusal Period”), to elect to purchase all or any part of its pro rata share of the remaining Offered Shares equivalent to the product obtained by multiplying the aggregate number of the remaining Offered Shares by a fraction, the numerator of which is the number of Ordinary Shares held by such Ordinary Holder at the time of the transaction and the denominator of which is the total number of Ordinary Shares owned by all the. Ordinary Holders at the time of the transaction, at the same price and subject to the same material terms and conditions as described in the Transfer Notice. To the extent that any Ordinary Holder does not exercise its right of first refusal to the full extent of its pro rata share of the Offered Shares, the Selling Shareholder and the participating Ordinary Holders shall, within fifteen (15) days after the end of the Ordinary First Refusal Period (the “Ordinary First Refusal Adjustment Period”), make such adjustments to each exercising Ordinary Holder’s pro rata share of the Offered Shares so that any remaining Offered Shares may be allocated to those Ordinary Holders exercising their rights of first refusal on a pro rata basis.

               (d) A Preferred Holder and an Ordinary Holder shall not have a right to purchase any of the Offered Shares or Preferred Offered Shares unless it exercises its right of first refusal within the relevant First Refusal Period, Preferred First Refusal Period or First Refusal Adjustment Period, or the Ordinary First Refusal Period or Ordinary First Refusal Adjustment Period to purchase up to all of its pro rata share of the Offered Shares or Preferred Offered Shares.

               (e) Expiration Notice. Within fifteen (15) days after expiration of the Ordinary First Refusal Adjustment Period or the First Refusal Adjustment Period, the Company will give written notice (the “First Refusal Expiration Notice”) to the Selling Shareholder or the Selling Preferred Holder (in the event of a Preferred Offer) specifying either (i) that all of the Offered Shares or Preferred Offered Shares was subscribed by the Preferred Holders and/or Ordinary Holders exercising their rights of first refusal or (ii) that the Ordinary Holders and/or Preferred Holders have not subscribed all of the Offered Shares or Preferred Offered Shares in which case the First Refusal Expiration Notice will specify the Co-Sale Pro-Rata Portion (as defined below) of the remaining Offered Shares or Preferred Offered Shares for the purpose of their co-sale rights described in Section 4.4 of this Appendix.

               (f) Purchase Price. The purchase price for the Offered Shares or Preferred Offered Shares (in the event of a Preferred Offer) to be purchased by the Ordinary Holders and/or Preferred Holders exercising their right of first refusal will be the price set forth in the Transfer Notice, but will be payable as set forth in Section 4.3(g) of this Appendix. If the purchase price in the Transfer Notice includes consideration other than cash, the cash equivalent value of the non-cash consideration will be determined by the Board in good faith, which determination will be binding upon the Ordinary Holders, Preferred Holders, the Selling Shareholder, and the Selling Preferred Holder absent fraud or error.

               (g) Payment. Payment of the purchase price for the Offered Shares or Preferred Offered Shares (in the event of a Preferred Offer) purchased by the Ordinary Holders and/or Preferred Holders shall be made within fifteen (15) days following the date of the First Refusal Expiration

Notice. Payment of the purchase price will be made by wire transfer or check as directed by the Selling Shareholder or Selling Preferred Holder (in the event of a Preferred Offer).

               (h) Rights of a Selling Shareholder and Selling Preferred Holder. If any Preferred Holder or Ordinary Holder exercises its right of first refusal to purchase the Offered Shares or Preferred Offered Shares (in the event of a Preferred Offer), then, upon the date the notice of such exercise is given by such Preferred Holder or Ordinary Holder (as the case may be), the Selling Shareholder or Selling Preferred Holder will have no further rights as a holder of such Offered Shares or Preferred Offered Shares except the right to receive payment for such Offered Shares or Preferred Offered Shares from such Preferred Holder or Ordinary Holder in accordance with the terms of the Shareholders Agreement, and the Selling Shareholder or Selling Preferred Holder Will forthwith cause all certificate(s) evidencing such Offered Shares or Preferred Offered Shares to be surrendered to the Company for transfer to such Preferred Holder or Ordinary Holder.

               (i) Application of Co-Sale Rights. If the Ordinary Holders and/or Preferred Holders have not elected to purchase all of the Offered Shares or Preferred Offered Shares (in the event of a Preferred Offer), then the sale of the remaining Offered Shares or Preferred Offered Shares will become subject to the co-sale rights set forth in Section 4.4 of this Appendix.

          4.4 Co-Sale Right. To the extent that the Ordinary Holders and/or Preferred Holders have not exercised right of first refusal with respect to any or all the Offered Shares or Preferred Offered Shares (in the event of a Preferred Offer), then each Preferred Holder shall have the right, exercisable upon written notice to the Selling Shareholder or Preferred Selling Holder (in the event of a Preferred Offer), the Company and each other Preferred Holder (the “Co-Sale Notice”) within twenty (20) days after receipt of the First Refusal Expiration Notice (the “Co-Sale Right Period”), to participate in such sale of the Offered Shares or Preferred Offered Shares on the same terms and conditions as set forth in the Transfer Notice. The Co-Sale Notice shall set forth the number of Company securities (on both an absolute and as-converted to Ordinary Shares basis) that such participating Preferred Holder wishes to include in such sale or transfer, which amount shall not exceed the Co-Sale Pro Rata Portion (as defined below) of such Preferred Holder. To the extent one or more of the Preferred Holders exercise such right of participation in accordance with the terms and conditions set forth below, the number of Restricted Shares that the Selling Shareholder may sell, or the number of Preferred Offered Shares that the Selling Preferred Shareholder may sell, in the transaction shall be correspondingly reduced. The co-sale right of each Preferred Holder shall be subject to the following terms and conditions:

          (a) Co-Sale Pro Rata Portion. Each Preferred Holder may sell all or any part of that number of Ordinary Shares held by it (on an as-converted basis) that is equal to the product obtained by multiplying (x) the aggregate number of the Offered Shares or Preferred Offered Shares (in the event of a Preferred Offer) subject to the co-sale right hereunder by (y) a fraction, the numerator of which is the number of Ordinary Shares (on an as-converted basis) owned by the Preferred Holder at the time of the sale or transfer and the denominator of which is the total combined number of Ordinary Shares (on an as-converted basis) at the time owned by all Preferred Holders and the Selling Shareholder, or at the time owned by all Preferred Holders and the Selling Preferred Holder (in the event of a Preferred Offer), (the “Co-Sale Pro Rata Portion”). To the extent that any Preferred Holder does not participate in the sale to the full extent of its Co-Sale Pro Rata Portion, the Selling Shareholder or the Selling Preferred Holder (in the event of a Preferred Offer) and the participating Preferred Holders shall, within five (5) days after the end of such Co-Sale Right Period, make such adjustments to the Co-Sale Pro Rata Portion of each participating Preferred Holder so that any remaining Offered Shares or Preferred Offered Shares may be allocated to other participating Preferred Holders on a pro rata basis.

          (b) Transferred Shares. Each participating Preferred Holder shall effect its participation in the sale by promptly delivering to the Selling Shareholder or Selling Preferred Holder (in the event of a Preferred Offer) for transfer to the prospective purchaser one or more certificates, properly endorsed for transfer, which represent:

               (i) the number of Ordinary Shares which such Preferred Holder elects to sell;

               (ii) that number of Preferred Shares which is at such time convertible into the number of Ordinary Shares that such Preferred Holder elects to sell; provided in such case that, if the prospective purchaser objects to the delivery of Preferred Shares in lieu of Ordinary Shares, such Preferred Holder shall convert such Preferred Shares into Ordinary Shares and deliver Ordinary Shares as provided in Section 4.4(b)(i) of this Appendix. The Company agrees to make any such conversion concurrent with the actual transfer of such shares to the purchaser; or

               (iii) or a combination of the above.

          (c) Payment to Preferred Holders. The share certificate or certificates that the participating Preferred Holder delivers to the Selling Shareholder pursuant to Section 4.4(b) of this Appendix shall be transferred to the prospective purchaser in consummation of the sale of the Restricted Shares or the sale of the Preferred Offered Shares, pursuant to the terms and conditions specified in the Transfer Notice, and the Selling Shareholder or Selling Preferred Holder (in the event of a Preferred Sale) shall concurrently therewith remit to such Preferred Holder that portion of the sale proceeds to which such Preferred Holder is entitled by reason of its participation in such sale. To the extent that any prospective purchaser or purchasers prohibits such assignment or otherwise refuses to purchase any shares or other securities from a Preferred Holder exercising its co-sale right hereunder, the Selling Shareholder or Selling Preferred Holder shall not sell to such prospective purchaser or purchasers any Restricted Shares or Preferred Offered Shares unless and until, simultaneously with such sale, the Selling Shareholder of Selling Preferred Shareholder shall purchase such shares or other securities from such Preferred Holder.

          4.5 Right to Transfer. To the extent the Preferred Holders and/or the other Ordinary Holders do not elect to purchase; or to participate in the sale of the Restricted Shares or Preferred Offered Shares subject to the Transfer Notice in accordance with the provisions of the Shareholders Agreement, as the case may be, the Selling Shareholder or Selling Preferred Holder may, not later than one hundred and twenty (120) days following delivery to the Company, each of the other Ordinary Holders and each of the Preferred Holders of the Transfer Notice, conclude a transfer of the Restricted Shares or Preferred Offered Shares covered by the Transfer Notice and not elected to be purchased by the Preferred Holders and/or the other Ordinary Holders, which in each case shall be on the same terms and conditions as those described in the Transfer Notice. Any proposed transfer on terms and conditions which are different from those described in the Transfer Notice as well as any subsequent proposed transfer of any Restricted Shares by the Selling Shareholder or any Preferred Offered Shares by the Selling Preferred Holder (including any transfer to the transferee(s) specified in the Transfer Notice that has not been completed within one hundred and twenty (120) days following delivery of the transfer Notice), shall again be subject to the right of first refusal and the co-sale right of the Preferred Holders and, if applicable, the other Ordinary Holders and shall require compliance by the Selling Shareholder or the Selling Preferred Holder with the procedures described in Section 4.3 and Section 4.4 of the Shareholders Agreement.

          4.6 Exempt Transfers. Notwithstanding anything to the contrary contained herein, the right of first refusal and co-sale rights of the Preferred Holders and/or the Ordinary Holders shall not apply to (a) any sale or transfer of Ordinary Shares to the Company pursuant to a repurchase right or right of first refusal held by the Company in the event of a termination of employment or consulting relationship; or (b) any transfer to the parents, children or spouse, or to trusts for the benefit of such persons, of any Founder for bona fide estate planning purposes; or (c) any sale or transfer of Ordinary Shares by Valuetrue Investments Limited (each transferee pursuant to the foregoing clauses (a), (b) and (c), a “Permitted Transferee”); or (d) any sale or transfer of Preferred Shares or Ordinary Shares by any Preferred Holder to an affiliate of such Preferred Holder; provided that adequate documentation therefor is provided to the Preferred Holders to their satisfaction and that any such Permitted Transferee agrees in writing to be bound by the Shareholders Agreement in place of the relevant transferor; provided, further, that such transferor shall remain liable for any breach by such Permitted Transferee of any provision hereunder.

          4.7 Prohibited Transfers.

               (a) Except for transfers by the Ordinary Holders to Permitted Transferees as provided in Section 4.6 of this Appendix, none of the Ordinary Holders or the Permitted Transferees shall, without the prior written consent of (i) the holders of a majority of the Series A Shares and the Series A-1 Shares voting together as a separate class, and (ii) the holders of a majority of the Series B Shares, voting together as a separate class, sell, assign, transfer, pledge, hypothecate, mortgage, encumber or otherwise dispose through one or a series of transactions of any Company Securities now held by him to any person any time prior to the Qualified IPO; provided that during such period each Existing Shareholder controlled by the Founders may sell, transfer; or otherwise dispose of, up to an aggregate of 10% of the issued outstanding Ordinary Shares held by such Existing Shareholder as of the date hereof; provided further, that any such sale, transfer or disposition shall nevertheless be subject to the right of first refusal and co-sale rights of the Preferred Holders and the Ordinary Holders under Sections 4.3, 4.4 and 4.5 of this Appendix.

               (b) Any attempt by a party to sell or transfer Restricted Shares or Preferred Shares in violation of Section 4 of this Appendix shall be void and the Company hereby agrees it will not effect such a transfer, nor will It treat any alleged transferee as the holder of such shares without the written consent of holders of a majority of Preferred Shares.

               (c) The. Investors and their respective affiliates to whom any Preferred Share or Ordinary Share has been duly assigned in accordance with this Agreement, may not sell or transfer part or all of their shares to any competitor of the Company. For the purpose of Section 4.7 of this: Appendix, a “competitor” of the Company shall mean any entity whose business or product competes directly or indirectly against the Principal Business of the Company, as defined herein, and its subsidiaries (including the Subsidiaries).

          4.8 Legend.

               (a) Each certificate representing the Restricted Shares or Preferred Offered Shares shall be endorsed with the following legend:

“THE SALE, PLEDGE, HYPOTHECATION OR TRANSFER OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER SET FORTH IN A SHAREHOLDERS AGREEMENT, A COPY OF WHICH MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY.”

               (b) Each party agrees that the Company may instruct its transfer agent to impose transfer restrictions on the shares represented by certificates bearing the legend referred to in Section 4.8(a) of this Appendix to enforce the provisions of the Shareholders Agreement and the Company agrees to promptly do so. The legend shall be removed upon termination of the provisions of Section 4 of this Appendix.

          4.9 Restriction on Indirect Transfers. Notwithstanding anything to the contrary contained herein, without the prior written approval of holders of at least a majority of the Preferred Shares:

               (a) Each of the Founders shall not, and shall use his best efforts to cause any shareholder of any Existing Shareholder not to, directly or indirectly, sell, assign, transfer, pledge, hypothecate, mortgage, encumber or otherwise dispose through one or a series of transactions any equity interest or equity securities or any economic interest deriving therefrom, held, directly or indirectly, by such Founder and/or shareholder in such Existing Shareholder to any person or entity other than one that is solely owned by such Founder and/or shareholder;

               (b) Each Existing Shareholder shall not, and each of the Founders shall use his best efforts to cause such Existing Shareholder not to, issue to any person any equity securities of such Existing Shareholder or any options of warrants for, or any other securities exchangeable for or convertible into, such equity securities of such Existing Shareholder; and

               (c) Notwithstanding the foregoing, the restrictions under Section 4.9 of this Appendix shall not apply to (i) any transfers or issuances with respect to the equity interest in Valuetrue Investments Limited; and (ii) any transfers or Issuances to the parents, children or spouse of any Founder and/or any shareholder of an Existing Shareholder occurring after the date hereof with respect to the equity interest in any Existing Shareholder which do not exceed 20% of the capital of such Existing Shareholder at any time in the aggregate; provided that each Founder shall, and shall use his best efforts to cause each other shareholder of an Existing Shareholder to, promptly notify the Company and each holder of Preferred Shares or any transfer of equity interests pursuant to Section 4.9 of this Appendix.

          4.10 Term. The provisions under Section 4 of this Appendix shall terminate upon a Qualified IPO.

     5. ASSIGNMENT AND AMENDMENT.

          5.1 Assignment. Notwithstanding anything herein to the contrary:

               (a) Information Rights Registration Rights. The Information and inspection Rights under Section 1 of this Appendix may be assigned to any holder of Preferred Shares; and the registration rights of the Holders under Section 2 of this Appendix may be assigned to any Holder or to any person acquiring Registrable Securities; provided, however, that in either case no party may be assigned any of the foregoing rights unless the Company is given written notice by the assigning party stating the name and address of the assignee and identifying the securities of the Company as to which the rights in question are being assigned; and provided further, that any such assignee shall receive such assigned rights subject to all the terms and conditions of the Shareholders Agreement, including without limitation the provisions of Section 5 of this Appendix.

               (b) Rights of Participation; Right of First Refusal; Co-Sale Rights. The rights of the Preferred Holders under Sections 3 and 4 of this Appendix are fully assignable in connection with a transfer of shares of the Company by the Preferred Holders; provided, however, that no party may be assigned any of the foregoing rights unless the Company is given written notice by the Preferred Holders stating the name and address of the assignee and identifying the securities of the Company as to which the rights in question are being assigned; and provided further, that any such assignee shall receive such assigned rights subject to all the terms and conditions of the Shareholders Agreement.

          5.2 Amendment of Rights. Any provision in the Shareholders Agreement may be amended and the observance thereof may be waived (either generally or in a particular instance and either retroactively or prospectively), only by the written consent of (i) as to the Company, only by the Company; (ii) as to each Subsidiary, by such Subsidiary; (iii) as to the Preferred Holders, by (x) persons or entities holding at least 66.6667% of the Series A Shares and Series A-1 Shares voting together as a separate class and (y) persons or entities holding at least 66.6667% of the Series B Shares voting together as a separate class; provided, however that any holder of Preferred Shares may waive any of its rights hereunder without obtaining the consent of any other Preferred Holders or their assigns; and (iv) as to each Existing Shareholder, by such Existing Shareholder and its assigns; and (v) as to each Founder, by such Founder, Any amendment or waiver effected in accordance with Section 5.2 of this Appendix shall be binding upon the Company, the Preferred Holders, the Subsidiaries, the Existing Shareholders, the Founders and their respective assigns.

EXHIBIT E

DISCLOSURE SCHEDULE

[ATTACHED]

[Series B Share Subscription Agreement]

Disclosure Schedule

This is the Disclosure Schedule as defined In the Series B Preferred Share Subscription Agreement (the “Agreement”) entered Into today among China Linong International limited (the “Company”), Land V. Group Limited, Land V. Limited, Hong Kong Linong Limited, Land V. Limited (Fujian), Land V. Limited (Shenzhen), Land V Limited (Hangzhou), Land V Limited (Tianjin), Land V. Limited (Liaoyang), (Weifang) Land V. Limited, Land V. Limited (Zhangjiakou), Land V. Limited (Huizhou), Xiamen Land V. Group Co., Ltd., Land V. Limited (Shantou), Ma ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇ ▇▇, SIG China Investment One, Ltd., Pacven ▇▇▇▇▇▇ Ventures VI, L.P., Pacven ▇▇▇▇▇▇ Ventures Parallel VI, L.P., Sequoia Capital China Growth Fund I, L.P. and PreIPO Capital Partners Limited, (SIG China Investments One, Ltd., Pacven ▇▇▇▇▇▇ Ventures VI, L.P., Pacven ▇▇▇▇▇▇ Ventures Parallel VI, L.P., Sequoia Capital China Growth Fund I, L.P., and PreIPO Capital Partners Limited are collectively referred to as the “Investors”) and relating to the allotment and issue by the Company to the Investors of, in the aggregate, the 329,100 Series B preferred shares, par value US$0,001 per share, of the Company.

Unless otherwise defined in this Disclosure Schedule, expressions defined in the Agreement Have the same meaning in this Disclosure Schedule.

The representations and warranties set out in section 3 of the Agreement (the “Warranties”) are made and given subject to the disclosures in this Disclosure Schedule. If there is any inconsistency between the Agreement and this Disclosure Schedule, this Disclosure Schedule shall prevail.

Although for ease of reference certain numbered paragraphs in schedule 1 to this disclosure Schedule correspond with particular paragraphs of section 3 of the Agreement, all disclosures in this Disclosure Schedule do and are to be taken as relating to all such Warranties to which such disclosures are reasonably expected to be applicable.

The contents of this Disclosure Schedule are confidential and the provisions of clause 8.13 (Confidentiality and Non-Disclosure) of the Agreement shall apply to all such information as if set out in full in this Disclosure Schedule.

1		General Disclosures
1.1		None of the Company, the Subsidiaries or the Founders is and shall be deemed to be in breach of any of the Warranties (and no claim shall lie or liability attach) in respect of any matter fully, fairly and specifically disclosed in, or deemed to be disclosed by, this Disclosure Schedule in the absence of any fraud or dishonesty on the part of any of the Company, the Subsidiaries or the Founders.

1.2		In addition, any matter or information disclosed noted or referred to in the financial statements to be delivered by the Company to the Investors pursuant to section 3.16 of the Agreement are disclosed or are deemed to have been disclosed by this Disclosure Schedule.
2		Specific Disclosures
		In addition, there are disclosed the specific matters set out in schedule 1 to this Disclosure Schedule.

Schedule 1

Specific disclosures

Warranty reference		Disclosure
3.2(c)		(1) The Company granted an option (the “Option”) to Winsome Group Limited in respect of 66.58 ordinary shares of the Company with a par value of US$1.00 on 23 May 2007.
		(2) Pursuant to a shareholders’ agreement (the “Series A1 Shareholders’ Agreement”) dated 14 February 2007 entered into by, among others, the Company, the Founders, the Existing Shareholders (as defined in the Series A1 Shareholders’ Agreement) and the Preferred Shareholders (as defined in the Series A1 Shareholders’ Agreement), certain rights of participation, rights of first refusal and co-sale rights have been granted to the Preferred Shareholders, the holders of ordinary shares of the Company and their permitted transferees.
3.2(d)		Subject to the adjustment for the Subdivision of the par value of all the Company’s shares from US$1.00 to US$0.001, the list of all outstanding shareholders, option holders and other security holders of the Company as of the date hereof is as set forth:

						No. of shares
Name of shareholder		Type of shares				(par value of US$1.00)
Grow Grand Limited		Ordinary					613
		Series A1					24.213
Magnetic Star Holdings Limited		Ordinary					60
Limewater Limited		Ordinary					60
Natural Eternity Limited		Ordinary					60
Honeycomb Assets Management Limited		Ordinary					70
		Series A1					16.142
Win Seasons Finance Ltd.		Ordinary					60
Valuetrue Investments Limited		Ordinary					77
Natural Scent Limited		Ordinary					50
Sequoia Capital China I, L.P.		Series A					169.38
		Series A1					31.784
Sequoia Capital China Principals Fund I, L.P.		Series A					26.22
		Series A1					4.919
Sequoia Capital China Partners Fund I, L.P.		Series A					19.46
		Series A1					3.652

Warranty reference		Disclosure

Name of option holder		Type of shares				No. of shares
Winsome Group Limited		Ordinary					86.58

		Note:
		(1) Ma ▇▇▇▇▇ ▇▇▇▇, one of the Founders, is the ultimate beneficial owner of the shares of Grow Grand Limited.
		(2) Law Kin Ip, the brother-in-law of ▇▇▇ ▇▇▇▇ Ho (▇▇▇ ▇▇▇▇ Ho is one of the directors of China Linong International Limited) is the ultimate beneficial owner of the shares of Natural Eternity Limited.
		(3) ▇▇▇▇ ▇▇ (one of the Founders) and her husband, ▇▇▇▇▇ ▇▇▇▇, are the ultimate beneficial owners of the shares of Magnetic Star Holdings Limited.
		(4) Ma Wen, Lie is the ultimate beneficial owner of the shares of Valuetrue Investments Limited.
		(5) Valuetrue Investments Limited, Limewater Limited, Honeycomb Assets Management Limited, Win Seasons Finance Ltd. and Natural Scent Limited were established by individuals who have contributed to the Company’s development.
		(6) Winsome Group Limited holds the option on behalf of Ma ▇▇▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ Ho, Ma Wen Lie, ▇▇▇▇ Lo Yin, Li Jin and other officers, employees and advisors of the Company.
3.6		(1) Land V. Limited (Fujian) entered into a loan agreement dated 28 February 2006 with Sun Jianguo whereby Land V. Limited (Fujian) borrowed RMB10,800,000 from Sun Jianguo.
		(2) Land V. Limited entered into a loan agreement dated 21 February 2006 with Ma ▇▇▇▇▇ ▇▇▇▇, one of the Founders, whereby Land V. Limited borrowed HK$10,000,000 from Ma ▇▇▇▇▇ ▇▇▇▇.
3.7		(1) All land leases signed by the Group Companies which, to the best knowledge of the Group Companies, are required by PRC laws and regulations to be submitted to the relevant government authorities for filing have been so submitted for filing, but there is no official document issued by such government authorities acknowledging receipt of such applications for filing, since the government authorities are not required to give such acknowledgement under PRC laws.

Warranty reference		Disclosure
		(2) The date of the land lease contract made between Land V. Limited (Fujian) and the Committee of Villagers of Dating (Production Team No. 3) of Qidu Town, Jiaocheng District, Ningde Municipality is 1 March 2006, but the term of the land lease contract is stated to be from 1 March 2005 to 30 February 2015.
		(3) The term of the land lease contract (undated) made between Land V. Limited (Fujian) and the Committee of Villagers of Dating (Production Team No. 4) of Qidu Town, Jiaocheng District, Ningde Municipality is stated to be from 1 March 2005 to 30 February 2015.
3.8		Trademark
		(1) An application for registration of trademark dated 14 June 2005 was submitted by Land V. Limited (Fujian) to the Trademark Office of the State Administration for industry and Commerce (application no.: 4718420). A Notice of Acceptance of Registration Application was received on 17 August 2005. The Announcement of Preliminary Review was made on 6 December 2007, which stated that the application had been accepted in principle but was still subject to final approval.
		(2) An application for registration of trademark dated 13 March 2006 was submitted by Land V. Limited (Fujian) to the Trademark Office of the State Administration for Industry and Commerce (application no.: 5208039). A Notice of Acceptance of Registration Application was received on 29 June 2006.
		List of domain names owned by Land V. Limited (Fujian)
		▇▇▇.▇▇▇▇▇▇▇▇▇▇.▇▇▇ (expiry date: 21 June 2008)
		www.landv.on (expiry date: 13 March 2011)
		▇▇▇.▇▇▇▇.▇.▇▇▇ (expiry date: 2 June 2011) (The registrant shown in the registration certificate is “Linong Nongyejishu (Fujian) Youxiangongsi”, which is the English transliteration of the name of Land V. Limited (Fujian) in Chinese
3.9		List of contracts required to be provided under this section 3.9
		Please refer to the Appendix and the specific disclosures on section 3.6, 3.7, 3.19 and 3.20.
3.12		In respect of the transfers of (i) 13,500 shares in Land V. Limited by ▇▇▇▇ ▇▇ to Land V. Group Limited and (ii) 86,500 shares in Land V. Limited by ▇▇▇▇▇ ▇▇▇▇ to Land V. Group Limited in 2006, such transfers were approved by the directors of Land V. Limited on 11 January 2006, whereas the relevant instruments of transfer and bought and sold notes were executed by the parties on 6 February 2006 and Land V. Group Limited was entered into the register of members of Land V. Limited as holder of the 100,000 shares on the same date. The relevant instruments of transfer and bought and sold notes were stamped by the Hong Kong Stamp

Warranty reference		Disclosure
		Office on 30 June 2006.
3.14		Pursuant to the Series A1 Shareholders’ Agreement, certain registration rights have been granted to the Holders (as defined in the Series A1 Shareholders’ Agreement).
3.15		(1) None of the Group Companies has obtained any insurance coverage other than (i) vehicle insurance; (ii) Insurance for all employees of Land V. Limited; (iii) Insurance for the office contents, business Interruption, money & assault and public liability of Land V. Limited and/or Hong Kong Linong Limited and (iv) social insurances, including pension insurance, unemployment insurance, industrial injury insurance and maternity insurance provided by the PRC Subsidiaries.
		(2) None of the PRC Subsidiaries has joined the housing fund scheme prescribed under applicable PRC laws and regulations.
3.19		(1) Ma ▇▇▇▇▇ ▇▇▇▇, one of the Founders, is (i) a director of China Linong International Limited; (ii) the sole shareholder and sole director of Grow Grand Limited, which is a shareholder of China Linong International Limited; (iii) the sole director of Land V. Group Limited; (iv) a director of Land V. Limited; (v) a director of Hong Kong Linong Limited; (vi) the executive director and legal representative of each of Land V. Limited (Huizhou), Land V. Limited (Zhangjiakou), Xiamen Land V. Group Co., Ltd. and Land V. Limited (Shantou) and (vii) a shareholder and director of Winsome Group Limited, the holder of the Option.
		(2) ▇▇▇▇ ▇▇, one of the Founders, is (i) a director of China Linong International Limited; (ii) a shareholder (and her husband, ▇▇▇▇▇ ▇▇▇▇, is the other shareholder) and director of Magnetic Star Holdings Limited, which is a shareholder of China Linong International Limited; (iii) a director of Land V. Limited; (iv) the legal representative of each of Land V. Limited (Fujian) and Land V Limited (Tianjin); (v) the legal representative and executive director of each of Land V. Limited (Shenzhen), Land V. Limited (Hangzhou) and (Weifang) Land V. Limited; (vi) the legal representative and the chairman of the board of directors of Land V. Limited (Liaoyang) and (vii) a director of Hong Kong Linong Limited.
		(3) Li Jin, one of the directors of China Linong International Limited, is a shareholder (and his wife is the other shareholder) and the sole director of Natural Scent Limited, which is a shareholder of China Linong International Limited. He is also a shareholder and director of Winsome Group Limited, the holder of the Option.
		(4) ▇▇▇ ▇▇▇▇ Ho, one of the directors of China Linong International Limited, is a shareholder and director of Winsome Group Limited, the holder of the Option.
		(5) The brother-in-law of ▇▇▇ ▇▇▇▇ Ho (▇▇▇ ▇▇▇▇ Ho is one of the directors of China Linong International Limited) is the sole shareholder and director of Natural Eternity Limited, which is a shareholder of China Linong International Limited.
		(6) Ma Wan Lie, an officer of Land V. Limited (Fujian), is the sole shareholder and a director of Valuetrue Investments Limited.

Warranty reference		Disclosure
		which is a shareholder of China Linong International Limited. He is also a shareholder and director of Winsome Group Limited, the holder of the Option.
		(7) ▇▇▇▇ Lo Yin, an officer of Land V. Limited, is a shareholder of Winsome Group Limited, the holder of the Option.
		(8) Shen Nanpeng, a director of China Linong International Limited, entered into a director indemnification agreement with China Linong International Limited on 27 April 2006.
		(9) Each of Ma ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇ ▇▇, ▇▇ ▇▇▇ and Lul ▇▇▇▇ ▇▇, directors of China Linong International Limited, entered into a confidentiality, non-competition and intellectual property transfer agreement with China Linong International Limited on 27 April 2006.
		(10) The Founders entered into a series A preferred share purchase agreement with, among others, the Company, Sequoia Capital China I, L.P., Sequoia Capital China Partners Fund I, L.P. and Sequoia Capital China Principals Fund I, L.P. on 12 April 2006.
		(11) The Founders entered into a series A1 preferred share purchase agreement with, among others, the Company, Sequoia Capital China I, L.P., Sequoia Capital China Partners Fund I, L.P., Sequoia Capital China Principals Fund I, L.P., Grow Grand Limited and Honeycomb Assets Management Limited on 14 February 2007.
		(12) The Founders entered into the Series A1 Shareholders’ Agreement with, among others, the Company, the Existing Shareholders (as defined in the Series A1 Shareholders’ Agreement) and the Preferred Shareholders (as defined in the Series A1 Shareholders’ Agreement) on 14 February 2007.
		(13) Land V. Limited entered into an agreement for subcontracting operation right with ▇▇▇▇▇ ▇▇▇▇, a shareholder of Magnetic Star Holdings Limited and husband of ▇▇▇▇ ▇▇, which is a shareholder of China Linong International Limited, on 26 January 2006.
		Please refer to the specific disclosure (2) on section 3.6.
		Please refer to the specific disclosure (1) on section 3.20.
3.20		(1) The Company entered into a labor contract dated 27 April 2006 with each of Ma ▇▇▇▇▇ ▇▇▇▇ and ▇▇▇▇ ▇▇.
		List of employment agreements with senior management personnel

Warranty reference		Disclosure
		(2) Below is a list of senior management personnel (“Senior Personnel”), each of whom has signed an employment agreement with a Group Company:
This is an English		Mr. Ye Quan, Deputy General Manager of Fujian Company
translation		▇▇. ▇▇▇▇ Yongbin, Assistant to the President and the officer of the training center
		Mr. Sun Lianrong, Deputy General Manager of Tianjin Company
		▇▇. ▇▇▇ Shengren, Deputy General Manager of Huizhou Company
		▇▇. ▇▇ Qiongying, who is responsible for the management of plant protection, seeds and experiments of the Group
		▇▇. ▇▇ Yongqiang, Assistant to the President, person in charge of Shantou Base and Deputy General Manager of Zhangjiakou Company
		▇▇. ▇▇▇▇ ▇▇▇▇▇▇, Technician of the base
		(3) The Company adopted an incentive stock option plan which took effect on 22 May 2007.
		(4) The Company granted the Option to Winsome Group Limited on 23 May 2007.
3.23		As regards the decisions in relation to the operation of the PRC Subsidiaries in their ordinary course of business, generally they were made upon the oral consensus of the senior management and no written minutes have been prepared.
3.25(b)		(1) The description of the scope of business of Land V Limited (Hangzhou) as shown in its current business license and approval certificate dated 27 August 2004 is different from that in its articles of association, but the substance of the scope of business is the same.
		(2) None of the processing facilities of Land V. Limited (Fujian), (Weifang) Land V. Limited, Land V. Limited (Tianjin) and Land V. Limited (Shenzhen) has gone through the inspection and acceptance procedures by the relevant environmental protection authorities before operation of the facilities commenced.
		(3) Other than Xiamen Land V. Group Co., Ltd., Land V. Limited (Zhangjiakou), Land V. Limited (Hulzhou), Land V. Limited (Hangzhou), Land V. Limited (Shantou) and Land V. Limited (Liaoyang), all of the PRC Subsidiaries have obtained the Hygiene Permit.
		(4) Only Land V. Limited (Fujian), Land V. Limited (Hangzhou), Land V. Limited (Liaoyang) and Land V. Limited (Tianjin) have obtained the Hygiene Registration Certificate.
		Please refer to the specific disclosure (2) on section 3.15.
3.25(d)		(1) As at the date of the Agreement, only US$150,000 of the registered capital of Xiamen Land V. Group Co., Ltd. has been paid

Warranty reference		Disclosure
		up. The remaining US$850,000 has yet to be paid.
		(2) The registered capital of Land V. Limited (Liaoyang) was increased by HK$5,000,000 from HK$5,000,000 to HK$10,000,000 in January 2008. As at the date of the Agreement, only HK$8,200,000 out of the total registered capital of HK$10,000,000 has been paid. The remaining HK$3,800,000 has yet to be paid.
		(3) The registered capital of Land V. Limited (Liaoyang) as shown in its incorporation approval letter, approval certificate and articles of association is denominated in Hong Kong dollars, but the registered capital as shown in its business licence is denominated in United States dollars pursuant to the request of the PRC authority during the registration process.
		(4) Before the increase of registered capital in January 2008, the articles of association of Land V. Limited (Liaoyang) stated that its registered capital was required to be paid up by 7 October 2004, but such registered capital was only fully paid up on 22 December 2004.

This is an English Translation

Appendix

A. China Linong International Limited

No.		Date		Parties		Document
1		2006-04-06		- Magnetic Star Holdings Limited - Win Seasons Finance Ltd. - Valuetrue investments Limited - Natural Scent Limited - Grow Grand Limited - Limewater Limited - Natural Eternity Limited - Honeycomb Assets Management Limited - China Linong International Limited		Agreement for transfer of shares in Land V. Group Limited
2		2006-04-12		- China Linong International Limited - Land V. Group Limited - Land V. Limited - Land V. Limited (Fujian)		Series A preferred share purchase agreement
				- Land V. Limited (Shenzhen)
				- LandV Limited (Hangzhou)
				- LandV Limited (Tianjin)
				- Land V. Limited (Liaoyang)
				- Land V. Limited (Weifang)
				- Ma ▇▇▇▇▇ ▇▇▇▇
				- ▇▇▇▇ ▇▇
				- Sequoia Capital China I, L.P.
				- Sequoia Capital China Partners Fund I, L.P.
				- Sequoia Capital China Principals Fund I, L.P.
3		2007-02-14		- China Linong International Limited - Land V. Group Limited - Land V. Limited		Series Al preferred share purchase agreement
				- Hong Kong Linong Limited
				- Land V. Limited (Fujian)
				- Land V. Limited (Shenzhen)
				- LandV Limited (Hangzhou)
				- LandV Limited (Tianjin)
				- Land V. Limited (Liaoyang)
				- Land V. Limited (Weifang)
				- Land V. Limited (Huizhou)
				- Land V. Limited (Zhangjiakou)
				- Ma ▇▇▇▇▇ ▇▇▇▇
				- ▇▇▇▇ ▇▇
				- Sequoia Capital China I, L.P.
				- Sequoia Capital China Partners Fund I, L.P.
				- Sequoia Capital China Principals Fund I, L.P.
				- Grow Grand Limited
				- Honeycomb Assets Management Limited
4		2006-04-06		- Magnetic Star Holdings Limited - Win Seasons Finance Ltd. - Valuetrue Investments Limited		Shareholders’ Agreement relating to China Linong International Limited
				- Natural Scent Limited
				- Grow Grand Limited
				- Limewater Limited
				- Natural Eternity Limited
				- Honeycomb Assets Management Limited

Appendix

No.		Date		Parties		Document
				- China Linong International Limited
5		2006-04-27		- Ma ▇▇▇▇▇ ▇▇▇▇		Deed of termination
				- ▇▇▇▇ ▇▇
				- ▇▇▇▇▇ ▇▇▇▇
				- ▇▇▇ ▇▇
				- Law Kin Ip
				- Fu ▇▇▇▇ ▇▇▇
				- ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇
				- Ma Wen Lie
				- ▇▇▇▇ ▇▇▇▇▇▇▇▇
				- Li Jin
				- ▇▇ ▇▇▇▇
				- Magnetic Star Holdings Limited
				- Win Seasons Finance Ltd,
				- Valuetrue Investments Limited
				- Natural Scent Limited
				- Grow Grand Limited
				- Limewater Limited
				- Natural Eternity Limited
				- Honeycomb Assets Management Limited
				- China Linong International Limited
6		2006-04-27		- China Linong International Limited		Shareholders agreement
				- Land V. Group Limited
				- Land V. Limited
				- Land V. Limited (Fujian)
				- Land V. Limited (Shenzhen)
				- LandV Limited (Hangzhou)
				- LandV Limited (Tianjin)
				- Land V. Limited (Liaoyang)
				- Land V. Limited (Weifang)
				- Grow Grand Limited
				- Magnetic Star Holdings Limited
				- Limewater Limited
				- Natural Eternity Limited
				- Valuetrue Investments Ltd.
				- Win Seasons Finance Ltd.
				- Honeycomb Assets Management Ltd.
				- Natural Scent Limited
				- Ma ▇▇▇▇▇ ▇▇▇▇
				- ▇▇▇▇ ▇▇
				- Sequoia Capital China I, L.P.
				- Sequoia Capital China Partners Fund I, L.P.
				- Sequoia Capital China Principals Fund I, L.P.
7		2007-02-14		- China Linong International Limited		Shareholders agreement
				- Land V. Group Limited
				- Land V. Limited
				- Hong Kong Linong Limited
				- Land V. Limited (Fujian)
				- Land V. Limited (Shenzhen)
				- LandV Limited (Hangzhou)
				- LandV Limited (Tianjin)
				- Land V. Limited (Liaoyang)